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  1 
Thesis Overview 
 
Chapter I. General Introduction 
The first chapter is a general introduction of organocatalysis dealing with the concept and 
mechanisms. The most representative activation modes of aminocatalysis are presented 
in this chapter, as some of them will be exploited in this thesis. The last part gives a brief 
introduction of immobilized catalysts and continuous flow chemistry. 
 
Chapter II. H-Bond-Directing Dienamine 
 
In Chapter II, an efficient, highly regio- and stereoselective [4+2] cycloaddition between 
alkylidene pyrazolones and enals through H-bond-directing dienamine catalysis has been 
developed. This methodology enables the synthesis of enantioenriched, 
multifunctionalized tetrahydropyranopyrazole derivatives with three contiguous 
stereocenters in good yields and excellent enantioselectivities.  
 
Chapter III. A Robust Immobilized Isothiourea Catalyst 
 
A polystyrene-supported (PS) isothiourea behaves as a robust, highly efficient 
organocatalyst in a variety of formal [4+2] cycloaddition reactions, that provide an 
efficient approach to access a series of highly versatile, six-membered heterocycles and 









up to 89% yield 
         99% ee
         13:1 dr



















































up to 91% yield











convenient yield. In comparison to its homogeneous counterpart, the immobilized 
isothiourea catalyst displays higher stereoselectivity and can be recycled for at least 11 
runs as well as applied in continuous flow process.
 
Chapter IV. Catalytic Enantioselective [8+2] Cycloaddition 
 
In this chapter, we report an asymmetric periselective [8+2] higher-order cycloaddition 
between chiral ammonium enolates and azaheptafulvenes catalyzed by an immobilized 
isothiourea catalyst. The resulting [8+2] cycloadducts can also undergo completely 
regioselective [4+2] cycloaddition with active dienophiles to afford bridged polycyclic 
products in a straightforward manner. 
 
Chapter V. Dual Catalytic System 
 
The cascade deoligomerization/cross-aldol reactions of electron-poor benzaldehydes or 
η6-benzaldehyde Cr(CO)3 complex with paraldehyde can be promoted by a dual catalytic 
system, which operates under site isolation conditions in a recyclable manner. In addition, 
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In organic chemistry, chemical reactions that are promoted by substoichiometric amounts 
of organic molecules are designated as organocatalyzed.[1] In the last twenty years, 
organocatalysis has become a thriving field, finding broad application in asymmetric 
transformations. Synthesis of enantiopure molecules having multiple chiral centers is one 
of the ultimate goals in organic chemistry due to their importance in a pharmaceutical 
context.[2] As a result, organocatalysts play pivotal roles in the preparation of complex 
and enantiopure molecular scaffolds owing to their efficient and selective catalytic 
properties.[3]  
 
In 1832, Wöhler and Liebig reported the first organocatalyzed benzoin reaction for the 
construction of α-hydroxyl ketone by employing cyanide as organocatalyst (Scheme 
1.1).[4]  
 
Scheme 1.1. First example of organocatalysis  
 
Until the middle of the twentieth century, only sporadic examples of asymmetric 
organocatalytic reactions appeared. Bredig and Fiske demonstrated the first asymmetric 
organocatalytic reaction for asymmetric addition of HCN to benzaldehyde, although only 
poor enantioselectivity could be achieved.[5] In 1960, Pracejus described an 
organocatalytic methanolysis reaction by using chiral O-acetylquinine as catalyst, 
affording the desired ester product in moderate enantioselectivity (74% ee).[6] In this 
report, one German terminology “Organische Katalysatoren” employed by the author, is 
a likely ancestor of what nowadays is termed “organocatalysis” by scientists. 
 
The major breakthrough in the field of organocatalysis was achieved in the 1970s. The 
transformation, better known as Hajos-Parrish-Eder-Sauer-Wiechert reaction,[7] consists 
in using L-proline to catalyze the intramolecular aldol condensation reaction, giving the 








Wöhler and Liebig, 1832
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Scheme 1.2. Hajos-Parrish-Eder-Sauer-Wiechert reaction 
Subsequently, the potential of organocatalysis was largely neglected in the next twenty 
years, despite the pioneering efforts achieved by these industrial chemists. Until the late 
1990s, a few examples of organocatalysis appeared. Shi and co-workers described an 
enantiopure ketone-catalyzed highly enantioselective epoxidation reaction of simple 
olefins.[8] The Jacobsen and Corey groups independently reported the first examples of 
hydrogen-bonding catalysis for asymmetric Strecker reaction (Scheme  1.3).[9]  
 
Scheme 1.3. Some representative pioneering work of organocatalysis 
 
At the turn of the 21st century, the field of organocatalysis was effectively revived by two 
seminal studies: one from the List, Barbas and Lerner on intermolecular aldol reactions 
via enamine catalysis[10] and the other from MacMillan et al. on the Diels-Alder reaction 
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Scheme 1.4. Asymmetric organocatalyzed aldol reaction and Diels-Alder cycloaddition 
 
Since the concept of organocatalysis was firmly established by these pioneering reports, 
a variety of organocatalysts have been developed in various asymmetric reactions. In 
general, organocatalysts can be divided into different categories according to the 
interaction of catalyst with substrate: covalent bond, noncovalent interactions (such as 
hydrogen bonding) and electrostatic ion pair interactions.[1, 4] Some representative 
organocatalysts are shown in Figure 1.1. 
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As one of the most important types of covalent organocatalysts, aminocatalysis is 
nowadays considered as a powerful synthetic tool for the chemo- and enantioselective 
functionalization of carbonyl compounds such as aldehydes and ketones. According to 
the activation mode, aminocatalysts are widely divided in three types, HOMO (highest 
occupied molecular orbital) activation,[12] LUMO (lowest unoccupied molecular orbital) 
activation[13] and SOMO (singly occupied molecular orbital) activation.[14] 
 




The general strategy of enamine catalysis is based on the condensation between an 
aminocatalyst and a carbonyl compound.[15] The resulting transient enamine intermediate 
can attack electrophiles to afford the corresponding a-functionalized carbonyl 
compounds (Scheme 1.5). 
 
Scheme 1.5. Enamine catalysis 
 
The pioneering research by Woodward, Wieland and Miescher in 1950s on the steroid 
total synthesis showed the potential of enamine catalysis for activation of carbonyl 
compounds (Scheme 1.6).[16] 
 
Scheme 1.6. Woodward-Wieland-Miescher enamine cyclization 
 
Since the first example of asymmetric intramolecular aldol reaction reported by Hajos et 
al. (Scheme 1.2), the application of asymmetric enamine catalysis in natural product 
synthesis was also explored. In 1976, Danishefsky and co-workers successfully extended 
the use of chiral amino acids as enamine catalysts in the asymmetric synthesis of estrone 






































Scheme 1.7. Asymmetric intramolecular aldol reaction 
To understand the mechanism of enamine catalysis in aldol reactions, many groups 
carried out mechanistic studies, proposing different transition states for the aldol reactions 
during this period (Figure 1.3).[18] 
 




The concept of dienamine catalysis was first introduced by Jørgensen and co-workers for 
the direct asymmetric g-amination of a,b-unsaturated aldehydes in 2006.[19] At the outset 
of this study, a chiral secondary amine catalyst was shown to activate 2-pentenal in the 
form of an electron-rich dienamine species which is in equilibrium with the iminium-ion 
intermediate. The g-amination reaction proceeded smoothly between the diethyl 
azodicarboxylate and the chiral dienamine formed in situ with the catalyst, affording the 
g-functionalized products in good yields and enantioselectivities. Subsequent 
investigation by means of computational calculations indicated that g-amination of a,b-
unsaturated aldehydes might proceed through a hetero-Diels-Alder cycloaddition reaction 
(Scheme 1.8). 











































Scheme 1.8. g-Amination of a,b-unsaturated aldehydes by dienamine catalysis 
 
In 2012, the same group described a novel [2+2] cycloaddition reaction based on the 
combination of a H-bond-directing and dienamine catalysis (Scheme 1.9).[20] To achieve 
this dual activation strategy, they designed a new bifunctional squaramide aminocatalyst 
derived from optically active 2-aminomethylpyrrolidine. The H-bond donor of the dual 
catalyst could control the electrophilic substrates while the secondary amine of the 
catalyst simultaneously activated the unsaturated aldehydes via dienamine catalysis, 
providing the desired product in high yields and excellent diastereo- and 
enantioselectivities.  
 
Scheme 1.9. H-bond directing and dienamine Catalysis 
 
In Chapter II, we report an asymmetric [4+2] cycloaddition catalyzed by a H-bond-




The first example of trienamine catalysis was reported by Chen and Jørgensen, when they 
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(Scheme 1.10).[21] The reaction employed trienamine intermediates that were in situ 
generated from optically active secondary amines, affording highly complex molecular 
structures with excellent stereoselectivities. It should be noted that the trienamine 
activation showed a perfect stereocontrol relay over a distance of up to eight bonds. 
 
Scheme 1.10. Diels-Alder reaction of trienamine catalysis 
 
Shortly after the linear trienamine catalysis work, the Jørgensen group developed the first 
cross trienamine catalysis by activation of g´,d-carbon centers of cyclic dienals in Diels-
Alder reaction (Scheme 1.11).[22] In addition, they also reported highly g´-selective 
additions with polarized vinyl bis-sulfones, providing the desired product in a highly 
stereoselective manner. Further computational calculation and NMR analysis of 
intermediates suggested that the reaction is thermodynamically driven. 
 









































































Jørgensen et al. 2012
Chapter I 
 11 




The iminium-ion catalysis was first reported by MacMillan in 2000 for the asymmetric 
Diels-Alder reaction of unsaturated aldehydes with dienes.[11] The iminium-ion 
intermediate, generated from the condensation of a chiral amine and an enal, enables the 
attack of nucleophiles to the b-position of unsaturated carbonyl compounds (Scheme 
1.12). Based on this powerful strategy, numerous types of reactions such as Friedel-Crafts, 
hydride reduction, cyclopropanation, conjugate amination, epoxidation reaction have 
been achieved in an asymmetric manner.[23] 
 
 




In 2012, Melchiorre and co-workers developed the concept of asymmetric vinylogous 
iminium-ion catalysis in 1,6-addition of alkyl thiols to cyclic dienones.[24] In this strategy, 
the condensation between a cinchona-based primary amine and 2,4-unsaturated carbonyl 
compounds led to the formation of an iminium ion intermediate of extended conjugation 
(Scheme 1.13). The d-carbon atom of this vinylogous iminium-ion intermediate presents 
higher electrophilicity than that of the cyclic dienone substrate, providing the 1,6-addition 
products with high stereocontrol and excellent enantioselectivities (Scheme 1.14).  
 



































Scheme 1.14. 1,6-Addition of alkyl thiols to cyclic dienones via vinylogous iminium-
ion catalysis 
 
1.1.3. SOMO Activation 
 
The SOMO (singly occupied molecular orbital) activation mode was first introduced by 
the MacMillan group in 2007.[25] SOMO catalysis is based on the generation of a three π-
electrons radical cation resulting from single electron oxidation of an electron-rich 
enamine. This highly reactive intermediate can be attacked at the a-carbon of the 
aldehyde by weak carbon nucleophiles. For example, they demonstrated the direct 
asymmetric allylic alkylation reaction of different aldehydes by using 
allyltrimethylsilanes as the SOMO nucleophiles and ceric ammonium nitrate (CAN) as 
the single-electron-transfer oxidant, affording the corresponding a-allylation products in 
very good selectivity. Moreover, SOMO catalysis has also been applied in asymmetric 
a-allylation, a-enolation, a-vinylation and a-heteroarylation transformations (Scheme 
1.15).[26] 
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1.1.4. Ammonium Enolates  
 
Ammonium enolates, another powerful tool in aminocatalysis, are prepared by the 
reaction of tertiary amines (R3N) and various electrophilic substrates including 
anhydrides, acyl halides α-halocarbonyls, and a,b-unsaturated carbonyls.[27] According 
to the number of atoms between the enolate oxygen atom and the Lewis base catalyst, 
ammonium enolates can be divided in C1-, C2- and C3-ammonium enolates (Figure 1.4). 
This thesis will focus on the C1-ammonium enolates. 
 
Figure 1.4. Classification of ammonium enolates 
  
Since the earliest work of ammonium enolates carried out by Sauer in 1947,[28] many 
synthetic efforts have been achieved over the past decades. In 1982, Wynberg and co-
workers reported the organocatalytic asymmetric aldol lactonization by using cinchona 
alkaloid as catalyst, affording the corresponding b-lactone in high yield and 
enantioselectivity (Scheme 1.16).[29]   
 
Scheme 1.16. b-Lactone synthesis mediated by ammonium enolate 
 
Inspired by the work of Wynberg, many groups have utilized ketenes as precursors for 
ammonium enolates in the synthesis of b-lactones and b-lactams.[30] The general catalytic 
cycle for these reactions proceeds through initial attack of the nucleophilic amine catalyst 
to the ketene electrophile, forming the ammonium enolate species A. The resulting 
zwitterion A undergoes conjugate addition (B), followed by cyclization, giving the 
































Scheme 1.17. Mechanism of b-lactones and b-lactams formation 
 
Recently, the development of cheap and highly stable alternative precursors to play the 
role of the unstable ketenes in the in situ generation of ammonium enolates attracted much 
attention. These alternative precursors include carboxylic acids, esters, acid chlorides and 
anhydrides, which are easily prepared, bench stable and user friendly.[31] In Chapter III 
and Chapter IV, we will focus on the use of carboxylic acids as precursors for ammonium 
enolates in various formal [4+2] and [8+2] cycloadditions. 
 
Figure 1.5. Different precursors for generation of C1-ammonium enolates 
 
1.2. Immobilized Catalysts 
 
The sharp increase of the demand for efficient and environmentally acceptable industrial 
processes has led to the immobilization of homogeneous catalysts.[32] These immobilized 
catalysts can be separated easily from the reaction mixture and reused several times. In 
addition, they provide the possibility of continuous flow operation and represent a cost-
















































activity, compared to its homogeneous counterpart, while having the reusability of a 
heterogeneous catalyst. In general, the immobilization of homogeneous catalysts can be 
achieved by two main strategies: covalent binding and non-covalent interactions.[33] 
 
Non-covalent interactions include adsorption (van der Waals forces), electrostatic or ionic 
interactions, and entrapment.[34] This approach of immobilization does not need re-
designing the catalyst but only limited applications can be achieved owing to the weak 
interactions. For example, immobilization of catalysts through adsorption tends to suffer 
from catalyst leaching, which leads to reduction in catalytic efficiency. 
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Covalent binding is the most common strategy of immobilization and provides broad 
applicability due to the stability of the resulting material in many reactions and work-up 
conditions. This strategy usually requires re-designing the catalyst to link it to a suitable 
support, commonly silicas, nanotubes, inorganic oxides or organic polymers. Over the 
past decades, our group has focused on the development of different polystyrene 
supported (PS) ligands and organocatalysts; some representative supported catalysts are 
shown in Figure 1.6. Chapters III and Chapters IV of this thesis will show the application 
of PS-benzotetramisole (BTM) catalyst. On the other hand, a dual catalytic system of two 
immobilized catalysts will be shown in Chapters V. 
 
1.3. Continuous Flow Methodology 
 
One of the main advantages of using immobilized catalysts is the possibility of 
implementing continuous flow processes. Compared with conventional batch synthesis, 
continuous flow features safe operation, cost-effectiveness, easy scale up and precise 
control of reaction conditions.[35] These advantages make it an attractive solution for 
industrial operation and large scale preparation.  
 
Continuous flow synthesis is achieved by pumping the initial reactants through the reactor 
and flowing out the product in a continuous manner. By the use of packed-bed columns 
for loading immobilized catalyst, the separation and recovery of the catalyst can be easily 
achieved in a single operation. In addition, no mechanical stirring is required in 
continuous flow processes, which could increase the service lifetime of the immobilized 
catalyst. Several applications of continuous flow with various of immobilized catalysts 
have been achieved in our group.[36] One application of continuous flow is shown in 
Figure 1.7 and Chapter III, in which an asymmetric formal [4+2] cycloaddition reaction 
catalyzed by a supported isothiourea catalyst has been successfully set up. 
 
























1.4. Aim of the thesis 
 
The discovery and design	 of organocatalysts for the efficient preparation of useful 
enantiopure compounds represents an important goal in organocatalysis. When 
asymmetric processes are concerned, the recycle and reuse of organocatalysts and 
implementation of continuous flow processes have attracted more attention due to many 
advantages.  
 
The aim of the present thesis includes two main sections: (a) studies towards the synthesis 
of organocatalysts especially polymer-supported ones in asymmetric transformations and 
their application in recycling experiments and continuous flow processes. (b) the 
development of new transformations for highly selective bond formations that will enable 
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H-Bond-Directing Organocatalyst for Asymmetric [4+2] 




The synthesis of optically active pyrazolones and their derivatives has attracted a great 
deal of attention due to their occurrence in many natural products and bioactive 
compounds. For instance, phenazone A and B are known as an effective analgesic and 
antipyretic agent, and the pyrazolone derivative C possesses potent activity in inhibiting 
p38 kinases. In addition, the tetrahydropyranopyrazole (THPP) of the type D and the 
trifluoromethylated analogue E are used as fungicide and AMPA receptor activity 
enhancer, respectively. Compound F is well known as a potential inhibitor of human 
Chk1 kinase (Figure 2.1).[1] As a result, many synthetic efforts have been devoted to the 
synthesis of functionalized pyrazolones.[2] Nevertheless, the catalytic asymmetric 
synthesis of fuctionalized tetrahydropyranopyrazoles (THPPs) or dihydropyrano-
pyrazolones (DHPPOs) has been less explored. 
 
Figure 2.1. Biologically active pyrazoles and pyranopyrazoles 
 
In 2012, Enders and co-workers developed a Michael/Wittig cascade reaction catalyzed 








































stereoselectivities.[3] Shortly after, Wang and co-workers disclosed an asymmetric b,g-
selective [4+2] cycloaddition for the enantioselective construction of functionalized 
THPPs.[4] As for the preparation of DHPPOs, the Ye and Biju groups demonstrated N-
heterocyclic carbene (NHC) catalyzed enantioselective annulations for the synthesis of 
these scaffolds, respectively (Scheme 2.1).[5] Despite these approaches to chiral THPPs, 
the development of an efficient methodology to access multifunctionalized and highly 
enantioenriched THPP frameworks bearing multiple stereocentres is still a challenging 
endeavor. 
 





















up to 88% yield
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Ar = 3,5-(CF3)2C6H3
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HOMO-raised dienamine species generated upon the condensation of a chiral amine 
catalyst and α,β-unsaturated aldehyde, have performed as dienophiles or dienes in various 
cycloaddition reactions. An excellent example of dienamine species playing the role of 
diene was reported by the Vicario group in 2012[6]. In this case, the dienamine 
intermediate undergoes a Diels-Alder/elimination cascade reaction and results in a highly 
efficient dynamic kinetic resolution process. 
 
Scheme 2.2. Dynamic kinetic resolution process of dienamine catalysis 
 
In 2012, the Jørgensen group first reported H-bond-directing dienamine catalysis by 
inverting the inherent reactivity of a,b-unsaturated aldehydes, which acted as dienophiles 
for the inverse-electron-demand hetero-Diels–Alder (IEDHDA) reactions.[7] This 
strategy based on employing a bifunctional H-bond-directing catalyst, which could carry 
out simultaneous activation of an a,b-unsaturated aldehyde via dienamine formation and 
recognize the heterodiene system by H-bonding interation (Scheme 2.3). 
 
Scheme 2.3. Dienamine-mediated asymmetric [4+2] cycloaddition 
 
To explain the stereochemical outcome, they proposed a transition state model and the 
plausible reaction mechanism depicted in Scheme 2.4. The two reagents are activated 
independently: the a,b-unsaturated aldehyde through HOMO activation and the b,g-
unsaturated a-ketoester through LUMO lowering, which in addition fixes the geometry 
of the approach thanks to the H-bond-directing interaction. Notably, the authors 
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up to 94% yield
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up to 82% yield
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postulated p-stacking interactions between the aromatic moieties of the heterodiene and 
the dienamine intermediate may play an important role to stabilize the transition state. 
 
Scheme 2.4. Plausible reaction mechanism of dienamine catalysis 
 
Later, the Chen group demostrated the asymmetric IEDHDA reaction of 1-aza-1,3-buta-
dienes with α,β-unsaturated aldehydes by employing dienamine catalysis.[8] The reaction 
exhibits excellent regioselectivity, producing the fused piperidine derivatives in good 
yields and high stereoselectivities. 
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2.2. Aim of the Project 
 
Despite the previous approaches to chiral DHPPOs and THPPs, dienamine catalysis for 
the conversion of unsaturated pyrazolones has never been reported, although it is a 
potentially useful approach for the construction of THPPs bearing multiple stereocenters. 
In this project, we aim to employ a bifunctional H-bond-directing aminocatalyst to 
activate the α,β-unsaturated aldehydes and  alkylidene pyrazolones, affording the 
fuctionalized THPPs in a highly stereoselectivitive manner (Scheme 2.6). 
 
Scheme 2.6. Dienamine activation strategy for the synthsis of chiral THPPs 
 
With this in mind, we decided to prepare a series of H-bond-directing aminocatalysts for 
the [4+2] cycloaddition between α,β-unsaturated aldehydes and alkylidene pyrazolones. 
The bifunctional aminocatalysts for this reaction is shown in Figure 2.2. 
 
Figure 2.2. H-bond-directing aminocatalyst for [4+2] cycloaddition of alkylidene 
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1. General information 
 
Unless otherwise stated, all commercial reagents were used as received. Flash chromatography 
was carried out using 60 mesh silica gel and dry-packed columns. Thin layer chromatography 
was carried out using Merck TLC Silicagel 60 F254 aluminum sheets. Components were 
visualized by UV light (λ = 254 nm) and stained with p-anisaldehyde or phosphomolybdic dip. 
NMR spectra were registered in a Bruker Advance 400 Ultrashield spectrometer in CDCl3 at room 
temperature, operating at 300 or 400 MHz (1H) and 75 or 100 MHz (13C). TMS was used as 
internal standard for 1H NMR and CDCl3 for 13C NMR. Chemical shifts are reported in ppm 
referred to TMS. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Elemental 
analyses of the polystyrene supported catalysts were performed on a LECO CHNS 932 micro-
analyzer at the Universidad Complutense de Madrid, Spain. High performance liquid 
chromatography (HPLC) was performed on an Agilent Technologies chromatograph (1100 
Series), using Chiralcel columns and guard columns.  
 
2. General procedure for the preparation of α, β-unsaturated aldehydes 
 
Different α, β-unsaturated aldehydes were prepared according to the literature procedure.1 
(E)-4-(3,4-Dimethoxyphenyl)but-2-enal 
1H NMR (400 MHz, CDCl3): δ = 3.59 (dd, J = 1.6, 6.8 Hz, 2H), 3.87 
(s, 6H), 6.08 (tdd, J = 1.6, 8.0, 15.6 Hz, 1H), 6.68-6.74 (m, 2H), 6.83-
6.85 (m, 1H), 6.94 (td, J = 6.8, 15.6 Hz, 1H), 9.54 (d, J = 8.0 Hz, 1H); 
13C NMR (100 MHz, CDCl3): δ = 38.6, 55.9, 56.0, 111.5, 112.0, 120.9, 129.5, 133.3, 148.1, 149.2, 
156.7, 193.8. 
 
3. General procedure for the preparation of catalysts 1h and 1i 
 


















































1h: Ar = Ph








White solid, Melting point: 201-203 ºC. 1H NMR [400 MHz, (CD3)2SO]: 
δ = 1.36-1.41 (m, 1H), 1.74-1.82 (m, 1H), 2.85 (d, J = 11.2 Hz, 1H), 3.01 
(dd, J = 4.0, 11.2 Hz, 1H), 4.18 (s, 1H), 4.84 (dd, J = 7.2, 8.8 Hz, 1H), 
7.42-7.58 (m, 5H), 7.68 (dd, J = 1.6, 8.4 Hz, 1H), 7.77-7.82 (m, 4H), 
7.91-7.97 (m, 2H), 8.14 (s, 1H), 8.29 (s, 1H); 13C NMR [100 MHz, 
(CD3)2SO]: δ = 36.5, 55.3, 62.6, 70.7, 77.8, 123.5, 124.4, 124.6, 125.7, 125.8, 125.9 (2C), 126.1, 
127.2, 127.3 (2C), 127.4, 128.1, 128.2, 131.6, 131.7, 132.7, 132.7, 143.7, 144.7; IR (ATR): ν = 
696, 743, 829, 1006, 1095, 1183, 1401, 1485, 1598, 1641, 2946, 3028, 3297, 3049 cm-1; HRMS 
calcd. for C25H24NO2 (M + H)+: 370.1802, found: 370.1795; [α]D25 = -116.3 (c = 0.1, MeOH). 
 
4. General procedure for the [4+2] cycloaddition reaction 
 
To a solution of the (Z)-arylidenylpyrazolone3 2 (0.15 mmol, 1.0 equiv.) in toluene (1.5 mL) were 
added the α,β-unsaturated aldehyde 3 (0.3 mmol, 2.0 equiv.) and catalyst 1i (0.015 mmol, 10 
mol%). The reaction mixture was stirred at room temperature and monitored by 1H NMR 
spectroscopy. After the given reaction time, solvent removal in vacuo gave the crude product 4, 
which was directly purified by flash chromatography (FC). The yield of cycloaddition product 4 
and diastereomeric ratio were determined at this stage.  
 
To determine the enantiomeric excess, the cycloaddition products 4 were transformed to the 
corresponding alcohol. To a solution of purified cycloaddition product 4 in DCM/MeOH (2:1, 
1.5 mL) was added NaBH4 (11.4 mg, 0.3 mmol) at 0 ºC and the mixture was stirred for 30 minutes. 
After that, the solvent was removed under vacuum and the residue was diluted with EtOAc (20 
mL). The solution was sequentially washed with sat. aq. NH4Cl (5.0 mL) and water (10.0 mL). 
The organic phase was dried with anhydrous Na2SO4, concentrated under vacuum and subjected 
to purification by FC to give the corresponding alcohol 4´. The physical data and the enantiomeric 


















































aReactions performed on a 0.1 mmol scale. bDetermined by 1H NMR spectroscopy. cDetermined 




White solid, melting point: 149-151 ºC. 1H NMR (400 MHz, CDCl3): δ = 
1.67 (s, 3H), 2.46 (ddd, J = 1.3, 3.3, 17.0 Hz, 1H), 2.72 (ddd, J = 2.5, 8.8, 
17.0 Hz, 1H), 2.95 (t, J = 10.4 Hz, 1H), 4.12 (d, J = 10.4 Hz, 1H), 5.10 (ddd, 
J = 3.3, 8.8, 10.5 Hz, 1H), 6.89-6.96 (m, 4H), 7.13-7.15 (m, 3H), 7.21-7.26 
(m, 4H), 7.39-7.43 (m, 2H), 7.74-7.76 (m, 2H), 9.71 (dd, J = 1.2, 2.3 Hz, 1H); 
13C NMR (100 MHz, CDCl3): δ = 13.5, 45.7, 47.1, 54.2, 78.7, 100.4, 120.0 
(2C), 125.4, 126.8, 127.6, 128.1 (2C), 128.2 (2C), 128.4 (2C), 129.0 (2C), 129.0 (2C), 138.4, 
138.6, 141.0, 147.0, 150.0, 198.6; IR (ATR): ν = 691, 755, 928, 1045, 1123, 1391, 1454, 1492, 






























Entry Cat. Loading (mol%) 
Concentration 
(M) 2/3 Ratio Conv. (%)
b ee (%)c 
1 20 0.1 1:2 >90 88 
2 10 0.1 1:2 >90 90 
3 5 0.1 1:2 71 86 
4 10 0.2 1:2 >90 84 
5 10 0.05 1:2 73 90 
6 10 0.1 1:1.5 81 87 
7 10 0.1 1:1 70 86 









6. Characterization Data 
2-((4R,5R,6R)-3-Methyl-1,4,5-triphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazol-6-yl) 
ethanol 
Cycloaddition product 4a was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 80% yield (49.1 mg) as a mixture 
of diastereoisomers (8:1); the corresponding alcohol 4a´ was isolated by FC 
on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 83% yield 
(41.5 mg) as a single diastereoisomer for enantiomeric excess determination. 
White solid, melting point: 193-195 ºC. 1H NMR (400 MHz, CDCl3): δ = 
1.62-1.65 (m, 1H), 1.67 (s, 3H), 1.69-1.70 (m, 1H), 1.74-1.83 (m, 1H), 2.87 (t, J = 10.4 Hz, 1H), 
3.76-3.86 (m, 2H), 4.03 (d, J = 10.0 Hz, 1H), 4.73 (td, J = 2.4, 10.0 Hz, 1H), 6.88-6.93 (m, 4H), 
7.12-7.13 (m, 3H), 7.14-7.25 (m, 4H), 7.42-7.46 (m, 2H), 7.77-7.79 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 13.5, 36.1, 46.0, 54.8, 59.4, 81.7, 100.5, 120.1 (2C), 125.4, 126.6, 127.1, 128.1 (4C), 
128.4 (2C), 128.7 (2C), 129.0 (2C), 138.7, 139.4, 141.3, 147.2, 150.4; IR (ATR): ν = 698, 753, 
935, 1044, 1128, 1390, 1455, 1492, 1513, 1598, 1610, 2960, 3341 cm-1; HRMS calcd. for 
C27H27N2O2 (M + H)+: 411.2067, found: 411.2064; [α]D25 = -92.0 (c = 0.1, CHCl3); HPLC 
(Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 254 nm, 90% ee): 




Cycloaddition product 4b was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 10:1) in 78% yield (56.9 mg) as a mixture 
of diastereoisomers (9:1); the corresponding alcohol 4b´ was isolated by FC 
on silica (eluting with cyclohexane/EtOAc from 8:1 to 5:1) in 82% yield 
(47.1 mg) as a single diastereoisomer for structural characterization and 
enantiomeric excess determination. White solid, melting point: 190-191 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.60-1.67 (m, 2H), 1.69 (s, 3H), 1.73-1.82 (m, 1H), 2.80 (t, J = 
10.0 Hz, 1H), 3.75-3.85 (m, 2H), 4.02 (d, J = 10.4 Hz, 1H), 4.72 (td, J = 2.4, 10.0 Hz, 1H), 6.75 
(d, J = 8.0 Hz, 2H), 6.91-6.92 (m, 2H), 7.21-7.27 (m, 6H), 7.40-7.45 (m, 2H), 7.76-7.78 (m, 2H); 
13C NMR (100 MHz, CDCl3): δ = 13.7, 36.0, 45.6, 54.8, 59.3, 81.5, 99.9, 120.1 (2C), 120.5, 125.5, 
127.4, 128.4 (2C), 128.9 (2C), 129.1 (2C), 129.8 (2C), 131.3 (2C), 138.6, 139.0, 140.6, 146.8, 
150.5; IR (ATR): ν = 692, 754, 934, 1044, 1129, 1391, 1441, 1486, 1514, 1660, 1610, 2923, 3331 
cm-1; HRMS calcd. for C27H26BrN2O2 (M + H)+: 489.1172, found: 489.1152; [α]D25 = -162.9 (c 
= 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ 


















Cycloaddition product 4c was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 75% yield (49.8 mg) as a mixture 
of diastereoisomers (10:1); the corresponding alcohol 4c´ was isolated by FC 
on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 72% yield 
(36.5 mg) as a single diastereoisomer for structural characterization and 
enantiomeric excess determination. White solid, melting point: 197-198 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.60-1.66 (m, 1H), 1.69 (s, 3H), 1.71-1.81 (m, 2H), 2.80 (t, J = 
10.4 Hz, 1H), 3.74-3.86 (m, 2H), 4.02 (d, J = 10.0 Hz, 1H), 4.71 (td, J = 2.4, 10.0 Hz, 1H), 6.80 
(d, J = 8.0 Hz, 2H), 6.90-6.91 (m, 2H), 7.10 (d, J = 8.4 Hz, 2H), 7.19-7.25 (m, 4H), 7.43 (t, J = 
8.4 Hz, 2H), 7.76-7.77 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.6, 36.0, 45.5, 54.8, 59.2, 
81.5, 100.0, 120.1 (2C), 125.5, 127.3, 128.4 (4C), 128.8 (2C), 129.1 (2C), 129.4 (2C), 132.3, 
138.6, 139.0, 140.0, 146.9, 150.5; IR (ATR): ν = 637, 754, 934, 1045, 1088, 1130, 1391, 1455, 
1489, 1515, 1612, 2956, 3323 cm-1; HRMS calcd. for C27H26ClN2O2 (M + H)+: 445.1677, found: 
445.1669; [α]D25 = -140.4 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (90:10), 




Cycloaddition product 4d was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 9:1) in 81% yield (52.3 mg) as a mixture of 
diastereoisomers (8:1); the corresponding alcohol 4d´ was isolated by FC on 
silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 75% yield (39.9 
mg) as a single diastereoisomer for structural characterization and 
enantiomeric excess determination. White solid, melting point: 176-178 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.61-1.66 (m, 1H), 1.68 (s, 3H), 1.71-1.80 
(m, 2H), 2.80 (t, J = 10.0 Hz, 1H), 3.72-3.85 (m, 2H), 4.00 (d, J = 10.4 Hz, 1H), 4.71 (td, J = 2.8, 
10.0 Hz, 1H), 6.80-6.91 (m, 6H), 7.17-7.25 (m, 4H), 7.43 (t, J = 8.4 Hz, 2H), 7.75-7.78 (m, 2H); 
13C NMR (100 MHz, CDCl3): δ = 13.5, 36.0, 45.3, 54.9, 59.1, 81.5, 100.2, 115.0 (d, J = 21.3 Hz, 
2C), 120.1 (2C), 125.5, 127.2, 128.3 (2C), 128.7 (2C), 129.0 (2C), 129.4 (d, J = 7.8 Hz, 2C), 
137.0 (d, J = 3.1 Hz), 138.6, 139.1, 146.9, 150.4, 161.6 (d, J = 244.7 Hz); IR (ATR): ν = 704, 
754, 935, 1047, 1131, 1221, 1393, 1455, 1508, 1599, 2924, 2958, 3314 cm-1; HRMS calcd. for 
C27H26FN2O2 (M + H)+: 429.1973, found: 429.1985; [α]D25 = -55.6 (c = 0.1, CHCl3); HPLC 
(Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 254 nm, 90% ee): 





















Cycloaddition product 4e was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 77% yield (48.8 mg) as a 
mixture of diastereoisomers (8:1); the corresponding alcohol 4e´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 
6:1) in 78% yield (38.6 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, 
melting point: 169-170 ºC. 1H NMR (300 MHz, CDCl3): δ = 1.60-1.64 (m, 
1H), 1.68 (s, 3H), 1.70-1.82 (m, 2H), 2.25 (s, 3H), 2.84 (t, J = 10.2 Hz, 1H), 3.74-3.85 (m, 2H), 
3.98 (d, J = 10.2 Hz, 1H), 4.70 (m, 1H), 6.74-6.77 (m, 2H), 6.91-6.94 (m, 4H), 7.18-7.26 (m, 4H), 
7.43 (t, J = 7.8 Hz, 2H), 7.76-7.79 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 13.7, 21.1, 36.1, 
45.5, 54.8, 59.4, 81.7, 100.7, 120.1 (2C), 125.4, 127.1, 127.9 (2C), 128.5 (2C), 128.7 (2C), 128.8 
(2C), 129.1 (2C), 136.0, 138.1, 138.7, 139.5, 147.2, 150.4; IR (ATR): ν = 698, 752, 934, 1045, 
1129, 1391, 1455, 1494, 1513, 1599, 2923, 3340 cm-1; HRMS calcd. for C28H29N2O2 (M + H)+: 
425.2224, found: 425.2210; [α]D25 = -134.2 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-




Cycloaddition product 4f was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 82% yield (53.9 mg) as a mixture 
of diastereoisomers (8:1); the corresponding alcohol 4f´ was isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 81% 
yield (44.2 mg) as a single diastereoisomer for structural characterization 
and enantiomeric excess determination. White solid, melting point: 173-
175 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.60-1.67 (m, 1H), 1.69 (s, 3H), 1.71-1.80 (m, 2H), 2.82 
(t, J = 10.4 Hz, 1H), 3.72 (s, 3H), 3.77-3.82 (m, 2H), 3.98 (d, J = 10.0 Hz, 1H), 4.70 (td, J = 2.4, 
10.0 Hz, 1H), 6.65-6.67 (m, 2H), 6.77-6.93 (m, 4H), 7.16-7.24 (m, 4H), 7.42 (t, J = 8.4 Hz, 2H), 
7.76-7.81 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.6, 36.1, 45.2, 54.9, 55.1, 59.4, 81.7, 
100.7, 113.5 (2C), 120.1 (2C), 125.4, 127.1, 128.5 (2C), 128.7 (2C), 129.0 (2C), 129.1 (2C), 
133.3, 138.7, 139.6, 147.2, 150.4, 158.2; IR (ATR): ν = 700, 753, 833, 1028, 1133, 1241, 1390, 
1455, 1510, 1601, 2924, 3311 cm-1; HRMS calcd. for C28H29N2O3 (M + H)+: 441.2173, found: 
441.2181; [α]D25 = -62.5 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (93:7), 





















Cycloaddition product 4g was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 85% yield (60.7 mg) as a mixture 
of diastereoisomers (10:1); the corresponding alcohol 4g´ was isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 77% 
yield (46.8 mg) as a single diastereoisomer for structural characterization 
and enantiomeric excess determination. White solid, melting point: 164-166 
ºC. 1H NMR (400 MHz, CDCl3): δ = 1.56-1.64 (m, 1H), 1.66 (s, 3H), 1.72-1.80 (m, 1H), 2.13 (br 
s, 1H), 2.82 (t, J = 10.0 Hz, 1H), 3.73-3.85 (m, 2H), 4.08 (d, J = 10.0 Hz, 1H), 4.71 (m, 1H), 6.88-
6.99 (m, 4H), 7.19-7.26 (m, 4H), 7.38-7.45 (m, 4H), 7.76 (d, J = 8.0 Hz, 2H); 13C NMR (100 
MHz, CDCl3): δ = 13.5, 35.9, 45.8, 54.6, 58.9, 81.3, 99.7, 120.1 (2C), 124.2 (q, J = 270.0 Hz), 
125.1 (q, J = 3.5 Hz, 2C), 125.6, 127.4, 128.3 (2C), 128.4 (2C), 128.9 (2C), 129.0 (q, J = 32.0 
Hz), 129.1 (2C), 138.4, 138.7, 145.6 (q, J = 1.6 Hz), 146.7, 150.6; IR (ATR): ν = 700, 755, 940, 
1043, 1121, 1323, 1393, 1455, 1495, 1517, 1601, 2926, 3332 cm-1; HRMS calcd. for 
C28H26F3N2O2 (M + H)+: 479.1941, found: 479.1935; [α]D25 = -52.8 (c = 0.1, CHCl3); HPLC 
(Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 254 nm, 93% ee): 




Cycloaddition product 4h was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 89% yield (57.9 mg) as a mixture 
of diastereoisomers (10:1); the corresponding alcohol 4h´ was isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) in 74% yield 
(42.9 mg) as a single diastereoisomer for structural characterization and 
enantiomeric excess determination. White solid, melting point: 162-164 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.66 (s, 3H), 1.69-1.81 (m, 3H), 2.81 (t, J = 10.0 Hz, 1H), 3.75-
3.86 (m, 2H), 4.13 (d, J = 10.0 Hz, 1H), 4.71 (td, J = 2.4, 10.0 Hz, 1H), 6.89-6.91 (m, 2H), 6.98 
(d, J = 7.6 Hz, 2H), 7.21-7.25 (m, 4H), 7.42-7.45 (m, 4H), 7.76-7.78 (m, 2H); 13C NMR (100 
MHz, CDCl3): δ = 13.6, 35.9, 46.3, 54.7, 59.0, 81.2, 99.2, 110.7, 118.7, 120.1 (2C), 125.7, 127.6, 
128.2 (2C), 128.8 (2C), 129.0 (2C), 129.1 (2C), 132.0 (2C), 138.4, 138.5, 146.4, 147.4, 150.6; IR 
(ATR): ν = 692, 759, 934, 1042, 1125, 1392, 1455, 1492, 1517, 1602, 1664, 2223, 2925, 3375 
cm-1; HRMS calcd. for C28H26N3O2 (M + H)+: 436.2020, found: 436.2014; [α]D25 = -133.9 (c = 
0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (93:7), flow rate = 1.0 mL min-1, λ = 





















Cycloaddition product 4i was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 73% yield (48.1 mg) as a 
mixture of diastereoisomers (5:1); the corresponding alcohol 4i´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 
6:1) in 72% yield (35.2 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, melting point: 208-210 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.62-1.68 (m, 2H), 1.73 (s, 3H), 1.75-1.79 (m, 1H), 2.83 (t, J = 
10.0 Hz, 1H), 3.63 (s, 3H), 3.74-3.88 (m, 2H), 3.90 (d, J = 10.4 Hz, 1H), 4.66 (td, J = 2.4, 10.0 
Hz, 1H), 6.37 (s, 1H), 6.46-6.48 (m, 1H), 6.66-6.68 (m, 1H), 6.88-6.90 (m, 2H), 7.04 (t, J = 8.0 
Hz, 1H), 7.17-7.25 (m, 4H), 7.45 (t, J = 8.4 Hz, 2H), 7.76 (d, J = 7.6 Hz, 2H); 13C NMR (100 
MHz, CDCl3): δ = 13.5, 36.1, 46.0, 54.6, 55.1, 59.1, 81.5, 100.4, 112.1, 113.6, 120.0 (2C), 120.5, 
125.4, 127.1, 128.4 (2C), 128.7 (2C), 129.1 (3C), 138.7, 139.4, 142.9, 147.2, 150.5, 159.4; IR 
(ATR): ν = 701, 755, 933, 1042, 1128, 1263, 1391, 1455, 1488, 1513, 1597, 2916, 3325 cm-1; 
HRMS calcd. for C28H29N2O3 (M + H)+: 441.2173, found: 441.2191; [α]D25 = -47.8 (c = 0.1, 
CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 254 




Cycloaddition product 4j was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 81% yield (53.0 mg) as a mixture 
of diastereoisomers (6:1); the corresponding alcohol 4j´ was isolated by 
FC on silica (eluting with Cyclohexane/EtOAc from 10:1 to 6:1) in 78% 
yield (41.8 mg) as a single diastereoisomer for structural characterization 
and enantiomeric excess determination. White solid, melting point: 174-
175 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.54-1.60 (m, 1H), 1.63 (s, 3H), 1.65-1.74 (m, 2H), 2.06 
(s, 6H), 2.77 (t, J = 10.4 Hz, 1H), 3.67-3.78 (m, 2H), 3.86 (d, J = 10.0 Hz, 1H), 4.61 (td, J = 2.4, 
10.0 Hz, 1H), 6.37 (s, 2H), 6.67 (s, 1H), 6.83-6.85 (m, 2H), 7.09-7.18 (m, 4H), 7.35 (t, J = 8.4 
Hz, 2H), 7.69-7.72 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.6, 21.2 (2C), 36.1, 45.7, 54.6, 
59.4, 81.7, 100.6, 120.2 (2C), 125.3, 125.9 (2C), 127.0, 128.1, 128.4 (2C), 128.6 (2C), 129.0 (2C), 
137.3 (2C), 138.7, 139.6, 141.0, 147.3, 150.4; IR (ATR): ν = 697, 797, 933, 1042, 1127, 1392, 
1454, 1494, 1512, 1598, 2869, 2923, 3324 cm-1; HRMS calcd. for C29H31N2O2 (M + H)+: 
439.2380, found: 439.2386; [α]D25 = -60.7 (c = 0.1, CHCl3); HPLC (Chiralcel OD-H, Hexane/i-






















Cycloaddition product 4k was isolated by FC on silica (eluting with cyclohexane/EtOAc from 
15:1 to 10:1) in 56% yield (39.4 mg) as a mixture of diastereoisomers (13:1); 
the corresponding alcohol 4k´ was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 10:1 to 6:1) in 88% yield (35.1 mg) as a single 
diastereoisomer for structural characterization and enantiomeric excess 
determination. White solid, melting point: 83-85 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 1.65 (s, 3H), 1.67-1.72 (m, 2H), 1.79-1.89 (m, 1H), 3.40 (s, 3H), 3.54 (t, J = 10.8 Hz, 
1H), 3.61 (s, 3H), 3.78-3.88 (m, 2H), 4.69 (td, J = 2.4, 10.0 Hz, 1H), 4.87 (d, J = 10.8 Hz, 1H), 
6.31 (d, J = 7.6 Hz, 1H), 6.45-6.48 (m, 1H), 6.98 (d, J = 7.6 Hz, 2H), 7.00-7.23 (m, 7H), 7.40-
7.44 (m, 2H), 7.76-7.82 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.7, 34.3, 36.1, 48.2, 55.9, 
56.0, 59.8, 82.6, 100.9, 104.3, 105.0, 116.8, 119.9 (2C), 125.0, 126.6, 127.8, 128.0 (2C), 128.5 
(2C), 129.0 (2C), 139.0, 140.4, 146.4, 149.6, 158.7, 159.4; IR (ATR): ν = 696, 753, 934, 1042, 
1106, 1248, 1391, 1454, 1472, 1495, 1513, 1597, 2924, 3322 cm-1; HRMS calcd. for C29H31N2O4 
(M + H)+: 471.2278, found: 471.2270; [α]D25 = +102.0 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, 
Hexane/i-propanol (93:7), flow rate = 1.0 mL min-1, λ = 254 nm, 87% ee): tmajor = 12.9 min, tminor 




Cycloaddition product 4l was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 73% yield (50.2 mg) as a 
mixture of diastereoisomers (4:1); the corresponding alcohol 4l´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 
6:1) in 66% yield (33.6 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, 
melting point: 245-247 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.63 (s, 3H), 1.65-1.73 (m, 2H), 
1.77-1.86 (m, 1H), 2.99 (t, J = 10.0 Hz, 1H), 3.77-3.88 (m, 2H), 4.23 (d, J = 10.4 Hz, 1H), 4.78 
(td, J = 2.8, 10.0 Hz, 1H), 6.92-6.94 (m, 2H), 7.05 (d, J = 8.4 Hz, 1H), 7.14-7.25 (m, 4H), 7.30 
(s, 1H), 7.37-7.47 (m, 4H), 7.60-7.66 (m, 2H), 7.74-7.76 (m, 1H), 7.79-7.82 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ = 13.6, 36.1, 46.1, 54.6, 59.4, 81.7, 100.4, 120.1 (2C), 125.4, 125.5, 125.8, 
126.0, 127.1, 127.2, 127.6, 127.7, 128.0, 128.4 (2C), 128.8 (2C), 129.1 (2C), 132.5, 133.3, 138.7, 
138.8, 139.3, 147.2, 150.5; IR (ATR): ν = 701, 752, 936, 1042, 1128, 1391, 1438, 1455, 1495, 
1512, 1596, 2923, 3307 cm-1; HRMS calcd. for C31H29N2O2 (M + H)+: 461.2224, found: 461.2220; 
[α]D25 = -174.7 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (90:10), flow rate 



















Cycloaddition product 4m was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 72% yield (45.6 mg) as a 
mixture of diastereoisomers (8:1); the corresponding alcohol 4m´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 
to 6:1) in 77% yield (35.6 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, melting point: 149-152 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.55-1.64 (m, 1H), 1.66 (s, 3H), 1.71-1.82 (m, 2H), 2.28 (s, 3H), 
2.82 (t, J = 10.4 Hz, 1H), 3.73-3.85 (m, 2H), 3.98 (d, J = 10.4 Hz, 1H), 4.67 (td, J = 2.4 Hz, 10.0 
Hz, 1H), 6.78-6.80 (m, 2H), 6.88-6.90 (m, 2H), 7.00-7.03 (m, 2H), 7.12-7.13 (m, 3H), 7.20-7.24 
(m, 1H), 7.42 (t, J = 8.4 Hz, 2H), 7.76-7.78 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.5, 21.1, 
36.1, 45.9, 54.3, 59.4, 81.8, 100.6, 120.1 (2C), 125.4, 126.5, 128.1 (2C), 128.2 (2C), 128.2 (2C), 
129.1 (2C), 129.4 (2C), 136.2, 136.7, 138.7, 141.5, 147.2, 150.5; IR (ATR): ν = 692, 753, 940, 
1054, 1128, 1392, 1453, 1492, 1511, 1599, 2922, 3334 cm-1; HRMS calcd. for C28H29N2O2 (M + 
H)+: 425.2224, found: 425.2213; [α]D25 = -133.9 (c = 0.1, CHCl3); HPLC (Chiralcel IB, Hexane/i-





Cycloaddition product 4n was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 10:1 to 8:1) in 74% yield (52.1 mg) as a 
mixture of diastereoisomers (8:1); the corresponding alcohol 4n´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 8:1 to 
5:1) in 83% yield (43.3 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, melting point: 87-89 ºC. 1H 
NMR (400 MHz, CDCl3): δ = 1.68 (s, 3H), 1.70-1.83 (m, 3H), 2.78 (t, J = 10.2 Hz, 1H), 3.72 (s, 
3H), 3.76-3.81 (m, 2H), 3.83 (s, 3H), 3.94 (d, J = 10.2 Hz, 1H), 4.67 (td, J = 3.2, 9.6 Hz, 1H), 
6.34 (s, 1H), 6.46 (dd, J = 1.6, 8.4 Hz, 1H), 6.72-6.74 (m, 1H), 6.86-6.90 (m, 2H), 7.11-7.15 (m, 
3H), 7.20-7.25 (m, 1H), 7.43 (t, J = 8.4 Hz, 2H), 7.76-7.78 (m, 2H); 13C NMR (100 MHz, CDCl3): 
δ = 13.5, 36.0, 46.2, 54.3, 55.8, 55.9, 59.3, 81.6, 100.5, 111.3, 111.6, 120.1 (2C), 120.3, 125.4, 
126.6, 128.2 (4C), 129.1 (2C), 131.8, 138.7, 141.5, 147.2, 147.9, 148.9, 150.5; IR (ATR): ν = 694, 
756, 1026, 1141, 1260, 1393, 1454, 1511, 1599, 2850, 2925 cm-1; HRMS calcd. for C29H31N2O4 
(M + H)+: 471.2278, found: 471.2272; [α]D25 = -39.2 (c = 0.1, CHCl3); HPLC (Chiralcel IB, 
Hexane/i-propanol (70:30), flow rate = 1.0 mL min-1, λ = 254 nm, 84% ee): tmajor = 11.6 min, tminor 



















Cycloaddition product 4o was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 8:1) in 83% yield (58.6 mg) as a 
mixture of diastereoisomers (8:1); the corresponding alcohol 4o´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 
to 5:1) in 78% yield (45.7 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, melting point: 205-206 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.57-1.65 (m, 2H), 1.66 (s, 3H), 1.73-1.82 (m, 1H), 2.98 (t, J = 
10.0 Hz, 1H), 3.78-3.90 (m, 2H), 4.03 (d, J = 10.4 Hz, 1H), 4.77 (td, J = 2.4 Hz, 10.0 Hz, 1H), 
6.83-6.88 (m, 2H), 7.04-7.06 (m, 2H), 7.14-7.16 (m, 3H), 7.22-7.26 (m, 1H), 7.44 (t, J = 8.4 Hz, 
2H), 7.49-7.51 (m, 2H), 7.76-7.79 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.5, 35.9, 46.2, 
54.7, 59.0, 80.9, 100.2, 120.1 (2C), 124.0 (q, J = 270.0 Hz), 125.5, 125.7 (q, J = 3.7 Hz, 2C), 
126.9, 128.0 (2C), 128.4 (2C), 128.7 (2C), 129.1 (2C), 129.2 (q, J = 33.0 Hz), 138.6, 140.7, 143.8 
(q, J = 1.1 Hz), 147.0, 150.2; IR (ATR): ν = 506, 695, 756, 842, 1066, 1115, 1155, 1325, 1456, 
1516, 1603, 2926, 3351 cm-1; HRMS calcd. for C28H26F3N2O2 (M + H)+: 479.1941, found: 
479.1927; [α]D25 = -62.6 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, Hexane/i-propanol (93:7), 




Cycloaddition product 4p was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 8:1) in 82% yield (52.7 mg) as a 
mixture of diastereoisomers (7:1); the corresponding alcohol 4p´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 
4:1) in 77% yield (40.8 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, melting point: 179-182 ºC. 
1H NMR (400 MHz, CDCl3): δ = 1.66 (s, 3H), 1.70-1.80 (m, 2H), 1.82-1.90 (m, 1H), 2.86 (t, J = 
10.4 Hz, 1H), 3.75-3.87 (m, 2H), 3.94 (d, J = 10.0 Hz, 1H), 4.68 (td, J = 2.4, 10.0 Hz, 1H), 6.85-
6.94 (m, 6H), 7.13-7.15 (m, 3H), 7.21-7.25 (m, 1H), 7.43 (t, J = 8.4 Hz, 2H), 7.76-7.78 (m, 2H); 
13C NMR (100 MHz, CDCl3): δ = 13.5, 36.0, 46.2, 54.0, 59.1, 81.3, 100.3, 115.6 (d, J = 21.3 Hz, 
2C), 120.0 (2C), 125.4, 126.7, 128.0 (2C), 128.2 (2C), 129.0 (2C), 129.7 (d, J = 8.1 Hz, 2C), 
135.1 (d, J = 3.3 Hz), 138.6, 141.0, 147.1, 150.4, 161.8 (d, J = 245.8 Hz); IR (ATR): ν = 504, 
697, 756, 840, 1047, 1134, 1224, 1390, 1455, 1508, 1600, 2923, 3302 cm-1; HRMS calcd. for 
C27H26FN2O2 (M + H)+: 429.1973, found: 429.1975; [α]D25 = -52.3 (c = 0.1, CHCl3); HPLC 
(Chiralcel OD-H, Hexane/i-propanol (95:5), flow rate = 1.0 mL min-1, λ = 254 nm, 87% ee): tmajor 

















Cycloaddition product 4q was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 10:1) in 88% yield (57.6 mg) as a 
mixture of diastereoisomers (7:1); the corresponding alcohol 4q´ was 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 10:1 to 6:1) 
in 83% yield (47.8 mg) as a single diastereoisomer for structural 
characterization and enantiomeric excess determination. White solid, 
melting point: 60-61ºC. 1H NMR (400 MHz, CDCl3): δ = 0.70 (t, J = 7.6 Hz, 3H), 1.23-1.40 (m, 
2H), 1.61-1.69 (m, 1H), 1.70-1.80 (m, 3H), 2.03-2.13 (m, 1H), 2.88 (t, J = 10.4 Hz, 1H), 3.74-
3.82 (m, 2H), 4.03 (d, J = 10.4 Hz, 1H), 4.73 (td, J = 2.4, 10.0 Hz, 1H), 6.88-6.92 (m, 3H), 7.11-
7.13 (m, 3H), 7.18-7.24 (m, 3H), 7.26-7.31 (m, 1H), 7.39-7.44 (m, 2H), 7.76-7.79 (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 13.8, 21.7, 30.0, 36.0, 46.3, 54.9, 59.3, 81.4, 99.9, 120.2 (2C), 
125.4, 126.6, 127.1, 128.0 (2C), 128.1 (2C), 128.4 (2C), 128.6 (2C), 129.0 (2C), 138.7, 139.4, 
141.3, 150.3, 151.2; IR (ATR): ν = 698, 753, 939, 1045, 1134, 1399, 1454, 1492, 1511, 1597, 
2876, 2930, 2958, 3341 cm-1; HRMS calcd. for C29H31N2O2 (M + H)+: 439.2380, found: 439.2369; 
[α]D25 = -50.2 (c = 0.1, CHCl3); HPLC (Chiralcel IB, Hexane/i-propanol (95:5), flow rate = 1.0 
mL min-1, λ = 254 nm, 90% ee): tmajor = 14.8 min, tminor = 12.9 min.  
 
7. X-Ray analysis data and determination of absolute configuration 
 
 
To a solution of 4b´ (0.05 mmol, 24.5 mg, 1.0 equiv.) in CH2Cl2 (0.5 mL) were added TsCl (0.1 
mmol, 19.0 mg, 2.0 equiv.), DMAP (0.025 mmol, 3.1 mg, 0.5 equiv.) and Et3N (0.15 mmol, 20.8 
µL, 3.0 equiv.). The reaction mixture was stirred overnight at room temperature and monitored 
by TLC. After the reaction was completed, solvent was removed in vacuo and the crude product 
was purified by flash chromatography (eluting with cyclohexane/EtOAc from 12:1 to 7:1) to 































White solid, melting point: 75-76 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.68 
(s, 3H), 1.76-1.81 (m, 2H), 2.37 (s, 3H), 2.70 (t, J = 10.0 Hz, 1H), 3.98 (d, J 
= 10.4 Hz, 1H), 4.10-4.15 (m, 1H), 4.25-4.31 (m, 1H), 4.51-4.56 (m, 1H), 
6.72 (d, J = 8.0 Hz, 2H), 6.85-6.86 (m, 2H), 7.19-7.26 (m, 8H), 7.38-7.42 (m, 
2H), 7.67-7.73 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 13.6, 21.6, 32.7, 
45.5, 54.5, 66.2, 79.4, 99.8, 119.9 (2C), 120.5, 125.4, 127.5, 127.7 (2C), 
128.2 (2C), 129.0 (2C), 129.0 (2C), 129.7 (2C), 129.8 (2C), 131.3 (2C), 132.8, 138.2, 138.5, 
140.2, 144.8, 146.7, 150.1. 
 
This compound crystallizes as a diethyl ether solvate. The 
solvent molecule is disordered in two orientations with a ratio 
of 50:50. This compound crystallizes in the chiral space group 
C2. The absolute structure could be determined reliable with a 
Flack value of -0.003(5) and a Flack value based on Parsons’ 
quotients of 0.003(2).4 R1 value = 3.43 %.  
The X-ray structure has been deposited with the CCDC 
number 1438957. The corresponding CIF file has also been 
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Asymmetric [4+2] Annulation Reactions Catalyzed by a Robust, 
Immobilized Isothiourea 
 
3.1. Introduction to Isothiourea Catalysis  
 
Lewis base organocatalysts have found widespread utility in asymmetric catalysis for 
useful synthetic transformations. Among them, chiral amidines and isothioureas have 
proved to be the most commonly used organocatalysts for a large number of 
enantioselective transformations, particularly in kinetic resolution, formal cycloadditions 
and domino reactions.[1] In 2004, Birman and co-workers were the first to introduce the 
chiral amidine-type catalysts CF3-PIP in enantioselective acyl transfer reactions.[2] 
Shortly after, the same group reported the second generation amidine-type catalysts Cl-
PIQ to increase the reaction rates of acyl transfer via p-stacking effect.[3] One year later, 
they turned their attention toward the synthesis of chiral isothiourea catalysts (tetramisole 
and benzotetramisole) in the same type of reaction (Scheme 3.1).[4] After the first efforts 
on enantioselective kinetic resolution for C-O bond formation, chiral isothiourea catalysts 
have also been applied to O-Si, C-N and C-C bond formation. 
 
Scheme 3.1. Chiral amidines and isothioureas reported by Birman 
 
The nucleophilicities of nitrogen-based organocatalysts such as isothioureas could be 
measured by use of benzhydrylium cations as electrophiles. In 2011, Mayr et al. 
determined the nucleophilicities of the isothioureas and compared them with other 
nitrogen-based organocatalysts.[5] The nucleophilicity values of isothioureas ranged from 
12.98 to 14.45, which means they are less nucleophilic than DMAP, amidines, guanidines, 


































Scheme 3.2. Nucleophilicity scale of different nitrogen-based organocatalysts 
 
Since the first chiral isothiourea catalyst reported by Birman, several new types of 
isothiourea catalysts were designed and employed in a large variety of asymmetric 
transformations (Scheme 3.3). In 2006, the group of Okamoto developed an achiral six-
membered ring isothiourea named dihydrobenzothiazolo-pyrimidine (DHPB) as an acyl 
transfer catalyst, which exhibited extremely high activity compare to benzotetramisole 
(BTM).[6] Inspired by Okamoto´s work, Birman developed a chiral analogue of six-
membered ring isothiourea catalyst, named homobenzotetramisole (HBTM).[7] In 2009, 
Birman and Smith explored the second generation of HBTM catalysts by adding a methyl 
group and an isopropyl group on the ring, respectively.[8] This additional stereocenter 
plays a key role on both reactivity and steroselectivity. In 2011, Okamoto synthesized a 
chiral analogue of previous DHPBs and explored them in the kinetic resolution as well as 
in the Steglich rearrangement reactions, which showed the possibility for remote 
stereocontrol by an additional substituent at the 4-position of DHPB.[9]  














































Scheme 3.3. Chronological development of significant isothiourea catalysts 
 
The general procedure for the preparation of chiral isothioureas starts from the chiral b-
amino alcohols or γ-amino alcohols. Coupling of these with chlorobenzothiazole can be 
performed through an aromatic nucleophilic substitution.[10] The final cyclization is 
promoted by methanesulfonyl chloride as activating reagent for the hydroxy group 
(Scheme 3.4). Notably, isothiourea catalysts such as BTM and HBTM can be synthesized 
on a multi-gram scale without any need for chromatographic purification. 
 
Scheme 3.4. General procedure for the synthesis of BTM and HBTM 
 
3.2. Different Transformations Catalyzed by Isothioureas 
 
To date, isothioureas have been explored in a large variety of asymmetric 
transformations, including kinetic resolution, rearrangements, silylations, formal 
cycloadditions and domino reactions (Figure 3.1). This thesis mainly focuses on the 
formal cycloaddition reaction, which is an important type of reaction catalyzed by 
isothiourea catalysis. 

































































Figure 3.1. Examples of enantioselective transformations catalyzed by isothioureas 
 
In general, isothioureas can react with various anhydrides, acyl chlorides, or triarylsilyl 
chlorides, and form the corresponding activated intermediates. The main types of 
activated intermediates can be classified into four types, which are shown in Figure 3.2 
 
Figure 3.2. Different activated intermediates derived from isothiourea catalysts 
 
The acylisothiouronium intermediates A present one reactive site on the acyl group, 
which can be well applied in kinetic resolutions and rearrangement reactions. The 
silylisothiouronium intermediates B are employed in asymmetric silylations due to the 
fact that they have one single reactive site on the silicon atom. The acylisothiouronium 
enolate intermediates C are formed from the deprotonation of the acylisothiouronium 






































reactions. The α,b-unsaturated acylisothiouronium intermediates D involved two 
electrophilic centers and one nucleophilic center, which could react as a Michael acceptor 
or bis-electrophile intermediates in formal [3+n] cycloaddition reactions. 
 
3.2.1. Kinetic Resolution 
 
The seminal work of Birman demonstrated the potential of chiral isothiourea catalysts for 
the kinetic resolution of secondary benzylic alcohols through acyl transfer (Scheme 3.5).[4] 
Comparison of tetramisole and BTM on various substrates suggested that an extended p-
system in the structure of BTM is beneficial for the chiral recognition of the substrates. 
 
Scheme 3.5. Kinetic resolution of benzylic alcohols 
 
In 2008, Birman reported the first HBTM catalyst, which is a ring expanded analogue of 
the BTM, proving that it displays higher catalytic reactivity in kinetic resolution processes 
(Scheme 3.6).[7] This HBTM catalyst led not only to high levels of selectivity in kinetic 
resolution of benzylic alcohols, but also to efficient kinetic resolution of aryl-substituted 
cycloalkanols. 
 




Since the first rearrangement reaction of acylated azlactones by acyl shift introduced by 
Höfle and Steglich in 1960s,[11] many efforts to achieve this transformation have been 














Na2SO4 s factor up to 355



















rearrangement reaction with excellent levels of enantiocontrol (Scheme 3.7).[8b] To 
understand the factors that lead to high stereocontrol in this process, they performed 
calculations on the rearrangement of oxazolyl carbonate A and proposed the catalytic 
cycle for this transformation. It was assumed that the formation of final product is 
initiated through nucleophilic attack of oxazolyl carbonate A to form the corresponding 
tetrahedral intermediate. Subsequently, enolate addition of azlactone B onto the N-
carboxyl intermediate C gives C-carboxylazlactone D with concomitant release of the 
catalyst. 
 
Scheme 3.7. Steglich rearrangement of oxazolyl carbonate 
 
In 2011, the same group reported a similar asymmetric acylation reaction between silyl 
ketene acetals and anhydrides, the desired C-acyl products could be obtained in good 
yields with high enantiocontrol (up to 98% ee) by employing of a range of chiral 
isothiourea catalysts (Scheme 3.8).[12] 
 
















up to 97% yield



































up to 86% yield








The Smith group developed the first catalytic asymmetric sigmatropic rearrangement of 
allylic ammonium ylides in 2014.[13] They used BTM to activate para-nitrophenyl esters, 
which in the presence of diisopropylamine as a base, provided the syn-configured α-
amino acid derivatives with excellent stereoselectivities. The resulting intermediate 
could be activated by HOBt as a nucleophilic co-catalyst and converted into amides or 
ester by use of amines or alcohols as nucleophiles (Scheme 3.9). 
 
Scheme 3.9. Sigmatropic rearrangement of ammonium ylides 
 
3.2.3. Asymmetric Silylation 
 
Silylation is one of the most common methods for present kinetic resolution due to the 
fact that silyl groups have a broad tolerance for other functional groups and have many 
advantages compare to other protecting groups. In 2011, the Wiskur group demonstrated 
the aymmetric silylation reaction by using tetramisole to activate the electrophilicity of 
triphenylsilyl chloride, resulting in high levels of selectivity for monofunctional bicyclic 
alcohols (Scheme 3.10).[14] 
 
Scheme 3.10. Tetramisole catalyzed silylation of secondary alcohols 
 
The same group also expanded the silylation-based kinetic resolutions for α-hydroxy 
lactones and α-hydroxy lactams, and selectivity factors up to 100 can be achieved 
utilizing BTM as catalyst.[15] Particularly, this transformation can be well applied in spiro-
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Scheme 3.11. BTM catalyzed silylation of α-hydroxy lactones and lactams 
 
3.2.4. Formal Cycloadditions 
 
Formal cycloadditions are important transformations that can be catalyzed by 
isothioureas catalysis. To date, these catalysts have been well explored and widely used 
in various formal [2+2], [3+2], [3+3], [4+2] and [4+3] cycloadditions. 
 
Formal [2+2] Cycloadditions 
 
The first study of formal [2+2] cycloaddition was carried out by the Romo group in 
2008.[16] Using a stoichiometric amount of chiral tetramisole for the desymmetrization of 
prochiral diketoacids, they produced the complex tricyclic b-lactones shown in Scheme 
3.12 with high enantioselectivity (Scheme 3.12). 
 
Scheme 3.12. Stoichiometric enantioselective synthesis of tricyclic b-lactones 
 
Smith and co-workers described a formal [2+2] cycloaddition by using N-sulfonylimines 
as electrophilic partners to react with arylacetic anhydrides or arylacetic acids, generating 
the corresponding four-membered ring lactam products in high stereoselectivities.[17] This 
cascade reaction involves a Mannich reaction followed by a lactamization. Another 
similar transformation of [2+2] cycloaddition was also reported by the same group. In 
this case, they used b,γ-unsaturated carboxylic acids instead of arylacetic acids as partners 
to react with N-sulfonylimines, providing the desired products in comparable 
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X = O, NAr































Scheme 3.13. Formal [2+2] cycloaddition catalyzed by HBTM 
 
Formal [3+2] Cycloadditions 
 
Studer et al. presented a highly stereoselective 1,3-dipolar cycloaddition of azomethine 
imines with active esters by using BTM as catalyst (Scheme 3.14).[18] Theoretical studies 
of the formal [3+2] cycloadditions reveal that a stepwise mechanism is operative. The 
first step is the formation of the C–C bond which determines the rate and stereocontrol. 
The second one consists in the C–N bond formation with a low barrier. 
 
Scheme 3.14. 1,3-Dipolar cycloaddition catalyzed by BTM 
 
Smith and co-workers developed a formal [3+2] cycloaddition of ammonium enolates 
with racemic oxaziridines, giving oxazolidin-4-ones in high yield and excellent 
enantioselectivities (Scheme 3.15).[19]  
 
Scheme 3.15. Synthesis of oxazolidinones via formal [3+2] cycloaddition 
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up to 97% yield
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Formal [4+2] Cycloadditions 
 
The first example of intra- and intermolecular Michael addition-lactonization was 
explored by the Smith group in 2011.[20] In this study, tetramisole promoted the 
intramolecular Michael addition-lactonization of a variety of enone acids and HBTM 
promoted the intermolecular Michael addition-lactonization of arylacetic acids with a-
keto-β,γ-unsaturated esters (Scheme 3.16). The same group also demonstrated a similar 
intermolecular process by using trifluoromethylenones, trichloromethylenones and α-
ketophosphonates as Michael acceptors. 
 
Scheme 3.16. Isothiourea catalyzed intramolecular and intermolecular Michael 
addition-lactonization 
 
This Michael/lactamization process could also be applied to N-tosylenimines under BTM 
catalysis, affording the dihydropyridones with high diastereo- and excellent 
enantioselectivities.[21] The dihydropyridone products can be readily derivatized to a 
range of synthetic building blocks via N- to C-sulfonyl transfer, N-deprotection and 
reduction (Scheme 3.17). 
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up to 98% yield
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Formal [3+3] Cycloadditions 
 
One year later, the same group presented the formal [3+3] cycloadditions of 1,3-diketones 
b-ketoesters or azaaryl ketones with anhydrides, giving the functionalized esters, 
dihydropyranones, or dihydropyridone in good yields and high enantioselectivities 
(Scheme 3.18).[22] 
 
Scheme 3.18. Formal [3+3] cycloaddition catalyzed by HBTM 
 
Formal [4+3] Cycloadditions 
 
More recently, Matsubara and co-workers reported the first example of asymmetric 
formal [4 + 3] cycloaddition to afford 1,5-benzothiazepines by utilizing α,β-unsaturated 
acylammonium as bis-electrophile intermediates (Scheme 3.19).[23] This formal [4+3] 
cycloaddition was promoted by chiral BTM and the intermediate underwent two 
sequential chemoselective nucleophilic attacks by 2-aminothiophenols. The mechanism 
of the net [4+3] cycloaddition suggested that the reversibility of the sulfa-Michael 
addition dictates the high regio- and enantioselectivity of the transformation. 
 




The group of Romo described a Michael-aldol-b-lactonization and Michael-Michael-
aldol-b-lactonization organocascade processes for the synthesis of complex 
cyclopentanes by utilizing chiral isothiourea as catalysts (Scheme 3.20).[24] This tandem 
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contiguous stereocentres, providing the complex cyclopentanes with high 
stereoselectivities. 
 
Scheme 3.20. Isothiourea catalyzed Michael-aldol-lactonization sequence 
 
Later, the same group demonstrated a highly stereoselective Diels−Alder-lactonization 
organocascade for the synthesis of bicyclic lactones utilizing chiral a,b-unsaturated 
acylammonium species, which are readily generated in situ from unsaturated acid 
chlorides with chiral BTM catalyst (Scheme 3.21).[25] The utility of this cascade protocol 
was demonstrated by transformation of the chiral bicyclic products to several core 
structures of natural products. 
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3.3.  Immobilization of Isothiourea Organocatalyst 
 
Considering the importance of the chiral isothiourea catalysts in organic synthesis and 
our continuing interest toward the immobilization of homogeneous catalytic species, we 
considered that BTM was an optimal candidate for immobilization due to its widespread 
use. An analysis of the BTM structure suggested that the g position could be ideal for 
immobilization purposes, since an additional substituent at this carbon would occupy a 
spatially remote position with respect to the catalytic site (Figure 3.3). 
 
Figure 3.3. Design for immobilization of BTM catalyst 
 
The retrosynthetic introduction of a functional group in g position ultimately leads to 
phenylglycidol, a material readily available in enantiopure form by catalytic asymmetric 
Sharpless epoxidation, as the chiral aducts for the preparation of the immobilized BTM 
analogue. The general procedure for the preparation of PS-BTM catalyst is shown in 
Scheme 3.23. 
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3.4. Aim of the Project 
 
As an initial assessment of the performance of the immobilized isothiourea, it was tested 
in the Michael addition/cyclization reaction previously reported by Smith and co-workers 
(see Scheme 3.17).[26] Immobilized isothiourea displayed a high level of recyclability in 
batch and flow in these processes. However, applications of this immobilized isothiourea 
catalyst in new transformations have not been investigated in depth. Herein, we aim to 
demonstrate a new application of immobilized isothiourea in asymmetric formal [4+2] 
cycloadditions. 
 
Scheme 3.24. Formal [4+2] cycloaddition of unsaturated heterocycles with in situ 
generated anhydrides 
 
Heterocyclic compounds containing nitrogen-nitrogen and nitrogen-sulfur arrays are 
frequently encountered as privileged structural frameworks in numerous bioactive natural 
products and pharmaceuticals. Given the manifold interest in heterocycles of these classes, 
we wish to report an asymmetric formal [4+2] cycloadditions of the ammonium enolate 
with unsaturated heterocycles catalyzed by immobilized isothiourea, affording a variety 
of optically pure, functionalized six-membered heterocycles bearing a tertiary or 
quaternary stereocenter (Scheme 3.24). From a practical perspective, another goal of this 
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1. General information 
 
Unless otherwise stated, all commercial reagents were used as received. Flash chromatography 
was carried out using 60 mesh silica gel and dry-packed columns. Thin layer chromatography 
was carried out using Merck TLC Silicagel 60 F254 aluminum sheets. Components were 
visualized by UV light (λ = 254 nm) and stained with p-anisaldehyde or phosphomolybdic dip. 
NMR spectra were registered in a Bruker Advance 400 Ultrashield spectrometer in CDCl3 at room 
temperature, operating at 300 or 400 MHz (1H) and 75 or 100 MHz (13C). TMS was used as 
internal standard for 1H NMR and CDCl3 for 13C NMR. Chemical shifts are reported in ppm 
referred to TMS. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Elemental 
analyses of the polystyrene supported catalysts were performed on a LECO CHNS 932 micro-
analyzer at the Universidad Complutense de Madrid, Spain. High performance liquid 
chromatography (HPLC) was performed on an Agilent Technologies chromatograph (1100 
Series), using Chiralcel columns and guard columns. The continuous flow experiments were 
carried out using P4.1S Azura pump developed by Knauer and a Legato 270 push/pull syringe 
pump developed by KD scientific. Racemic reference samples were prepared using 20-40 mol% 
DMAP instead of the PS-BTM, following the same conditions used for the asymmetric reaction. 
 
 
2. General procedure for the preparation of PS-BTM catalyst 
 

































1. MsCl, Et3N, CH2Cl2, 5 h




40 ºC, 16 h
73% yield 79% yield
93% yield 98% yield, f = 0.9 mmol g−1







3. General procedure for the preparation of oxoindolylidene pyrazolones 
 
Different methyloxoindolylidene pyrazolones were prepared according to the literature 
procedure[2] or the following method.[3] 
 
To a mixture of methyl isatin (5 mmol, 1 equiv.), sodium acetate (7.5 mmol, 1.5 equiv.) and the 
pyrazolone (6 mmol, 1.2 equiv.) were added 15 mL of glacial acetic acid. The resulting mixture 
was refluxed for 24 h. After that, the reaction mixture was diluted with EtOAc (40 mL) and 
washed with water (3 × 20 mL). The organic layers were dried with anhydrous Na2SO4 and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography on silica gel to afford the desired product. 
 
(E)-1-Methyl-3-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)indolin-2-one 
Dark red solid, melting point: 168-170 ºC. 1H NMR (400 MHz, CDCl3): δ = 
2.66 (s, 3H), 3.21 (s, 3H), 6.75 (d, J = 7.6 Hz, 1H), 7.03-7.08 (m, 1H), 7.20-
7.23 (m, 1H), 7.41-7.46 (m, 3H), 7.93-7.95 (m, 2H), 9.29 (d, J = 8.0 Hz, 1H); 
13C NMR (100 MHz, CDCl3): δ = 20.1, 26.2, 108.2, 119.2 (2C), 121.2, 123.0, 
125.2, 128.8 (2C), 129.9, 131.7, 135.6, 137.7, 139.1, 147.4, 148.6, 164.0, 166.1; 
IR (ATR): ν = 538, 584, 690, 757, 1009, 1097, 1185, 1288, 1338, 1366, 1475, 1595, 1687, 1719, 




Dark purple solid, melting point: 160-161 ºC. 1H NMR (400 MHz, CDCl3): 
δ = 2.65 (s, 3H), 3.19 (s, 3H), 6.68 (d, J = 8.4 Hz, 1H), 7.21-7.24 (m, 1H), 
7.39-7.46 (m, 3H), 7.91-7.94 (m, 2H), 9.37 (d, J = 2.0 Hz, 1H); 13C NMR 
(100 MHz, CDCl3): δ = 20.1, 26.3, 109.0, 119.2 (2C), 122.0, 125.4, 128.3, 
128.9 (2C), 131.0, 131.2, 134.8, 137.5, 137.7, 145.7, 148.4, 163.8, 165.6; IR 
(ATR): ν = 590, 688, 729, 757, 901, 1157, 1286, 1366, 1456, 1595, 1683, 1716, 2926 cm–1; HRMS 














































Dark blue solid, melting point: 181-183 ºC. 1H NMR (400 MHz, CDCl3): 
δ = 2.65 (s, 3H), 3.16 (s, 3H), 3.85 (s, 3H), 6.62 (d, J = 8.4 Hz, 1H), 6.99-
7.02 (m, 1H), 7.19-7.23 (m, 1H), 7.41-7.45 (m, 2H), 7.93-7.95 (m, 2H), 
9.04 (d, J = 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 20.1, 26.2, 
56.0, 108.6, 116.4, 119.2 (2C), 121.7, 122.3, 125.2, 128.8 (2C), 129.9, 
137.7, 139.6, 141.6, 148.6, 155.6, 164.0, 165.9; IR (ATR): ν = 643, 693, 755, 811, 935, 1033, 
1169, 1255, 1287, 1366, 1455, 1565, 1587, 1685, 1709, 2923 cm–1; HRMS calcd. for C20H18N3O3 





A 25 mL round-bottom flask containing a magnetic stirring bar was charged with oxoindolylidene 
pyrazolone (303 mg, 1.0 mmol, 1.0 equiv.), DMAP (12.2 mg, 10 mol%, 0.1 equiv.) and 
acetonitrile (5 mL) was added via syringe. A solution of (Boc)2O (261 mg, 1.2 mmol, 1.0 equiv.) 
in acetonitrile (5 mL) was added to the mixture via syringe over 10 min, and the reaction was 
allowed to stir at room temperature for 12 h. The solvent was then removed in vacuo and the 
residue was purified by flash column chromatography (eluting with cyclohexane/EtOAc from 
20:1 to 5:1) to give the desired product (370 mg, 92% yield) as a red solid. 
 
Dark red solid, melting point: 174-175 ºC. 1H NMR (400 MHz, CDCl3): δ = 
1.67 (s, 9H), 2.62 (s, 3H), 7.19-7.24 (m, 2H), 7.41-7.45 (m, 2H), 7.51-7.55 (m, 
1H), 7.84-7.86 (m, 1H), 7.91-7.94 (m, 2H), 9.40 (d, J = 8.0 Hz, 1H); 13C NMR 
(100 MHz, CDCl3): δ = 19.7, 28.1 (3C), 85.2, 114.7, 119.2 (2C), 121.5, 124.6, 
125.4, 128.9 (2C), 130.2, 130.8, 135.9, 137.5, 137.6, 143.2, 148.3, 148.5, 163.6, 
164.2; IR (ATR): ν = 650, 689, 750, 903, 1011, 1100, 1158, 1251, 1298, 1342, 1396, 1461, 1684, 














































A solution of oxoindolylidene pyrazolone (303 mg, 1.0 mmol, 1.0 equiv.) in anhydrous CH2Cl2 
(10 mL) was cooled to 0 °C in an ice bath and treated with pivaloyl chloride (148 µL, 1.2 mmol, 
1.2 equiv.) followed by i-Pr2NEt (261 µL, 1.5 mmol, 1.5 equiv.). The mixture was stirred at 0 °C 
for 20 min and then warmed up to room temperature for 3 hours. After that, aqueous NH4Cl (5 
mL) was added and it was extracted with CH2Cl2 (3 × 5 mL). The organic layer was then washed 
with brine (5 mL), dried with anhydrous Na2SO4 and the solvent was removed under reduced 
pressure. The crude residue was purified by flash column chromatography (eluting with 
cyclohexane/EtOAc from 20:1 to 5:1) to give the desired product (352 mg, 91% yield) as a red 
solid. 
 
Dark red solid, melting point: 164-166 ºC. 1H NMR (400 MHz, CDCl3): δ = 
1.46 (s, 9H), 2.59 (s, 3H), 7.17-7.25 (m, 2H), 7.41-7.46 (m, 3H), 7.48-7.52 (m, 
1H), 7.92-7.94 (m, 2H), 9.39 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): 
δ = 19.5, 27.1 (3C), 43.6, 113.9, 119.2 (2C), 122.4, 124.6, 125.4, 128.9 (2C), 
130.2, 131.0, 135.8, 137.6, 137.9, 144.5, 148.1, 163.6, 165.7, 182.1; IR (ATR): 
ν = 580, 651, 690, 748, 898, 986, 1084, 1118, 1279, 1332, 1458, 1572, 1596, 1683, 1709, 1738, 
2929 cm–1; HRMS calcd. for C23H22N3O3 [M + H]+: 388.1656, found: 388.1667. 
 
4. General procedure for the [4+2] cycloaddition reaction 
 
To a solution of 2 (0.10 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL) were added the phenylacetic acid 
derivative 3 (0.20 mmol, 2.0 equiv.) and polymer-supported BTM (0.010 mmol, 11.2 mg, 10 
mol%). The mixture was shaken at 0 ºC in an ice bath and i-Pr2NEt (0.20 mmol, 34.8 μL, 2.0 
equiv.) and pivaloyl chloride (0.20 mmol, 24.5 µL, 2.0 equiv.) were added dropwise. The reaction 
was shaken from 0 ºC to r.t. for the given reaction time. After that the resin was filtered off, 
washed with CH2Cl2 (3 × 1 mL) and the combined organic layers were concentrated under 





























Cat. 1a (10 mol%)
PivCl (2.0 equiv.)
i-Pr2NEt (2.0 equiv.)














To a solution of oxoindolylidene pyrazolone 7 (0.10 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL) were 
added the phenylacetic acid derivative 3 (0.20 mmol, 2.0 equiv.), polymer-supported BTM (0.010 
mmol, 22.4 mg, 20 mol%) and the mixture was shaken at 0 ºC in an ice bath. Then, i-Pr2NEt (0.20 
mmol, 2.0 equiv.) and pivaloyl chloride (0.20 mmol, 2.0 equiv.) were added dropwise. The 
reaction was shaken at 0 ºC for 15-40 min and monitored by TLC. After that the resin was filtered 
off, washed with CH2Cl2 (3 × 1 mL) and the combined organic layers were concentrated under 
reduced pressure. Crude products 8 were directly purified by flash chromatography (FC). 
 




























































































Cat. 1a (10 mol%)
RCl (2.0 equiv.)
Cat. 1a
Entry Solvent Conv. (%)[b] dr[b] ee (%)[c] 
1 CH2Cl2 >95 8:1 98/93 
2 THF 90 3:1 98/93 
3 CHCl3 >95 5:1 98/93 
4 toluene 60 6:1 96/– 
5 Et2O 31 4:1 –/– 
Entry RCl Base Conv. (%)[b] dr[b] ee (%)[c] 
1 PivCl Et3N >95 5:1 98 
2 PivCl i-Pr2NEt >95 8:1 98 
3 TsCl i-Pr2NEt 76 7:1 98 










[a] Reactions performed on a 0.1 mmol scale. [b] Determined by 1H NMR spectroscopy. [c] Determined 
by chiral HPLC.  
 





The following acids afforded only traces (<5%) of the desired cycloaddition product. 
 
 
6. General procedure for the recycling experiments  
To a solution of (Z)-4-benzylidene-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one 2a (0.15 mmol, 
39.3 mg, 1.0 equiv.) in CH2Cl2 (1.5 mL) were added phenylacetic acid 3a (0.30 mmol, 40.8 mg, 
2.0 equiv.) and polymer-supported BTM 1 (0.015 mmol, 16.8 mg, 10 mol%). The mixture was 
shaken at 0 ºC in an ice bath. Then, i-Pr2NEt (0.30 mmol, 52.2 µL, 2.0 equiv.) and pivaloyl 
chloride (0.30 mmol, 36.8 µL, 2.0 equiv.) were added dropwise. The reaction was shaken from 0 
ºC to r.t. for 2 hours and the resin was filtered off and washed with freshly distilled CH2Cl2 (3 × 
1 mL). The recovered catalyst was gently dried under vacuum at 30 ºC for 2-3 h. The dried catalyst 
























































Entry x y z Conv. (%)[b] dr[b] ee (%)[c] 
1 2.0 2.0 2.5 >95 8:1 98 
2 2.0 2.0 2.0 >95 9:1 99 






Isolated yield. [b] Determined by chiral HPLC. [c] Reactions run for 24 h.  
 
7. General procedure for the continuous flow process 
The packed-bed reactor consisted of a vertically mounted Omnifit glass chromatography column 
(10 mm pore size and up to maximal 70 mm of adjustable bed height) loaded with the PS-BTM 
1a (600 mg, 0.54 mmol; ƒ = 0.9 mmol·g–1). The resin was swollen by pumping freshly distilled 
CH2Cl2 at 100 µL min–1 for 30 min. The three streams used to introduce reagents in the system 
were (see diagram below): 
(a) A mixture of i-Pr2NEt and phenylacetic acid in CH2Cl2 (0.8 M each). 
(b) A solution of pivaloyl chloride (0.8 M in CH2Cl2). 
(c) A solution of 2a (0.2 M) in freshly distilled CH2Cl2 through a P 4.1S Azura pump 
developed by Knauer at 50 µL min–1. 
Solutions (a) and (b) were pumped through a Legato 270 push/pull dual syringe pump developed 
by KD scientific in 2 different syringes with a flow of 25.0 µL min–1 for each of them (50 µL 
min–1 combined flow rate a + b). 
 
A T-type mixing chamber mixed current (a+b) with (c) before the combined stream reached the 
reactor (total flow rate: 100 µL min–1). Conversion and enantiomeric ratio of the final product 
were determined by 1H NMR spectroscopy and HPLC analysis respectively of periodically 
collected samples. The experiment was run for 18 h and was stopped when a slight deactivation 
of the catalyst was detected. All of the final crude products were combined, washed with water 
and the aqueous layer was extracted with CH2Cl2. Combined organic layers were dried over 
NaSO4, filtered and concentrated under reduced pressure. The crude residue was recrystallized to 

























Cat. 1a (10 mol%)
PivCl (2.0 equiv.)
Cycle Yield. (%)[a] ee (%)[b]  Cycle Yield (%)[a ] ee (%)[b] 
1 83 99  7 64 98 
2 84 98  8 58 98 
3 79 98  9 48 96 
4 78 98  10 75 89[c] 
5 74 98  11 56 89[c] 





















































Entry Time Period Conv. (%)[a ] ee (%)[b] 
1 1 h 1 h >99 97 
2 2 h 1 h >99 98 
3 3 h 1 h >99 98 
4 5 h 2 h >99 98 
5 7 h 2 h >99 98 
6 12 h 5 h 99 98 
7 14 h 2 h 98 98 
8 16 h 2 h 96 98 











8. Configuration and X-Ray structures 
 
The structures depicted below have been deposited in the Cambridge Crystallographic Data 
Centre with the following CCDC Numbers: 
 4b   –   CCDC 1519361 
6a   –   CCDC 1519360 
8c   –   CCDC 1519359 












































9. Stereochemical models 
 
The following stereochemical models for the pyrazolone and the thiazolone have been proposed 
according to the X-ray structures and literature precedents. The depicted attack minimizes 
undesired gauche interactions between R1 and R2, but leads to the C5-epimer of the observed 
compound (C6 in the second case, due to the different numbering of the heterocyclic moiety). 
Subsequently, an epimerization of the relatively acidic stereocentre takes place to lead to the 
observed major diastereomer. Such an epimerization has been previously described by Smith et 
al.[4] for related systems. In the same paper, going from (E) to (Z)-Michael acceptors entailed a 
change in the major diastereomer obtained (before epimerization). In our case, however, given 
that the electrophile is trisubstituted and no chelation is expected, we postulate that the E/Z 
stereochemistry of the electrophile does not have an impact in the stereochemical outcome of the 
reaction. 















































































10. Compound characterization 
 (4R,5R)-3-Methyl-1,4,5-triphenyl-4,5-dihydropyrano[2,3-c]pyrazol-6(1H)-one 
Cycloaddition product 4a was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 83% yield (9:1 dr) and the major 
diastereoisomer was isolated in 74% yield (28.0 mg). White solid, melting 
point: 160-162 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.87 (s, 3H), 4.13 (d, J = 
6.8 Hz, 1H), 4.33 (d, J = 6.8 Hz, 1H), 7.09-7.14 (m, 4H), 7.24-7.32 (m, 7H), 7.44-7.48 (m, 2H), 
7.77-7.80 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.0, 43.2, 54.8, 99.1, 120.9 (2C), 126.6, 
127.5 (2C), 127.6, 128.0, 128.2 (2C), 128.9 (2C), 129.0 (2C), 129.2 (2C), 135.8, 137.6, 140.2, 
146.3, 146.3, 166.6; IR (ATR): ν = 506, 693, 938, 1066, 1094, 1309, 1454, 1485, 1594, 1687, 
1784, 2925 cm–1; HRMS calcd. for C25H20N2NaO2 [M + Na]+: 403.1417, found: 403.1409; [α]D25 
= –109.7 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (98:2), flow rate = 1.0 mL 




Cycloaddition product 4b was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 83% yield (9:1 dr) and the major 
diastereoisomer was isolated in 72% yield (32.8 mg). White solid, melting 
point: 154-155 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.86 (s, 3H), 4.03 (d, J = 
7.6 Hz, 1H), 4.30 (d, J = 7.6 Hz, 1H), 6.96-6.98 (m, 2H), 7.09-7.11 (m, 2H), 
7.29-7.32 (m, 4H), 7.40-7.42 (m, 2H), 7.45-7.49 (m, 2H), 7.76-7.78 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 13.2, 42.8, 54.7, 98.6, 120.9 (2C), 121.6, 126.7, 128.2, 128.3 (2C), 129.0 (2C), 129.3 
(2C), 129.3 (2C), 132.1 (2C), 135.3, 137.5, 139.2, 146.0, 146.3, 166.3; IR (ATR): ν = 699, 732, 
932, 1010, 1066, 1100, 1396, 1452, 1487, 1513, 1617, 1787, 2923 cm–1; HRMS calcd. for 
C25H20BrN2O2 [M + H]+: 459.0703, found: 459.0708; [α]D25 = –99.2 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 99% ee): tmajor = 




Cycloaddition product 4c was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 14:1 to 6:1) in 81% yield (7:1 dr) and the major 
diastereoisomer was isolated in 70% yield (29.0 mg). White solid, melting 
point: 120-121 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.85 (s, 3H), 4.03 (d, J = 
7.8 Hz, 1H), 4.31 (d, J = 7.8 Hz, 1H), 7.01-7.04 (m, 2H), 7.08-7.11 (m, 2H), 




















42.8, 54.8, 98.7, 120.9 (2C), 126.7, 128.2, 128.3 (2C), 128.9 (2C), 129.0 (2C), 129.2 (2C), 129.3 
(2C), 133.5, 135.3, 137.5, 138.6, 146.1, 146.3, 166.3; IR (ATR): ν = 693, 753, 824, 1014, 1089, 
1409, 1454, 1491, 1596, 1703, 1790, 2924 cm–1; HRMS calcd. for C25H20ClN2O2 [M + H]+: 
415.1208, found: 415.1201; [α]D25 = –116.2 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-





Cycloaddition product 4d was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 82% yield (8:1 dr) and the major 
diastereoisomer was isolated in 72% yield (28.7 mg). White solid, melting 
point: 121-123 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.85 (s, 3H), 4.04 (d, J = 
7.6 Hz, 1H), 4.32 (d, J = 7.6 Hz, 1H), 6.95-6.99 (m, 2H), 7.04-7.11 (m, 4H), 
7.28-7.32 (m, 4H), 7.44-7.48 (m, 2H), 7.76-7.79 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.1, 
42.6, 55.0, 99.0, 115.9 (d, J = 21.6 Hz, 2C), 120.9 (2C), 126.7, 128.1, 128.3 (2C), 128.9 (2C), 
129.2 (d, J = 8.2 Hz, 2C), 129.3 (2C), 135.5, 135.9 (d, J = 3.2 Hz), 137.6, 146.1, 146.3, 162.1 (d, 
J = 246.8 Hz), 166.4; IR (ATR): ν = 511, 693, 735, 759, 840, 930, 1096, 1224, 1453, 1508, 1598, 
1783, 2925 cm–1; HRMS calcd. for C25H19FN2NaO2 [M + Na]+: 421.1323, found: 421.1310; [α]D25 
= –46.5 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–
1, λ = 254 nm, 98% ee): tmajor = 12.0 min, tminor = 9.7 min.  
 
(4R,5R)-3-Methyl-1,5-diphenyl-4-(p-tolyl)-4,5-dihydropyrano[2,3-c]pyrazol-6(1H)-one 
Cycloaddition product 4e was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 72% yield (5:1 dr) and the major 
diastereoisomer was isolated in 60% yield (23.7 mg). White solid, melting 
point: 127-128 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.88 (s, 3H), 2.31 (s, 
3H), 4.11 (d, J = 6.8 Hz, 1H), 4.29 (d, J = 6.8 Hz, 1H), 6.97-6.99 (m, 2H), 
7.07-7.15 (m, 4H), 7.26-7.31 (m, 4H), 7.46 (t, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 2H); 13C NMR 
(100 MHz, CDCl3): δ = 13.0, 21.0, 42.7, 54.9, 99.3, 120.9 (2C), 126.5, 127.4 (2C), 128.0, 128.2 
(2C), 128.9 (2C), 129.2 (2C), 129.6 (2C), 136.0, 137.3, 137.3, 137.7, 146.3, 146.3, 166.7; IR 
(ATR): ν = 510, 665, 694, 735, 757, 931, 1060, 1099, 1452, 1487, 1616, 1787, 2923 cm–1; HRMS 
calcd. for C26H22N2NaO2 [M + Na]+: 417.1573, found: 417.1560; [α]D25 = –89.7 (c = 0.1, CHCl3); 
HPLC (Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 99% ee): 



















Cycloaddition product 4f was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 14:1 to 7:1) in 84% yield (7:1 dr) and the major 
diastereoisomer was isolated in 74% yield (30.6 mg). White solid, melting 
point: 128-130 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.90 (s, 3H), 4.08 (d, J 
= 6.4 Hz, 1H), 4.31 (d, J = 6.4 Hz, 1H), 6.95-6.98 (m, 1H), 7.11-7.13 (m, 3H), 7.20-7.25 (m, 2H), 
7.29-7.33 (m, 4H), 7.45-7.49 (m, 2H), 7.77-7.79 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.1, 
42.9, 54.6, 98.3, 120.9 (2C), 125.8, 126.7, 127.7, 128.0, 128.2 (2C), 128.2, 129.0 (2C), 129.3 
(2C), 130.3, 134.9, 135.4, 137.5, 142.3, 146.1, 146.4, 166.2; IR (ATR): ν = 513, 663, 695, 734, 
942, 1065, 1095, 1385, 1433, 1485, 1620, 1786, 2924 cm–1; HRMS calcd. for C25H20ClN2O2 [M 
+ H]+: 415.1208, found: 415.1199; [α]D25 = –79.8 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-
propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 97% ee): tmajor = 10.9 min, tminor = 8.6 min.  
 
(4R,5R)-3-Methyl-1,5-diphenyl-4-(m-tolyl)-4,5-dihydropyrano[2,3-c]pyrazol-6(1H)-one: 
Cycloaddition product 4g was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 71% yield (7:1 dr) and the major 
diastereoisomer was isolated in 62% yield (24.5 mg). White solid, melting 
point: 178-179 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.91 (s, 3H), 2.29 (s, 
3H), 4.13 (d, J = 6.4 Hz, 1H), 4.29 (d, J = 6.4 Hz, 1H), 6.88-6.91 (m, 2H), 7.04-7.06 (m, 1H), 
7.13-7.18 (m, 3H), 7.25-7.31 (m, 4H), 7.43-7.48 (m, 2H), 7.78-7.81 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 13.0, 21.4, 42.9, 54.7, 99.0, 120.8 (2C), 124.5, 126.5, 128.0 (2C), 128.1 (2C), 128.4, 
128.8, 128.9 (2C), 129.2 (2C), 136.0, 137.7, 138.7, 140.3, 146.3, 146.3, 166.7; IR (ATR): ν = 506, 
696, 729, 782, 944, 1062, 1091, 1388, 1484, 1513, 1612, 1784, 2923 cm–1; HRMS calcd. for 
C26H22N2NaO2 [M + Na]+: 417.1573, found: 417.1559; [α]D25 = –108.9 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 99% ee): tmajor = 




Cycloaddition product 4h was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 68% yield (28.0 mg, >20:1 dr). 
Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 2.04 (s, 3H), 3.79 (s, 3H), 
4.25 (d, J = 2.0 Hz, 1H), 4.41 (d, J = 2.0 Hz, 1H), 6.88-6.93 (m, 2H), 7.07-
7.10 (m, 1H), 7.25-7.34 (m, 7H), 7.43-7.47 (m, 2H), 7.79-7.82 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 12.7, 39.8, 52.0, 54.6, 97.2, 111.0, 120.7 (3C), 126.3, 127.3 (2C), 128.0, 128.6, 128.9, 





















943, 1125, 1217, 1365, 1456, 1490, 1508, 1598, 1738, 1791, 2970 cm–1; HRMS calcd. for 
C26H23N2O3 [M + H]+: 411.1703, found: 411.1698; [α]D25 =        –121.3 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 99% ee): tmajor = 




Cycloaddition product 4i was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 81% yield (6:1 dr) and the major 
diastereoisomer was isolated in 69% yield. White solid, melting point: 152-
153 ºC. 1H NMR (400 MHz, CDCl3): δ = 2.04 (s, 3H), 4.27 (d, J = 6.0 Hz, 
1H), 4.63 (d, J = 6.0 Hz, 1H), 6.77-6.78 (m, 1H), 6.88-6.91 (m, 1H), 7.17-7.22 (m, 3H), 7.28-7.34 
(m, 4H), 7.44-7.48 (m, 2H), 7.76-7.78 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.8, 38.2, 55.4, 
99.2, 120.9 (2C), 125.0, 125.4, 126.7, 127.1, 127.9 (2C), 128.2, 129.0 (2C), 129.2 (2C), 135.4, 
137.5, 144.3, 145.9, 146.2, 166.1; IR (ATR): ν = 505, 665, 691, 908, 930, 1060, 1092, 1386, 1453, 
1485, 1618, 1787, 2924 cm–1; HRMS calcd. for C23H19N2O2S [M + H]+: 387.1162, found: 
387.1156; [α]D25 = –35.7 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (95:5), flow 




Cycloaddition product 4j was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 75% yield (7:1 dr) and the major 
diastereoisomer was isolated in 64% yield (29.3 mg). White solid, melting 
point: 138-139 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.80 (s, 3H), 4.06 (d, J 
= 8.4 Hz, 1H), 4.27 (d, J = 8.4 Hz, 1H), 6.95-6.98 (m, 2H), 7.06-7.09 (m, 
2H), 7.25-7.32 (m, 4H), 7.38-7.42 (m, 2H), 7.44-7.49 (m, 2H), 7.75-7.78 (m, 2H); 13C NMR (100 
MHz, CDCl3): δ = 13.4, 43.4, 54.4, 99.1, 120.9 (2C), 122.1, 126.7, 127.7 (2C), 127.8, 129.0 (2C), 
129.3 (2C), 130.2 (2C), 131.9 (2C), 134.6, 137.5, 139.5, 146.1, 146.2, 166.3; IR (ATR): ν = 506, 
666, 697, 757, 934, 1066, 1099, 1394, 1454, 1488, 1595, 1786, 2924 cm–1; HRMS calcd. for 
C25H20BrN2O2 [M + H]+: 459.0703, found: 459.0706; [α]D25 = –68.0 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (98:2), flow rate = 1.0 mL min–1, λ = 254 nm, 98% ee): tmajor = 






















Cycloaddition product 4k was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 5:1) in 82% yield (6:1 dr) and the major 
diastereoisomer was isolated in 70% yield (28.7 mg). White solid, melting 
point: 89-90 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.87 (s, 3H), 3.76 (s, 3H), 
4.08 (d, J = 6.8 Hz, 1H), 4.29 (d, J = 6.8 Hz, 1H), 6.79-6.83 (m, 2H), 7.03-
7.05 (m, 2H), 7.09-7.11 (m, 2H), 7.22-7.31 (m, 4H), 7.43-7.47 (m, 2H), 7.77-7.79 (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 13.0, 43.1, 54.0, 55.2, 99.2, 114.3 (2C), 120.8 (2C), 126.5, 127.5 
(2C), 127.6, 127.7, 129.0 (2C), 129.2 (2C), 129.3 (2C), 137.6, 140.3, 146.3, 146.3, 159.2, 166.9; 
IR (ATR): ν = 694, 753, 834, 943, 1031, 1066, 1097, 1178, 1245, 1454, 1510, 1612, 1788, 2924 
cm–1; HRMS calcd. for C26H23N2O3 [M + H]+: 411.1703, found: 411.1708; [α]D25 = –87.8 (c = 
0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (98:2), flow rate = 1.0 mL min–1, λ = 254 
nm, 98% ee): tmajor = 18.7 min, tminor = 21.5 min. 
 
(4R,5R)-3-Methyl-1,4-diphenyl-5-(m-tolyl)-4,5-dihydropyrano[2,3-c]pyrazol-6(1H)-one 
Cycloaddition product 4l was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 86% yield (6:1 dr) and the major 
diastereoisomer was isolated in 73% yield (28.8 mg). White solid, melting 
point: 112-114 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.89 (s, 3H), 2.29 (s, 
3H), 4.09 (d, J = 6.4 Hz, 1H), 4.33 (d, J = 6.8 Hz, 1H), 6.91-6.96 (m, 2H), 7.07-7.19 (m, 4H), 
7.23-7.31 (m, 4H), 7.44-7.48 (m, 2H), 7.77-7.80 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 13.0, 
21.4, 43.0, 54.7, 99.0, 120.9 (2C), 125.0, 126.5, 127.5 (2C), 127.6, 128.8, 128.8, 129.0 (2C), 
129.0, 129.2 (2C), 135.8, 137.7, 138.6, 140.5, 146.3, 146.3, 166.7; IR (ATR): ν = 697, 749, 1094, 
1397, 1454, 1491, 1599, 1702, 1788, 2923 cm–1; HRMS calcd. for C26H23N2O2 [M + H]+: 
395.1754, found: 395.1757; [α]D25 = –115.4 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-




Cycloaddition product 4m was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 73% yield (5:1 dr) and the major 
diastereoisomer was isolated in 61% yield (26.9 mg). White solid, 
melting point: 93-95 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.89 (s, 3H), 
3.70 (s, 6H), 4.06 (d, J = 6.4 Hz, 1H), 4.33 (d, J = 6.4 Hz, 1H), 6.28-6.29 
(m, 2H), 6.35-6.37 (m, 1H), 7.11-7.14 (m, 2H), 7.25-7.32 (m, 4H), 7.44-7.48 (m, 2H), 7.76-7.79 

























120.9 (2C), 126.6, 127.5 (2C), 127.7, 129.0 (2C), 129.2 (2C), 137.6, 137.9, 140.3, 146.3, 146.3, 
160.9 (2C), 166.4; IR (ATR): ν = 692, 754, 834, 1063, 1151, 1203, 1455, 1594, 1716, 1790, 2924 
cm–1; HRMS calcd. for C27H25N2O4 [M + H]+: 441.1816, found: 411.1819; [α]D25 = –177.6 (c = 
0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 




Cycloaddition product 4n was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 7:1) in 81% yield (13:1 dr) and the major 
diastereoisomer was isolated in 75% yield (32.3 mg). White solid, melting 
point: 124-126 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.83 (s, 3H), 4.50 (d, 
J = 6.8 Hz, 1H), 4.77 (d, J = 6.8 Hz, 1H), 7.08-7.14 (m, 3H), 7.23-7.34 (m, 
5H), 7.47-7.57 (m, 4H), 7.79 (d, J = 8.0 Hz, 1H), 7.84-7.90 (m, 4H); 13C NMR (100 MHz, CDCl3): 
δ = 13.1, 43.0, 51.8, 99.0, 120.9 (2C), 123.2, 125.2, 125.9, 126.4, 126.6, 126.7, 127.4 (2C), 127.7, 
129.0 (3C), 129.3 (2C), 129.4, 130.5, 132.2, 134.2, 137.7, 140.9, 146.2, 146.5, 166.4; IR (ATR): 
ν = 691, 754, 793, 934, 1026, 1070, 1102, 1393, 1486, 1510, 1596, 1776, 2922 cm–1; HRMS 
calcd. for C29H23N2O2 [M + H]+: 431.1754, found: 431.1742; [α]D25 = –58.4 (c = 0.1, CHCl3); 
HPLC (Chiralcel IA, hexane/i-propanol (95:5), flow rate = 1.0 mL min–1, λ = 254 nm, 96% ee): 




Cycloaddition product 4o was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 12:1 to 5:1) in 85% yield (5:1 dr) and the major 
diastereoisomer was isolated in 70% yield (30.2 mg). White solid, melting 
point: 93-94 ºC. 1H NMR (400 MHz, CDCl3): δ = 2.06 (s, 3H), 3.68 (s, 3H), 
4.45 (d, J = 3.6 Hz, 1H), 4.48 (d, J = 3.6 Hz, 1H), 6.73 (s, 1H), 7.16-7.19 (m, 
3H), 7.26-7.35 (m, 6H), 7.42-7.46 (m, 2H), 7.68 (d, J = 8.0 Hz, 1H), 7.79-7.81 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ = 12.8, 32.9, 41.9, 46.4, 99.0, 109.4, 109.6, 118.9, 119.9, 120.6 (2C), 122.4, 
126.4 (3C), 127.0 (2C), 127.6, 129.1 (2C), 129.2 (2C), 136.8, 137.8, 141.4, 146.4, 146.7, 165.8; 
IR (ATR): ν = 690, 739, 926, 1059, 1122, 1332, 1390, 1440, 1509, 1596, 1784, 2849, 2923 cm–
1; HRMS calcd. for C28H23N3NaO2 [M + Na]+: 456.1682, found: 456.1686; [α]D25 = –146.0 (c = 
0.1, CHCl3); HPLC (Chiralcel IC, hexane/i-propanol (90:10), flow rate = 1.0 mL min–1, λ = 254 




















Cycloaddition product 6a was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 7:1) in 77% yield (29.5 mg, >20:1 dr). White 
solid, melting point: 179-180 ºC. 1H NMR (400 MHz, CDCl3): δ = 4.20 (d, J = 
7.8 Hz, 1H), 4.53 (d, J = 7.8 Hz, 1H), 7.11-7.15 (m, 4H), 7.25-7.32 (m, 6H), 
7.41-7.45 (m, 3H), 7.87-7.90 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 44.7, 54.7, 110.1, 125.8 
(2C), 127.4 (2C), 128.0, 128.2, 128.3 (2C), 128.9 (2C), 129.0 (2C), 129.1 (2C), 130.7, 132.8, 
135.5, 140.3, 155.8, 165.7, 167.1; IR (ATR): ν = 696, 763, 902, 998, 1129, 1242, 1364, 1454, 
1496, 1560, 1774, 2923 cm–1; HRMS calcd. for C24H17NNaO2S [M + Na]+: 406.0872, found: 
406.0865; [α]D25 = –19.3 (c = 0.1, CHCl3); HPLC (Chiralcel IC, hexane/i-propanol (75:25), flow 
rate = 1.0 mL min–1, λ = 210 nm, 99% ee): tmajor = 61.7 min, tminor = 75.0 min. 
 
(6R,7R)-6-(4-Fluorophenyl)-2,7-diphenyl-6,7-dihydro-5H-pyrano[2,3-d]thiazol-5-one 
Cycloaddition product 6b was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 7:1) in 70% yield (>20:1 dr). White 
solid, melting point: 180-181 ºC. 1H NMR (400 MHz, CDCl3): δ = 4.15 
(d, J = 8.4 Hz, 1H), 4.47 (d, J = 8.4 Hz, 1H), 6.94-6.98 (m, 2H), 7.05-7.11 (m, 4H), 7.26-7.31 (m, 
3H), 7.40-7.44 (m, 3H), 7.87-7.89 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 44.9, 54.1, 110.3, 
115.8 (d, J = 21.7 Hz, 2C), 125.8 (2C), 127.5 (2C), 128.3, 129.0 (2C), 129.1 (2C), 130.2 (d, J = 
8.2 Hz, 2C), 130.8, 131.0 (d, J = 3.4 Hz), 132.7, 139.9, 155.7, 162.3 (d, J = 247.4 Hz), 165.7, 
167.0; IR (ATR): ν = 499, 524, 643, 680, 763, 782, 827, 945, 1113, 1228, 1351, 1456, 1509, 1561, 
1603, 1769, 2923 cm–1; HRMS calcd. for C24H17FNO2S [M + H]+: 402.0959, found: 402.0952; 
[α]D25 = –31.6 (c = 0.1, CHCl3); HPLC (Chiralcel IC, hexane/i-propanol (75:25), flow rate = 1.0 
mL min–1, λ = 210 nm, 99% ee): tmajor = 57.9 min, tminor = 78.9 min. 
 
(6R,7R)-2,7-Diphenyl-6-(p-tolyl)-6,7-dihydro-5H-pyrano[2,3-d]thiazol-5-one Cycloaddition 
product 6c was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 7:1) in 73% yield (28.9 mg, >20:1 
dr). White solid, melting point: 181-182 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 2.29 (s, 3H), 4.17 (d, J = 7.6 Hz, 1H), 4.50 (d, J = 7.6 Hz, 1H), 7.01-7.09 (m, 4H), 
7.11-7.14 (m, 2H), 7.26-7.32 (m, 3H), 7.39-7.45 (m, 3H), 7.87-7.90 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 21.1, 44.6, 54.3, 110.1, 125.8 (2C), 127.3 (2C), 128.0 (2C), 128.1, 129.0 (2C), 129.1 
(2C), 129.6 (2C), 130.7, 132.4, 132.8, 137.8, 140.4, 155.8, 165.6, 167.2; IR (ATR): ν = 500, 636, 
674, 754, 775, 814, 931, 1100, 1238, 1308, 1352, 1456, 1518, 1564, 1772, 2917 cm–1; HRMS 
calcd. for C25H20NO2S [M + H]+: 398.1209, found: 398.1218; [α]D25 = –70.3 (c = 0.1, CHCl3); 
HPLC (Chiralcel IC, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 210 nm, 99% ee): 
























product 6d was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 15:1 to 7:1) in 71% yield (28.2 mg, >20:1 dr). 
White solid, melting point: 184-185 ºC. 1H NMR (400 MHz, CDCl3): δ 
= 2.28 (s, 3H), 4.17 (d, J = 7.6 Hz, 1H), 4.52 (d, J = 7.6 Hz, 1H), 6.92-6.97 (m, 2H), 7.06-7.07 
(m, 1H), 7.12-7.18 (m, 3H), 7.27-7.33 (m, 3H), 7.40-7.45 (m, 3H), 7.88-7.90 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ = 21.4, 44.6, 54.6, 110.0, 125.0, 125.8 (2C), 127.3 (2C), 128.1, 128.7, 128.8, 
128.9, 129.0 (2C), 129.1 (2C), 130.7, 132.8, 135.4, 138.6, 140.4, 155.8, 165.6, 167.1; IR (ATR): 
ν = 680, 731, 762, 955, 1106, 1243, 1349, 1455, 1490, 1562, 1770, 2922 cm–1; HRMS calcd. for 
C25H20NO2S [M + H]+: 398.1209, found: 398.1209; [α]D25 = –105.6 (c = 0.1, CHCl3); HPLC 
(Chiralcel AD-H, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 210 nm, 99% ee): 
tmajor = 20.6 min, tminor = 13.5 min.  
 
(6R,7R)-2,7-Diphenyl-6-(o-tolyl)-6,7-dihydro-5H-pyrano[2,3-d]thiazol-5-one Cycloaddition 
product 6e was isolated by FC on silica (eluting with cyclohexane/EtOAc 
from 15:1 to 7:1) in 68% yield (27.0 mg, >20:1 dr). White solid, melting 
point: 88-89 ºC. 1H NMR (400 MHz, CDCl3): δ = 2.10 (s, 3H), 4.39 (d, J 
= 8.8 Hz, 1H), 4.49 (d, J = 8.8 Hz, 1H), 7.08-7.18 (m, 6H), 7.26-7.29 (m, 3H), 7.40-7.45 (m, 3H), 
7.87-7.92 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 19.7, 44.6, 51.0, 110.4, 125.8 (2C), 126.6, 
127.5 (2C), 128.0, 128.0, 128.2, 129.0 (2C), 129.0 (2C), 130.7, 130.8, 132.8, 134.3, 136.4, 140.4, 
155.9, 165.6, 167.1; IR (ATR): ν = 681, 740, 934, 969, 1103, 1236, 1352, 1455, 1494, 1562, 1777, 
2924 cm–1; HRMS calcd. for C25H19NNaO2S [M + Na]+: 420.1029, found: 420.1032; [α]D25 = –
8.9 (c = 0.1, CHCl3); HPLC (Chiralcel AD-H, hexane/i-propanol (80:20), flow rate = 1.0 mL min–
1, λ = 210 nm, 99% ee): tmajor = 18.3 min, tminor = 11.1 min.  
 
(S)-3,4,4-Trimethyl-1,5-diphenyl-4,5-dihydropyrano[2,3-c]pyrazol-6(1H)-one 
Cycloaddition product 8a was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 20:1 to 10:1) as a colorless oil in 21% yield. 1H NMR 
(400 MHz, CDCl3): δ = 1.19 (s, 3H), 1.35 (s, 3H), 2.36 (s, 3H), 3.84 (s, 1H), 
7.19-7.21 (m, 2H), 7.27-7.31 (m, 1H), 7.33-7.36 (m, 3H), 7.43-7.47 (m, 2H), 
7.75-7.77 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 14.8, 24.5, 28.2, 35.2, 59.1, 105.7, 121.0 
(2C), 126.5, 128.1, 128.4 (2C), 129.2 (2C), 130.2 (2C), 133.3, 137.6, 144.8, 144.9, 167.3; IR 
(ATR): ν = 667, 693, 755, 901, 1058, 1110, 1392, 1454, 1510, 1599, 1787, 2971 cm–1; HRMS 
calcd. for C21H21N2O2 [M + H]+: 333.1598, found: 333.1600; [α]D25 = +34.0 (c = 0.1, CHCl3); 
HPLC (Chiralcel IA, hexane/i-propanol (98:2), flow rate = 1.0 mL min–1, λ = 254 nm, 96% ee): 



























Cycloaddition product 8b was isolated by FC on silica (eluting from CH2Cl2 
to CH2Cl2/EtOAc 20:1) in 88% yield (2:1 dr), the major diastereoisomer was 
isolated in 58% yield (25.2 mg) and the minor diastereoisomer was isolated 
in 29% yield (12.6 mg). Major diastereoisomer: white solid, melting point: 
190-191 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.83 (s, 3H), 3.01 (s, 3H), 4.56 (s, 1H), 6.66 (d, J 
= 7.6 Hz, 1H), 6.86-6.88 (m, 2H), 6.95-6.97 (m, 1H), 7.01-7.05 (m, 1H), 7.09-7.13 (m, 2H), 7.18-
7.22 (m, 1H), 7.26-7.35 (m, 2H), 7.47-7.51 (m, 2H), 7.78-7.81 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 12.7, 26.4, 51.7, 53.3, 97.8, 108.5, 121.2 (2C), 123.1, 124.7, 126.9, 127.1, 127.8 (2C), 
128.4, 129.3 (2C), 129.6, 130.0 (2C), 130.6, 137.4, 142.9, 144.6, 147.4, 165.5, 174.8; IR (ATR): 
ν = 538, 685, 740, 969, 1057, 1092, 1368, 1489, 1511, 1609, 1706, 1787, 2925 cm–1; HRMS 
calcd. for C27H22N3O3 [M + H]+: 436.1656, found: 436.1649; [α]D25 = +254.5 (c = 0.1, CHCl3); 
HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 254 nm, 96% ee): 




Minor diastereoisomer 8b´: white solid, melting point: 182-183 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 1.57 (s, 3H), 2.97 (s, 3H), 4.37 (s, 1H), 6.59 (d, J = 
8.0 Hz, 1H), 7.01-7.03 (m, 2H), 7.09-7.17 (m, 4H), 7.23-7.27 (m, 1H), 7.29-
7.33 (m, 1H), 7.38-7.40 (m, 1H), 7.45-7.49 (m, 2H), 7.78-7.81 (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 13.0, 26.1, 52.2, 53.8, 97.4, 108.6, 121.3 (2C), 123.0, 124.1, 126.7, 
126.8, 127.7 (2C), 128.2, 129.2 (2C), 129.6, 130.2 (2C), 130.5, 137.5, 144.0, 144.7, 147.8, 165.2, 
175.0; IR (ATR): ν = 696, 726, 751, 967, 1063, 1098, 1350, 1372, 1455, 1491, 1517, 1610, 1712, 
1791, 2923 cm–1; HRMS calcd. for C27H22N3O3 [M + H]+: 436.1656, found: 436.1663; [α]D25 = –
63.6 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–





Cycloaddition product 8c was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 20:1) in 89% yield (2.5:1 dr), the major 
diastereoisomer was isolated in 62% yield (29.0 mg) and the minor 
diastereoisomer was isolated in 27% yield (12.7 mg). Major 































(s, 3H), 3.03 (s, 3H), 4.61 (s, 1H), 6.69 (d, J = 7.6 Hz, 1H), 6.79-6.82 (m, 2H), 7.05-7.10 (m, 4H), 
7.27-7.35 (m, 2H), 7.46-7.50 (m, 2H), 7.76-7.79 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.6, 
26.4, 51.7, 52.7, 97.9, 108.7, 121.1 (2C), 123.3, 124.4, 126.9 (2C), 128.0 (2C), 129.0, 129.3 (2C), 
129.8, 131.4 (2C), 134.5, 137.4, 142.7, 144.4, 147.1, 165.3, 174.4; IR (ATR): ν = 538, 687, 756, 
850, 915, 971, 1015, 1056, 1087, 1371, 1491, 1510, 1610, 1715, 1792, 3068 cm–1; HRMS calcd. 
for C27H21ClN3O3 [M + H]+: 470.1266, found: 470.1254; [α]D25 = +305.1 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 254 nm, 89% ee): tmajor = 




Minor diastereoisomer 8c´:  white solid, melting point: 143-145 ºC. 1H 
NMR (400 MHz, CDCl3): δ = 1.55 (s, 3H), 3.00 (s, 3H), 4.36 (s, 1H), 
6.66 (d, J = 7.6 Hz, 1H), 6.96-6.98 (m, 2H), 7.08-7.11 (m, 2H), 7.13-
7.17 (m, 1H), 7.27-7.34 (m, 2H), 7.37-7.39 (m, 1H), 7.45-7.49 (m, 2H), 
7.77-7.79 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.9, 26.2, 52.2, 53.1, 97.2, 108.9, 121.3 
(2C), 123.2, 124.0, 126.4, 126.9, 128.0 (2C), 129.2, 129.2 (2C), 129.8, 131.6 (2C), 134.3, 137.4, 
143.9, 144.6, 147.7, 164.9, 174.8; IR (ATR): ν = 537, 691, 752, 855, 968, 1060, 1087, 1372, 1492, 
1516, 1610, 1706, 1797, 2925 cm–1; HRMS calcd. for C27H21ClN3O3 [M + H]+: 470.1266, found: 
470.1262;  [α]D25 = –24.0 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow 




Cycloaddition product 8d was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 20:1) in 91% yield (3:1 dr) and the major 
diastereoisomer was isolated in 67% yield (29.9 mg). White solid, 
melting point: 182-184 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.82 (s, 3H), 
2.24 (s, 3H), 3.03 (s, 3H), 4.51 (s, 1H), 6.69 (d, J = 7.6 Hz, 1H), 6.74-6.76 (m, 2H), 6.90-6.95  (m, 
3H), 7.01-7.05 (m, 1H), 7.26-7.34 (m, 2H), 7.46-7.50 (m, 2H), 7.78-7.80 (m, 2H); 13C NMR (100 
MHz, CDCl3): δ = 12.7, 21.1, 26.4, 51.6, 52.9, 97.9, 108.5, 121.1 (2C), 123.0, 124.8, 126.8, 127.1, 
127.6, 128.6 (2C), 129.3 (2C), 129.5, 129.8 (2C), 137.5, 138.2, 143.0, 144.6, 147.4, 165.7, 174.9; 
IR (ATR): ν = 539, 688, 755, 913, 1054, 1087, 1371, 1492, 1509, 1609, 1713, 1799, 2923 cm–1; 
HRMS calcd. for C28H24N3O3 [M + H]+: 450.1812, found: 450.1809; [α]D25 = +246.7 (c = 0.1, 
CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 254 nm, 


























Cycloaddition product 8e was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 20:1) in 88% yield (3:1 dr) and the major 
diastereoisomer was isolated in 65% yield (29.0 mg). White solid, 
melting point: 156-158 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.82 (s, 3H), 
2.14 (s, 3H), 3.01 (s, 3H), 4.49 (s, 1H), 6.63-6.69 (m, 3H), 6.93-6.95  (m, 1H), 6.98-7.05 (m, 3H), 
7.25-7.34 (m, 2H), 7.47-7.51 (m, 2H), 7.78-7.80 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.7, 
21.2, 26.3, 51.6, 53.3, 97.7, 108.4, 121.2 (2C), 123.0, 124.8, 126.9 (2C), 127.2, 127.7, 129.1, 
129.3 (2C), 129.5, 130.5, 130.7, 137.5, 137.5, 143.0, 144.7, 147.4, 165.5, 174.9; IR (ATR): ν = 
687, 749, 1060, 1096, 1371, 1489, 1514, 1611, 1713, 1790, 2921 cm–1; HRMS calcd. for 
C28H24N3O3 [M + H]+: 450.1812, found: 450.1801; [α]D25 = +233.1 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 254 nm, 97% ee): tmajor = 




Cycloaddition product 8f was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 20:1) in 86% yield (3:1 dr) and the major 
diastereoisomer was isolated in 63% yield (30.2 mg). White solid, 
melting point: 125-127 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.85 (s, 3H), 
2.92 (s, 3H), 4.77 (s, 1H), 6.58 (d, J = 7.6 Hz, 1H), 6.90-6.92 (m, 1H), 7.02-7.07 (m, 2H), 7.22-
7.27 (m, 1H), 7.31-7.35 (m, 1H), 7.38-7.46 (m, 3H), 7.47-7.51 (m, 2H), 7.54 (d, J = 8.4 Hz, 1H), 
7.64-7.66 (m, 1H), 7.70-7.73 (m, 1H), 7.80-7.83 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.6, 
26.4, 51.8, 53.4, 98.0, 108.6, 121.2 (2C), 123.1, 124.7, 126.0, 126.5, 126.9, 127.0, 127.1, 127.3, 
127.4, 128.0, 128.1, 129.3 (2C), 129.6, 129.8, 132.6, 132.8, 137.4, 142.8, 144.6, 147.3, 165.6, 
174.8; IR (ATR): ν = 479, 541, 662, 689, 748, 975, 1057, 1091, 1371, 1490, 1511, 1610, 1715, 
1791, 2924 cm–1; HRMS calcd. for C31H24N3O3 [M + H]+: 486.1812, found: 486.1793; [α]D25 = 
+206.5 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (75:25), flow rate = 1.0 mL 




Cycloaddition product 8g was isolated by FC on silica (eluting from CH2Cl2 
to CH2Cl2/EtOAc 20:1) in 81% yield (3:1 dr) and the major diastereoisomer 
was isolated in 59% yield (25.9 mg). White solid, melting point: 187-188 ºC. 
































6.51 (dd, J = 1.2, 4.2 Hz, 1H), 6.73 (d, J = 7.6 Hz, 1H), 6.92-6.94 (m, 2H), 7.02-7.08 (m, 2H), 
7.28-7.34 (m, 2H), 7.46-7.50 (m, 2H), 7.77-7.80 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.7, 
26.5, 48.9, 51.4, 97.7, 108.6, 121.1 (2C), 123.2, 124.4, 125.1, 125.6, 126.9, 127.2, 127.9, 129.3 
(2C), 129.7, 130.5, 137.4, 143.0, 144.6, 147.4, 165.2, 174.9; IR (ATR): ν = 507, 661, 690, 751, 
979, 1058, 1107, 1443, 1492, 1512, 1611, 1712, 1787, 2923 cm–1; HRMS calcd. for 
C25H19N3NaO3S [M + Na]+: 464.1039, found: 464.1026; [α]D25 = +187.3 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 254 nm, 93% ee): tmajor = 




Cycloaddition product 8h was isolated by FC on silica (eluting from CH2Cl2 
to CH2Cl2/EtOAc 50:1) in 76% yield (3:1 dr) and the major diastereoisomer 
was isolated in 57% yield. White solid, melting point: 99-101 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 1.58 (s, 9H), 1.82 (s, 3H), 4.51 (s, 1H), 6.77-6.79 
(m, 1H), 6.85-6.87 (m, 2H), 7.07-7.17 (m, 3H), 7.23-7.36 (m, 3H), 7.47-7.51 (m, 2H), 7.67-7.69 
(m, 1H), 7.79-7.82 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.9, 28.0 (3C), 52.2, 54.1, 85.0, 
97.7, 115.3, 121.2 (2C), 124.7, 124.8, 125.5, 127.0, 128.2 (2C), 128.7, 129.3 (2C), 129.9, 129.9 
(2C), 130.4, 137.3, 139.3, 144.9, 147.3, 148.3, 164.7, 174.0; IR (ATR): ν = 692, 753, 840, 1146, 
1249, 1287, 1343, 1370, 1455, 1605, 1732, 2926 cm–1; HRMS calcd. for C31H28N3O5 [M + H]+: 
522.2023, found: 522.2015; [α]D25 = –104.8 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-





Cycloaddition product 8i was isolated by FC on silica (eluting with 
cyclohexane/EtOAc from 20:1 to 10:1) in 75% yield (4:1 dr) and the major 
diastereoisomer was isolated in 60% yield. White solid, melting point: 133-
135 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.28 (s, 9H), 1.84 (s, 3H), 4.54 (s, 
1H), 6.86-6.88 (m, 3H), 7.08-7.12 (m, 1H), 7.14-7.17 (m, 2H), 7.26-7.31 (m, 3H), 7.32-7.36 (m, 
1H), 7.48-7.52 (m, 2H), 7.80-7.82 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.9, 26.4 (3C), 
43.3, 52.3, 54.0, 98.3, 114.8, 121.1 (2C), 124.7, 124.8, 126.9, 127.0, 128.4 (2C), 128.9, 129.3 
(2C), 129.8, 130.0 (2C), 130.4, 137.4, 140.6, 144.6, 147.1, 165.0, 174.4, 181.5; IR (ATR): ν = 
595, 698, 752, 1022, 1075, 1179, 1302, 1398, 1456, 1472, 1617, 1700, 1798, 2925 cm–1; HRMS 






















HPLC (Chiralcel IA, hexane/i-propanol (90:10), flow rate = 1.0 mL min–1, λ = 254 nm, 97% ee): 




Cycloaddition product 8j was isolated by FC on silica (eluting with 
CH2Cl2/EtOAc from 100:1 to 10:1) in 78% yield (2:1 dr) and the major 
diastereoisomer was isolated in 53% yield. White solid, melting point: 218-
220 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.86 (s, 3H), 4.51 (s, 1H), 6.75 (d, 
J = 7.6 Hz, 1H), 6.84-6.86 (m, 1H), 6.91-6.93 (m, 2H), 6.97-7.01 (m, 1H), 7.13-7.16 (m, 2H), 
7.19-7.27 (m, 2H), 7.31-7.35 (m, 1H), 7.47-7.51 (m, 2H), 7.78-7.81 (m, 2H), 8.39 (s, 1H); 13C 
NMR (100 MHz, CDCl3): δ = 12.7, 51.9, 53.1, 97.6, 110.4, 121.2 (2C), 123.1, 125.2, 126.9, 127.3, 
128.1 (2C), 128.6, 129.3 (2C), 129.7, 130.1 (2C), 130.8, 137.4, 140.0, 144.7, 147.3, 165.3, 177.0; 
IR (ATR): ν = 695, 741, 926, 1075, 1097, 1212, 1395, 1455, 1471, 1489, 1513, 1614, 1722, 1792, 
3063 cm–1; HRMS calcd. for C26H20N3O3 [M + H]+: 422.1499, found: 422.1499; [α]D25 = +285.9 
(c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (90:10), flow rate = 1.0 mL min–1, λ = 




Cycloaddition product 8k was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 50:1) in 82% yield (4:1 dr) and the major 
diastereoisomer was isolated in 65% yield. White solid, melting point: 113-
115 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.84 (s, 3H), 2.99 (s, 3H), 4.56 
(s, 1H), 6.59 (d, J = 7.6 Hz, 1H), 6.88-6.92 (m, 3H), 7.14-7.17 (m, 2H), 7.22-7.27 (m, 2H), 7.32-
7.36 (m, 1H), 7.48-7.52 (m, 2H), 7.78-7.81 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.7, 26.5, 
51.8, 53.2, 97.1, 109.4, 121.2 (2C), 125.1, 127.0, 128.0 (2C), 128.6, 128.6, 128.8, 129.3 (2C), 
129.6, 129.9 (2C), 130.3, 137.3, 141.4, 144.5, 147.3, 165.0, 174.4; IR (ATR): ν = 692, 754, 813, 
1101, 1361, 1454, 1487, 1514, 1609, 1717, 1793, 2924 cm–1; HRMS calcd. for C27H21ClN3O3 [M 
+ H]+: 470.1266, found: 470.1263; [α]D25 = +141.3 (c = 0.1, CHCl3); HPLC (Chiralcel IA, 
hexane/i-propanol (90:10), flow rate = 1.0 mL min–1, λ = 254 nm, 93% ee): tmajor = 29.2 min, tminor 





























Cycloaddition product 8l was isolated by FC on silica (eluting from 
CH2Cl2 to CH2Cl2/EtOAc 50:1) in 92% yield (3:1 dr) and the major 
diastereoisomer was isolated in 69% yield. White solid, melting point: 
93-95 ºC. 1H NMR (400 MHz, CDCl3): δ = 1.82 (s, 3H), 3.00 (s, 3H), 
3.68 (s, 3H), 4.53 (s, 1H), 6.47 (d, J = 2.4 Hz, 1H), 6.59 (d, J = 8.4 Hz, 1H), 6.78-6.81 (m, 1H), 
6.91-6.93 (m, 2H), 7.13-7.16 (m, 2H), 7.20-7.24 (m, 1H), 7.31-7.35 (m, 1H), 7.47-7.51 (m, 2H), 
7.78-7.81 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 12.7, 26.4, 52.0, 53.2, 55.8, 97.7, 109.0, 
111.7, 114.3, 121.2 (2C), 126.9, 127.9 (2C), 128.1, 128.5, 129.3 (2C), 130.0 (2C), 130.8, 136.4, 
137.4, 144.7, 147.4, 156.2, 165.4, 174.6; IR (ATR): ν = 692, 739, 1098, 1233, 1289, 1363, 1454, 
1495, 1599, 1712, 1792, 2850, 2925 cm–1; HRMS calcd. for C28H24N3O4 [M + H]+: 466.1761, 
found: 466.1764; [α]D25 = +172.0 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol 
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Catalytic Asymmetric [8+2] Annulation Reactions Promoted by a 




Cycloaddition reactions that involve more than six π electrons can be regarded as higher- 
order cycloadditions and represent an efficient approach to synthesize medium and large 
rings. These ring systems are core scaffolds in numerous natural products and have been 
applied in total synthesis. For instance, the thermally allowed [6+4] cycloaddition of 
tropone with 1,3-butadienyl acetate was employed by Rigby et al. in the synthesis of 
tetracyclic isoingenane system (Scheme 4.1).[1] 
 
Scheme 4.1.  Higher-order cycloaddition for the synthesis of a tetracyclic isoingenane 
system 
 
General examples of higher-order cycloaddition include [8π + 2π], [6π + 4π], [4π + 4π], 
and [6π + 2π] cycloaddition reactions. Although higher-order cycloaddition reactions 
exhibit characteristics similar to the Diels-Alder reaction, most of them only proceed with 
modest chemical efficiency. This can be attributed to the fact that the extended π system 
exhibits a broader reactivity spectrum depending on the substrate and conditions, thus 
leading to poor periselectivities. For example, the reaction between tropone and 1,3-
butadienyl acetate under mild conditions gave rise to four products, none of which 


















Scheme 4.2.  Higher-order cycloadditions of tropone with 1,3-butadienyl acetate 
 
Heptafulvenes and their heteroanalogues (tropone, tropothione, and azaheptafulvenes), a 
subclass of the family of “non-benzenoid aromatic compounds”, have been recognized as 
important synthons for higher-order cycloaddition owing to their conjugated cyclic 
polyolefin systems. These compounds can be applied as 2π, 4π, 6π, or 8π components in 
various cycloadditions to provide the corresponding annulated products (Figure 4.1). 
 
Figure 4.1. Different types of cycloadditions with heptafulvenes and their 
heteroanalogues 
 
4.2. [8+2] Cycloaddition 
 
As the most important category of higher-order cycloadditions, [8+2] cycloadditions 
provide a direct approach to highly functionalized bicyclic [5.3.0] rings, which represent 
a framework that can be found in numerous biologically active molecules. As mentioned 
before, heptafulvenes and their heteroanalogues can act as 8π components and are thus 
widely employed in various [8+2] cycloadditions. In addition, a few other rigidly fused 
systems containing four p bonds like dienylisobenzofurans and indolizines have also been 
found undergo [8+2] processes (Figure 4.2).  





































Figure 4.2. Reported 8π components in various [8+2] cycloadditions 
 
4.2.1 [8+2] Cycloadditions with Heptafulvenes 
 
The first [8+2] cycloaddition was introduced by Doering and Wiley in 1960, who 
employed methylenecycloheptatriene as 8π component and dimethyl acetylene-
dicarboxylate as 2π component.[3] In general, the electron-rich heptafulvenes tend to react 
as 8p partners and electron-deficient heptafulvenes exhibit multiple reactivity profiles. In 
1972, Prinzbach and co-workers described a highly efficient [8+2] cycloaddition reaction 
between vinyl heptafulvene and tetracyanoethylene (TCNE), affording the [8+2] product 
in quantitative yield (Scheme 4.3).[4] 
 
Scheme 4.3. [8+2] Cycloaddition of vinyl heptafulvene with TCNE 
 
Intramolecular [8+2] cycloadditions were well established by Houk and co-workers 
utilizing heptafulvenes with tethered enophiles to afford the corresponding tricyclic 























Scheme 4.4. Intramolecular [8+2] cycloadditions 
 
Morita et al. employed a special kind of ketene, 8-oxoheptafulvene, as 8π component 
with cycloheptatriene iron carbonyl for the [8+2] cycloaddition (Scheme 4.5).[6] Although 
the reaction afforded a mixture of products, the [8+2] derivative was the major one. 
 
Scheme 4.5. [8+2] Cycloaddition of 8-oxoheptafulvene with cycloheptatriene iron 
carbonyl 
 
Dicyanoheptafulvenes are another type of heptafulvenes that have been applied in [8+2] 
cycloaddition reactions. In 2005, Nair et al. reported that dicyanoheptafulvene undergoes 
efficient cycloaddition reaction with styrenes.[7] The product was isolated as 1:1 ratio of 
the [8+2] and [4+2] cycloaddition product (Scheme 4.6). 
 




























Houk et al. 1983






















Nair et al. 2005
Chapter IV 
 162
4.2.2. [8+2] Cycloadditions with Tropones 
 
Tropone is well-explored to serve as 4p component in [4+2] cycloadditions and as 6p 
component in [6+3] and [6+4] cycloadditions. There are only a few examples in which 
tropone serves as an 8π component. For many of these reactions, tropone was shown to 
react with various ketenes, such as dichloroketene,[8] 8-oxoheptafulvene,[9] 
diphenylketene,[8] phenyl sulfonyl allene[10] (Scheme 4.7). 
 
Scheme 4.7. [8+2] Cycloaddition of tropone with ketenes 
 
Recently, Alemán and co-workers reported a formal [8+2] cycloaddition of tropones with 
azlactones under Brønsted acid catalysis.[11] The cycloaddition products obtained in this 
transformation can easily be opened by nucleophiles to form α,α-disubstituted amino 
acids (or dipeptides) bearing seven-membered rings at the quaternary position (Scheme 
4.8). 
 




































Alemán et al. 2014
up to 98% yield










4.2.3. [8+2] Cycloadditions with Tropothione 
 
The first [8+2] cycloaddition of tropothione was reported by Machiguchi and co-workers 
in 1973.[12] The reaction of tropothione with maleic anhydride afforded the [8+2] 
cycloadduct in quantitative yield, while the addition of dimethyl acetylene dicarboxylate 
(DMAD) provided the rearrangement product in moderate yield. 
 
Scheme 4.9. [8+2] Cycloadditions of tropothione with maleic anhydride and DMAD 
 
In contrast to tropone, tropothione is not very stable and prefers to serve as an 8p 
component in cycloaddition reactions. Indeed, whereas it is stable at –78 ºC under 
nitrogen, it dimerizes readily at 0 ºC. This dimerization of tropothione was found to give 
a head-to-tail [8+8] type dimer (Scheme 4.10).[13] 
 
Scheme 4.10. Dimerization of tropothione 
 
The same group reported that tropothione could undergo an efficient [8+2] cycloaddition 
with diphenyl ketene yielding the corresponding cycloaddition product in good yield 
(Scheme 4.11).[14] 
 
Scheme 4.11. [8+2] Cycloadditions of tropothione with diphenylketene 
 
In contrast to the [6+4] cycloaddition between tropone and dimethylfulvene, Machiguchi 
et al. found that tropothione reacts with dimethyl and diphenyl pentafulvenes via an [8+2] 
cycloaddition pathway.[15] They performed theoretical investigation that seems to indicate 






































that the large lobe of the HOMO on the sulfur atom is responsible for the selective [8+2] 
cycloaddition, while the secondary orbital interactions in the course of the intrinsic 
reaction coordinate account for the endo configuration observed. 
 
Scheme 4.12. [8+2] Cycloaddition of tropothione with pentafulvenes 
 
4.2.4. [8+2] Cycloadditions with Azaheptafulvenes 
 
Azaheptafulvenes are very appealing reagents because they can serve as excellent 
8p components in various [8+n] cycloadditions. Moreover, they are stable and easy 
prepare. In 1977, Kanemasa and co-workers developed the first efficient method for the 
synthesis of azaheptafulvenes.[16] Since then, they have been mainly used with electron-
deficient 2p systems, such as isocyanates,[17] isothiocyanates,[17] carbon disulfide, 
sulfenes[18] and ketenes,[19] providing the corresponding [8+2] adducts in good yields 
(Scheme 4.13). 
 
Scheme 4.13. [8+2] Cycloadditions of azaheptafulvenes with 2p systems 







R = Me, 81% yield









































Kanemasa and co-workers reported that the reaction of azaheptafulvene with dimethyl 
acetylene dicarboxylate (DMAD) delivered three different products.[20] The ratio of these 
three products depends on the polarity of the solvent. In a polar solvent like methanol 1,7-
H shift was the major product, whereas in a non-polar solvent such as benzene, 1,5-H 
shift predominated. The initially formed [8+2] product could also undergo ring 
contraction and hydrogen shift to yield a dihydroquinoline derivertive (Scheme 4.14). 
 
Scheme 4.14. [8+2] Cycloaddition of azaheptafulvenes with DMAD 
 
Gandolfi and co-workers demonstrated the cycloaddition reactions of azaheptafulvenes 
with cyclopentadienones, giving the major exo [6+4] cycloaddition products with minor 
quantities of endo [4+2] and [8+2] cycloaddition products.[21] They observed that the [6+4] 
cycloaddition adducts could undergo [3,3] sigmatropic rearrangement to afford the [8+2] 





























Scheme 4.15. Cycloaddition of azaheptafulvenes with cyclopentadienones 
 
4.2.5. [8+2] Cycloadditions with Other Systems 
 
Herndon and co-workers described an efficient [8+2] cycloaddition by utilizing dienyl 
isobenzofurans with dimethyl acetylene dicarboxylate for the synthesis of oxa-bridged 
macrocycles (Scheme 4.16).[22] The dienyl isobenzofurans were generated through the 
coupling of a,b-unsaturated Fischer carbene complexes with 2-alkynylbenzophenone 
derivatives. The macrocyclic system is a key scaffold of many biologically active 
compounds, such as 2,11-cyclized cembranoids or cladiellanes. 
 
Scheme 4.16. [8+2] Cycloaddition of dienyl isobenzofurans with DMAD 
 
Indolizines are another class of heterocycles which contain eight p electrons in the 
perimeter and have been widely used in cycloaddition reactions. Kanemasa and co-
workers reported the reaction of indolizines with maleates and acrylates yielding the 
corresponding [8+2] products (Scheme 4.17).[23] They proposed a stepwise mechanism 
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Scheme 4.17. [8+2] Cycloaddition of indolizines with maleates and acrylates 
 
4.3. Asymmetric [8+2] Cycloaddition 
 
As described above, numerous methodologies to carry out [8+2] cycloaddition have been 
reported, but enantioselective versions remain scarce. Feng and co-workers developed the 
first asymmetric [8+2] cycloaddition reaction of azaheptafulvenes with alkylidene 
malonates mediated by a chiral N,N´-dioxide nickel complex (Scheme 4.18).[24] They 
found that the allylic rearrangement products are promoted by silica gel, which could be 
avoided by using basic Al2O3 for flash chromatography. 
 
Scheme 4.18. Enantioselective [8+2] cycloaddition of azaheptafulvenes with alkylidene 
malonates 
 
From the mechanistic point of view, the authors propose that the [8+2] cycloadditions 
proceed via a stepwise pathway (Scheme 4.19). First, the N,N´-dioxide and the alkylidene 
malonates coordinate with NiII to form an octahedral complex A as the intermediate. Then 
the azaheptafulvenes attack from the Si face to generate the zwitterionic intermediate B. 
Last, the ring closure occurs to afford intermediate C, followed by release of the catalyst 
and generation of the cycloaddition product D. 


























































Scheme 4.19. Proposed reaction pathway for the asymmetric [8+2] cycloaddition of 
azaheptafulvenes with alkylidene malonates 
 
Very recently, the Jørgensen group reported the organocatalytic asymmetric [8+2] 
cycloaddition reactions of 2-cycloalkenones with heptafulvenes in the presence of 
cinchona alkaloid primary amines as catalysts (Scheme 4.20).[25] In this study, the linear 
dienamine generated upon condensation of the 2-cycloalkenones with the aminocatalyst 
served as the 2p component in [8+2] or [4+2] cycloadditions whereas a cross-dienamine 
intermediate could serve as 4p component in [6+4] cycloadditions. The periselectivities 
of these cycloadditions depended on the ring size of the 2-cycloalkenones and the 
substitution pattern of the heptafulvenes. In addition, the products of the [8+2] 
cycloaddition reactions can undergo simple one-step transformations with triazolinedione 






































































































99% ee, 9:1 dr
55% yield 




4.4. Aim of the Project 
 
Considering the importance of [8+2] cycloadditions in organic synthesis and the limited 
examples of asymmetric [8+2] cycloadditions, we aim to develop a general and efficient 
approach for peri-, regio-, and stereoselective [8+2] cycloaddition. On the basis of our 
previous project on formal [4+2] cycloaddition reactions promoted by an immobilized 
isothiourea, we envisioned that chiral ammonium enolates (derived from activated 
carboxylic acids and isothioureas) could be suitable reaction partners for catalytic [8+2] 
cycloaddition with azaheptafulvenes, which would play the role of 8p dipolarophiles. 
 
Scheme 4.21. Enantioselective [8+2] cycloaddition of azaheptafulvenes with 
ammonium enolates 
 
In order to further explore the synthetic potential of this methodology, we aim to test a 
Diels–Alder reaction of the resulting [8+2] cycloadducts with highly active dienophiles, 
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1. General information 
 
Unless otherwise stated, all commercial reagents were used as received. Flash chromatography 
was carried out using 60 mesh silica gel and dry-packed columns. Thin layer chromatography 
was carried out using Merck TLC Silicagel 60 F254 aluminum sheets. Components were 
visualized by UV light (λ = 254 nm) and stained with p-anisaldehyde or phosphomolybdic dip. 
NMR spectra were registered in a Bruker Advance 400 Ultrashield spectrometer in CDCl3 at room 
temperature, operating at 400 MHz (1H) and 100 MHz (13C). TMS was used as internal standard 
for 1H NMR and CDCl3 for 13C NMR. Chemical shifts are reported in ppm referred to TMS. IR 
spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Elemental analyses of the 
polystyrene supported catalysts were performed on a LECO CHNS 932 micro-analyzer at the 
Universidad Complutense de Madrid, Spain. High performance liquid chromatography (HPLC) 
was performed on an Agilent Technologies chromatograph (1100 Series), using Chiralcel 
columns and guard columns. Racemic samples were prepared using 20-40 mol% DMAP instead 
of the polymer-supported benzotetramisole (PS-BTM), following the same conditions used for 
the asymmetric reaction. Azaheptafulvenes were prepared according to the literature 
procedure.[1] PS-BTM catalyst was prepared according to our previously reported procedure.[2]  
 
2. Screening of conditions for the [8+2] cycloaddition reaction[a] 
 









































0 ºC, 1 h
Cat. 1 (10 mol%)
PivCl (1.5 equiv.)
2a 3a 4a
Entry Cat. Conv. (%)[b] dr[b] ee (%)[c] 
1 1a >95 75:25 91 
2 1b >95 96:4 91 






















[a] Reactions performed on a 0.1 mmol scale. [b] Determined by 1H NMR spectroscopy. [c] Determined by chiral 
HPLC.  
 
3. General procedure for the [8+2] cycloaddition reaction 
 
To a solution of acid 3 (0.15 mmol, 1.5 equiv.) in CH2Cl2 (0.5 mL) at 0 ºC was added polymer-
supported BTM 1b (0.010 mmol, f = 0.9 mmol/g, 11.2 mg, 10 mol%). Pivaloyl chloride (0.15 
mmol, 18.4 µL, 1.5 equiv.) and DBU (0.15 mmol, 22.4 μL, 1.5 equiv.) were added dropwise to 
the mixture, which was shaken at 0 ºC for 10 min. Then 2 (0.10 mmol, 1.0 equiv.) was added to 
the reaction mixture and it was shaken at the same temperature until 2 was consumed (determined 
by TLC). After that, the resin was filtered off, washed with CH2Cl2 (4 × 1 mL) and the combined 
organic layers were concentrated under reduced pressure. Crude products 4 were directly purified 












0 ºC, 1 h



















Cat. 1b (10 mol%)
PivCl (1.5 equiv.)
2 3 4
Entry Solvent Conv. (%)[b] dr[b] ee (%)[c] 
1 CH2Cl2 >95 96:4 91 
2 THF 88 98:2 20 
3 CHCl3 >95 97:3 88 
4 toluene 67 97:3 10 
5 Et2O <15 76:24 - 
Entry Base Conv. (%)[b] dr[b] ee (%)[c] 
1 i-Pr2NEt >95 96:4 87 
2 DBU >95 96:4 91 


















 0 ºC, 1 h




4. General procedure for the recycling experiments  
To a solution of phenylacetic acid 3a (0.15 mmol, 20.4 mg, 1.5 equiv.) in CH2Cl2 (0.5 mL) at 0 
ºC was added polymer-supported BTM 1b (0.010 mmol, f = 0.9 mmol/g, 11.2 mg, 10 mol%). 
Pivaloyl chloride (0.15 mmol, 18.4 µL, 1.5 equiv.) and DBU (0.15 mmol, 22.4 μL, 1.5 equiv.) 
were added dropwise to the mixture, which was shaken at 0 ºC for 10 min. Then 2a (0.10 mmol, 
19.5mg, 1.0 equiv.) was added and the reaction mixture and it was shaken at the same temperature 
for 3 hours. After that the resin was filtered off and washed with dry CH2Cl2 (4 × 1 mL). The 
recovered catalyst was dried under vacuum at 30 ºC for 2-3 h. The dried catalyst was directly 












[a] Isolated yield. [b] Determined by 1H NMR spectroscopy. [c] Determined by chiral HPLC. 
 
5. Compound characterization  
(3R,3aS)-3-Phenyl-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4a was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 75% yield 
(23.4 mg, >20:1 dr). White solid, melting point: 118-119 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 2.40 (s, 3H), 3.11-3.13 (m, 1H), 4.02 (d, J = 4.8 Hz, 1H), 5.37-5.41 
(m, 1H), 5.45 (d, J = 6.4 Hz, 1H), 6.20-6.26 (m, 2H), 6.38-6.43 (m, 1H), 7.18-
7.20 (m, 2H), 7.28-7.32 (m, 3H), 7.35-7.38 (m, 4H); 13C NMR (100 MHz, 
CDCl3): δ = 21.2, 44.7, 54.7, 100.0, 122.8, 125.4, 127.0 (2C), 127.5, 127.5 (2C), 127.9, 129.0 
(2C), 129.4, 130.2 (2C), 132.2, 138.5, 139.1, 139.2, 175.5; IR (ATR): ν = 515, 571, 678, 706, 825, 
1205, 1246, 1364, 1397, 1513, 1631, 1717, 3021 cm–1; HRMS calcd. for C22H19NNaO [M + Na]+: 
336.1359, found: 336.1357; [α]D25 = +45.1 (c = 0.1, CHCl3); HPLC (Chiralcel IB, hexane/i-
propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 91% ee): tmajor = 6.7 min, tminor = 11.0 
min.  
Cycle Yield (%)[a] dr[b] ee (%)[c] 
1 75 >95:5 91 
2 75 >95:5 90 
3 71 >95:5 90 
4 70 >95:5 91 
5 63 >95:5 90 
6 53 >95:5 87 























Cycloaddition product 4b was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 73% 
yield (28.5 mg, >20:1 dr). White solid, melting point: 135-137 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.42 (s, 3H), 3.09-3.11 (m, 1H), 4.00 (d, J = 5.2 Hz, 
1H), 5.37-5.40 (m, 1H), 5.48 (d, J = 6.4 Hz, 1H), 6.23-6.29 (m, 2H), 6.40-
6.45 (m, 1H), 7.18-7.20 (m, 2H), 7.26-7.32 (m, 4H), 7.51-7.53 (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 21.2, 44.4, 54.1, 100.3, 121.5, 122.5, 125.5, 
127.0 (2C), 128.1, 129.3 (2C), 129.4, 130.3 (2C), 132.0, 132.1 (2C), 137.9, 138.6, 138.9, 174.9; 
IR (ATR): ν = 510, 557, 701, 812, 1008, 1215, 1248, 1399, 1513, 1619, 1636, 1716, 2961, 3023 
cm–1; HRMS calcd. for C22H18BrNNaO [M + Na]+: 414.0464, found: 414.0462; [α]D25 = –13.2 (c 
= 0.1, CHCl3); HPLC (Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 
nm, 90% ee): tmajor = 6.8 min, tminor = 12.3 min.  
 
(3R,3aS)-3-(4-Chlorophenyl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4c was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 70% 
yield (24.3 mg, >20:1 dr). White solid, melting point: 119-121 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.39 (s, 3H), 3.06-3.09 (m, 1H), 3.99 (d, J = 5.2 Hz, 
1H), 5.34-5.38 (m, 1H), 5.45 (dd, J = 1.6, 6.4 Hz, 1H), 6.20-6.26 (m, 2H), 
6.38-6.43 (m, 1H), 7.15-7.18 (m, 2H), 7.27-7.36 (m, 6H); 13C NMR (100 MHz, 
CDCl3): δ = 21.2, 44.4, 54.0, 100.3, 122.5, 125.5, 127.0 (2C), 128.1, 128.9 
(2C), 129.1 (2C), 129.4, 130.3 (2C), 132.0, 133.5, 137.4, 138.6, 138.9, 174.9; IR (ATR): ν = 512, 
561, 689, 818, 1014, 1090, 1205, 1255, 1364, 1398, 1515, 1627, 1716, 2922 cm–1; HRMS calcd. 
for C22H18ClNNaO [M + Na]+: 370.0969, found: 370.0971; [α]D25 = –7.5 (c = 0.1, CHCl3); HPLC 
(Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 94% ee): tmajor = 
6.4 min, tminor = 10.8 min.  
 
(3R,3aS)-3-(4-Fluorophenyl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4d was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from from 20:1 to 7:1) in 
68% yield (22.5 mg, >20:1 dr). White solid, melting point: 99-101 ºC. 1H 
NMR (400 MHz, CDCl3): δ = 2.39 (s, 3H), 3.06-3.09 (m, 1H), 3.99 (d, J = 
4.8 Hz, 1H), 5.35-5.39 (m, 1H), 5.45 (dd, J = 1.2, 6.4 Hz, 1H), 6.20-6.26 (m, 
2H), 6.38-6.42 (m, 1H), 7.04-7.08 (m, 2H), 7.16-7.18 (m, 2H), 7.27-7.35 (m, 
4H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 44.6, 53.9, 100.2, 115.9 (d, J = 












134.8 (d, J = 3.3 Hz), 138.6, 139.0, 162.2 (d, J = 246.2 Hz), 175.2; IR (ATR): ν = 504, 568, 696, 
806, 1158, 1219, 1268, 1369, 1400, 1509, 1546, 1635, 1718, 2856, 2921 cm–1; HRMS calcd. for 
C22H18FNNaO [M + Na]+: 354.1265, found: 354.1267; [α]D25 = +8.6 (c = 0.1, CHCl3); HPLC 
(Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 95% ee): tmajor = 
6.1 min, tminor = 9.8 min.  
 
(3R,3aS)-3-(4-Methoxyphenyl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4e was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 65% 
yield (22.3 mg, >20:1 dr). White solid, melting point: 115-116 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.39 (s, 3H), 3.07-3.09 (m, 1H), 3.80 (s, 3H), 3.95 
(d, J = 5.2 Hz, 1H), 5.35-5.39 (m, 1H), 5.43 (dd, J = 1.6, 6.4 Hz, 1H), 6.19-
6.24 (m, 2H), 6.37-6.41 (m, 1H), 6.88-6.92 (m, 2H), 6.16-6.18 (m, 2H), 
7.27-7.29 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 44.7, 53.9, 55.3, 100.0, 114.4 (2C), 
122.9, 125.4, 127.0 (2C), 127.9, 128.6 (2C), 129.4, 130.2 (2C), 131.2, 132.2, 138.4, 139.3, 159.0, 
175.7; IR (ATR): ν = 527, 697, 811, 1027, 1180, 1210, 1244, 1400, 1513, 1623, 1642, 1715, 2917 
cm–1; HRMS calcd. for C23H21NNaO2 [M + Na]+: 366.1464, found: 366.1463; [α]D25 = –10.1 (c = 
0.1, CHCl3); HPLC (Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 230 
nm, 95% ee): tmajor = 10.7 min, tminor = 19.5 min.  
 
(3R,3aS)-3-([1,1'-Biphenyl]-4-yl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4f was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 15:1 to 5:1) in 71% 
yield (27.6 mg, >20:1 dr).  White solid, melting point: 155-156 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.40 (s, 3H), 3.16-3.19 (m, 1H), 4.07 (d, J = 5.2 Hz, 
1H), 5.40-5.43 (m, 1H), 5.47 (dd, J = 1.6, 6.4 Hz, 1H), 6.21-6.27 (m, 2H), 
6.40-6.44 (m, 1H), 7.20-7.22 (m, 2H), 7.29-7.31 (m, 2H), 7.33-7.37 (m, 1H), 
7.43-7.46 (m, 4H), 7.57-7.61 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 44.6, 54.4, 100.1, 
122.8, 125.4, 127.0 (2C), 127.1 (2C), 127.3, 127.8 (2C), 128.0 (3C), 128.8 (2C), 129.4, 130.2 
(2C), 132.2, 138.1, 138.5, 139.2, 140.6, 140.7, 175.4; IR (ATR): ν = 513, 696, 756, 816, 1215, 
1262, 1366, 1396, 1512, 1541, 1633, 1721, 2918, 3012 cm–1; HRMS calcd. for C28H23NNaO [M 
+ Na]+: 412.1672, found: 412.1674; [α]D25 = –20.5 (c = 0.1, CHCl3); HPLC (Chiralcel IB, 
hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 210 nm, 94% ee): tmajor = 7.9 min, tminor 














Cycloaddition product 4g was prepared as described in section 3 and 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) 
in 80% yield (27.8 mg, >20:1 dr). Yellow oil. 1H NMR (400 MHz, CDCl3): 
δ = 2.39 (s, 3H), 3.07-3.10 (m, 1H), 3.98 (d, J = 5.2 Hz, 1H), 5.34-5.38 (m, 
1H), 5.45 (dd, J = 1.6, 6.4 Hz, 1H), 6.20-6.26 (m, 2H), 6.38-6.42 (m, 1H), 
7.17-7.19 (m, 2H), 7.24-7.31 (m, 5H), 7.34-7.35 (m, 1H); 13C NMR (100 
MHz, CDCl3): δ = 21.2, 44.4, 54.3, 100.3, 122.4, 125.6, 125.9, 127.0 (2C), 127.8, 127.8, 128.1, 
129.4, 130.3 (3C), 132.0, 134.8, 138.6, 138.8, 140.9, 174.7; IR (ATR): ν = 512, 687, 797, 1081, 
1210, 1252, 1366, 1398, 1478, 1513, 1633, 1720, 2922 cm–1; HRMS calcd. for C22H18ClNNaO 
[M + Na]+: 370.0969, found: 370.0968; [α]D25 = +10.9 (c = 0.1, CHCl3); HPLC (Chiralcel IB, 
hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 230 nm, 94% ee): tmajor = 6.5 min, tminor 
= 11.9 min.  
 
(3R,3aS)-3-(m-Tolyl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4h was prepared as described in section 3 and 
isolated by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) 
in 73% yield (23.9 mg, >20:1 dr). Light yellow oil. 1H NMR (400 MHz, 
CDCl3): δ = 2.36 (s, 3H), 2.39 (s, 3H), 3.09-3.11 (m, 1H), 3.96 (d, J = 5.2 
Hz, 1H), 5.36-5.39 (m, 1H), 5.44 (dd, J = 1.6, 6.4 Hz, 1H), 6.18-6.24 (m, 
2H), 6.37-6.42 (m, 1H), 7.09-7.20 (m, 5H), 7.25-7.29 (m, 3H); 13C NMR 
(100 MHz, CDCl3): δ = 21.2, 21.5, 44.8, 54.7, 100.0, 122.9, 124.5, 125.4, 127.0 (2C), 127.9, 
128.3, 128.3, 128.9, 129.4, 130.2 (2C), 132.2, 138.4, 138.7, 139.0, 139.3, 175.6; IR (ATR): ν = 
512, 706, 745, 1211, 1253, 1366, 1398, 1513, 1634, 1726, 2923, 3019 cm–1; HRMS calcd. for 
C23H21NNaO [M + Na]+: 350.1515, found: 350.1508; [α]D25 = +11.8 (c = 0.1, CHCl3); HPLC 
(Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 97% ee): tmajor = 
6.3 min, tminor = 15.1 min.  
 
(3R,3aS)-3-(Naphthalen-2-yl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4i was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 81% 
yield (29.4 mg, >20:1 dr). White solid, melting point: 137-139 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.39 (s, 3H), 3.20-3.22 (m, 1H), 4.17 (d, J = 5.2 Hz, 
1H), 5.42-5-45 (m, 1H), 5.48 (dd, J = 1.2, 6.8 Hz, 1H), 6.20-6.25 (m, 2H), 
6.38-6.43 (m, 1H), 7.20-7.24 (m, 2H), 7.28-7.30 (m, 2H), 7.42-7.50 (m, 3H), 
7.79-7.86 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 44.6, 54.9, 100.1, 122.8, 125.2, 125.5, 











136.3, 138.5, 139.2, 175.4; IR (ATR): ν = 478, 506, 568, 699, 735, 817, 1214, 1267, 1366, 1399, 
1512, 1630, 1721, 2922 cm–1; HRMS calcd. for C26H21NNaO [M + Na]+: 386.1515, found: 
386.1517; [α]D25 = –19.2 (c = 0.1, CHCl3); HPLC (Chiralcel IB, hexane/i-propanol (75:25), flow 
rate = 1.0 mL min–1, λ = 210 nm, 90% ee): tmajor = 7.8 min, tminor = 21.4 min.  
 
(3S,3aS)-3-(Thiophen-2-yl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4j was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 15:1 to 5:1) in 83% 
yield (26.4 mg, 12:1 dr). White solid, melting point: 153-155 ºC. 1H NMR (400 
MHz, CDCl3): δ = 2.32 (s, 3H), 3.20-3.23 (m, 1H), 4.19 (d, J = 6.4 Hz, 1H), 
5.29-5.32 (m, 1H), 5.35 (dd, J = 1.6, 6.4 Hz, 1H), 6.14-6.20 (m, 2H), 6.29-6.34 
(m, 1H), 6.92-6.94 (m, 1H), 7.02-7.03 (m, 1H), 7.08-7.10 (m, 2H), 7.17-7.21 
(m, 3H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 44.6, 49.8, 100.4, 122.5, 124.9, 125.2, 125.5, 
127.0, 127.0 (2C), 128.2, 129.4, 130.2 (2C), 132.0, 138.6, 138.8, 140.1, 173.9; IR (ATR): ν = 514, 
703, 821, 1021, 1219, 1243, 1362, 1397, 1514, 1630, 1716, 2924 cm–1; HRMS calcd. for 
C20H17NNaOS [M + Na]+: 342.0923, found: 342.0921; [α]D25 = –26.3 (c = 0.1, CHCl3); HPLC 
(Chiralcel IA, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 93% ee): tmajor = 
11.7 min, tminor = 20.7 min.  
 
(3S,3aS)-3-((E)-Styryl)-1-(p-tolyl)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4k was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 25:1 to 10:1) in 70% 
yield (23.7 mg, 13:1 dr). Light yellow solid, melting point: 61-62 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 2.39 (s, 3H), 3.08-3.11 (m, 1H), 3.64 (t, J = 7.2 Hz, 
1H), 5.30-5.33 (m, 1H), 5.40 (dd, J = 1.2, 6.4 Hz, 1H), 6.23-6.27 (m, 2H), 
6.36-6.42 (m, 2H), 6.68 (d, J = 16.8 Hz, 1H), 7.15-7.17 (m, 2H), 7.25-7.33 (m, 
5H), 7.39-7.41 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 41.8, 52.0, 100.3, 122.7, 125.2, 
125.4, 126.5 (2C), 127.1 (2C), 127.8, 128.2, 128.5 (2C), 129.3, 130.2 (2C), 132.1, 132.8, 136.5, 
138.5, 139.5, 175.1; IR (ATR): ν = 510, 691, 733, 817, 963, 1208, 1254, 1366, 1398, 1512, 1632, 
1721, 2922, 3020 cm–1; HRMS calcd. for C24H21NNaO [M + Na]+: 362.1515, found: 362.1517; 
[α]D25 = –20.7 (c = 0.1, CHCl3); HPLC (Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 
















Cycloaddition product 4l was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 73% yield 
(27.6 mg, >20:1 dr). White solid, melting point: 93-95 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.09-3.12 (m, 1H), 4.01 (d, J = 4.8 Hz, 1H), 5.38 (dd, J = 4.0, 9.2 
Hz, 1H), 5.47 (dd, J = 1.2, 6.4 Hz, 1H), 6.20-6.29 (m, 2H), 6.39-6.43 (m, 1H), 
7.20-7.24 (m, 2H), 7.28-7.41 (m, 5H), 7.60-7.64 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 44.6, 54.6, 100.1, 122.2, 122.8, 125.9, 127.5 (2C), 127.7, 128.0, 128.9 (2C), 129.1 
(2C), 129.2, 132.8 (2C), 133.8, 138.2, 138.8, 175.3; IR (ATR): ν = 510, 695, 783, 1011, 1069, 
1253, 1365, 1487, 1540, 1633, 1723, 2849, 2922 cm–1; HRMS calcd. for C21H16BrNNaO [M + 
Na]+: 400.0307, found: 400.0294; [α]D25 = +32.9 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-




Cycloaddition product 4m was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 72% yield 
(24.0 mg, >20:1 dr). White solid, melting point: 53-55 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.10-3.12 (m, 1H), 4.01 (d, J = 4.8 Hz, 1H), 5.38 (dd, J = 4.0, 9.2 
Hz, 1H), 5.47 (d, J = 6.0 Hz, 1H), 6.20-6.28 (m, 2H), 6.39-6.43 (m, 1H), 7.25-
7.27 (m, 2H), 7.30-7.39 (m, 5H), 7.44-7.46 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 44.6, 54.6, 
100.1, 122.8, 125.9, 127.5 (2C), 127.6, 128.0, 128.6 (2C), 129.1 (2C), 129.2, 129.8 (2C), 133.3, 
134.2, 138.3, 138.8, 175.3; IR (ATR): ν = 515, 696, 938, 783, 830, 1015, 1088, 1205, 1365, 1491, 
1632, 1723, 2923, 3016 cm–1; HRMS calcd. for C21H16ClNNaO [M + Na]+: 356.0813, found: 
356.0811; [α]D25 = +30.8 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow 




Cycloaddition product 4n was prepared as described in section 3 and isolated 
by FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 83% 
yield (31.8 mg, >20:1 dr). White solid, melting point: 106-107 ºC. 1H NMR 
(400 MHz, CDCl3): δ = 3.12-3.15 (m, 1H), 4.04 (d, J = 4.8 Hz, 1H), 5.40 (dd, 
J = 3.6, 9.2 Hz, 1H), 5.49 (dd, J = 1.2, 6.4 Hz, 1H), 6.22-6.31 (m, 2H), 6.41-
6.45 (m, 1H), 7.30-7.41 (m, 9H); 13C NMR (100 MHz, CDCl3): δ = 44.6, 54.6, 
100.1, 120.4 (q, J = 256.5 Hz) 122.0 (2C), 122.9, 125.9, 127.5 (2C), 127.7, 128.0, 128.8 (2C), 















1264, 1400, 1508, 1542, 1635, 1717, 3028 cm–1; HRMS calcd. for C22H16F3NNaO2 [M + Na]+: 
406.1025, found: 406.1030; [α]D25 = –24.1 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-




Cycloaddition product 4o was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 70% yield 
(23.0 mg, >20:1 dr). White solid, melting point: 144-145 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.10-3.13 (m, 1H), 3.83 (s, 3H), 4.00 (d, J = 4.8 Hz, 1H), 5.36-5.40 
(m, 1H), 5.43 (dd, J = 1.2, 6.4 Hz, 1H), 6.18-6.24 (m, 2H), 6.37-6.42 (m, 1H), 
6.97-6.99 (m, 2H), 7.20-7.23 (m, 2H), 7.26-7.31 (m, 1H), 7.34-7.37 (m, 4H); 13C NMR (100 MHz, 
CDCl3): δ = 44.7, 54.7, 55.5, 99.9, 114.8 (2C), 122.8, 125.4, 127.4, 127.5 (2C), 127.5, 127.9, 
128.4 (2C), 129.0 (2C), 129.4, 139.1, 139.5, 159.4, 175.6; IR (ATR): ν = 529, 711, 779, 1021, 
1156, 1218, 1247, 1371, 1402, 1512, 1632, 1713, 2930 cm–1; HRMS calcd. for C22H19NNaO2 [M 
+ Na]+: 352.1308, found: 352.1309; [α]D25 = +10.6 (c = 0.1, CHCl3); HPLC (Chiralcel IA, 
hexane/i-propanol (80:20), flow rate = 1.0 mL min–1, λ = 210 nm, 92% ee): tmajor = 12.6 min, tminor 




Cycloaddition product 4p was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 85% yield 
(30.2 mg, >20:1 dr). White solid, melting point: 63-64 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 1.34 (s, 9H), 3.09-3.12 (m, 1H), 4.02 (d, J = 5.2 Hz, 1H), 5.37-5.40 
(m, 1H), 5.49 (dd, J = 1.2, 6.4 Hz, 1H), 6.19-6.24 (m, 2H), 6.37-6.42 (m, 1H), 
7.21-7.24 (m, 2H), 7.27-7.30 (m, 1H), 7.36-7.37 (m, 4H), 7.47-7.49 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 31.3 (3C), 34.7, 44.7, 54.7, 100.0, 122.8, 125.4, 126.5 (2C), 126.6 (2C), 127.5, 127.5 
(2C), 127.9, 129.0 (2C), 129.4, 132.0, 139.1, 139.1, 151.4, 175.5; IR (ATR): ν = 582, 702, 1021, 
1217, 1250, 1367, 1401, 1453, 1513, 1631, 1714, 2962 cm–1; HRMS calcd. for C25H26NO [M + 
H]+: 356.2009, found: 356.2005; [α]D25 = +29.8 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-

















Methyl 4-((3R,3aS)-2-oxo-3-phenyl-3,3a-dihydrocyclohepta[b]pyrrol-1(2H)-yl) benzoate 
Cycloaddition product 4q was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 20:1 to 7:1) in 70% yield (25.0 
mg, >20:1 dr). White solid, melting point: 134-135 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.09-3.12 (m, 1H), 3.94 (s, 3H), 4.03 (d, J = 5.2 Hz, 1H), 5.39 (dd, J 
= 4.0, 9.2 Hz, 1H), 5.52 (dd, J = 1.2, 6.8 Hz, 1H), 6.22-6.31 (m, 2H), 6.40-6.45 
(m, 1H), 7.28-7.33 (m, 1H), 7.35-7.38 (m, 4H), 7.41-7.43 (m, 2H), 8.14-8.16 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ = 44.5, 52.3, 54.6, 100.3, 122.9, 126.0, 127.0 (2C), 127.5 (2C), 127.7, 128.0, 
129.1 (2C), 129.2, 129.9, 130.9 (2C), 137.7, 138.7, 138.8, 166.2, 175.2; IR (ATR): ν = 501, 694, 
762, 1019, 1109, 1276, 1370, 1401, 1431, 1551, 1639, 1715, 3025 cm–1; HRMS calcd. for 
C23H19NNaO3 [M + Na]+: 380.1257, found: 380.1246; [α]D25 = +87.0 (c = 0.1, CHCl3); HPLC 
(Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 230 nm, 94% ee): tmajor = 




Cycloaddition product 4r was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 15:1 to 3:1) in 71% yield 
(29.1 mg, >20:1 dr). White solid, melting point: 162-164 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.16-3.19 (m, 1H), 4.02 (d, J = 5.2 Hz, 1H), 5.38.5.41 (m, 2H), 6.20-
6.28 (m, 2H), 6.37-6.41 (m, 1H), 7.17-7.19 (m, 2H), 7.33-7.43 (m, 5H), 7.52-7.54 
(m, 2H), 8.73 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 44.6, 55.0, 100.8, 115.6 
(d, J = 286.8 Hz), 121.7 (2C), 122.8, 126.1, 127.5 (2C), 127.8, 128.0 (2C), 128.1, 129.1, 129.1 
(2C), 131.8, 135.7, 138.3, 138.5, 154.8 (d, J = 37.5 Hz), 176.5; 19F NMR (376 MHz, CDCl3): δ = 
–75.67 (s, 3F); IR (ATR): ν = 516, 696, 836, 1146, 1246, 1368, 1402, 1511, 1538, 1612, 1632, 
1698, 2923, 3086, 3267 cm–1; HRMS calcd. for C23H17F3N2NaO2 [M + Na]+: 433.1134, found: 
433.1120; [α]D25 = +38.5 (c = 0.1, CHCl3); HPLC (Chiralcel IA, hexane/i-propanol (80:20), flow 
rate = 1.0 mL min–1, λ = 210 nm, 90% ee): tmajor = 8.4 min, tminor = 12.0 min.  
 
(3R,3aS)-3-Phenyl-1-(phenylamino)-3,3a-dihydrocyclohepta[b]pyrrol-2(1H)-one 
Cycloaddition product 4s was prepared as described in section 3 and isolated by 
FC on silica (eluting with cyclohexane/EtOAc from 15:1 to 5:1) in 37% yield 
(11.6 mg, >20:1 dr). White solid, melting point: 147-148 ºC. 1H NMR (400 MHz, 
CDCl3): δ = 3.20-3.23 (m, 1H), 3.90 (d, J = 5.2 Hz, 1H), 5.33 (dd, J = 3.2, 9.2 
Hz, 1H), 5.87 (dd, J = 1.6, 6.8 Hz, 1H), 6.18-6.26 (m, 2H), 6.36 (s, 1H), 6.44-6.48 (m, 1H), 6.80 
(d, J = 8.0 Hz, 1H), 6.95 (t, J = 7.2 Hz, 1H), 7.22-7.26 (m, 2H), 7.29-7.31 (m, 3H), 7.34-7.38 (m, 


















(2C), 127.7, 128.3, 129.1 (2C), 129.2, 129.3 (2C), 135.8, 138.2, 145.3, 173.3; IR (ATR): ν = 498, 
579, 749, 1224, 1280, 1447, 1494, 1541, 1602, 1640, 1712, 3020, 3254 cm–1; HRMS calcd. for 
C21H18N2NaO [M + Na]+: 337.1311, found: 337.1306. 
 
6. General procedure for the [4+2] cycloaddition reaction 
 
To a solution of the 4b (0.10 mmol, 1.0 equiv.) in CHCl3 (1.0 mL) were added the triazolinedione 
5 (0.15 mmol, 1.5 equiv.). The reaction mixture was stirred at room temperature for 3 hours and 
monitored by TLC. After the reaction completed, solvent removal in vacuo and the crude product 




Cycloaddition product 6a was prepared as described in section 6 and 
isolated by FC on silica (eluting with CH2Cl2/EtOAc from 100:1 to 40:1) 
in 75% yield (36.6 mg, >20:1 dr). White solid, melting point: 203-205 
ºC. 1H NMR (400 MHz, CDCl3): δ = 2.36 (s, 3H), 3.52 (dt, J = 2.4, 12.0 
Hz, 1H), 4.16 (d, J = 12.0 Hz, 1H), 5.16 (t, J = 6.8 Hz, 1H), 5.86 (dd, J 
= 2.0, 11.2 Hz, 1H), 6.02-6.07 (m, 1H), 6.41 (d, J = 9.2 Hz, 1H), 6.64 (dd, J = 7.2, 9.2 Hz, 1H), 
7.22-7.26 (m, 2H), 7.30-7.41 (m, 6H), 7.44-7.48 (m, 4H), 7.58-7.60 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 21.0, 50.1, 50.7, 56.6, 79.7, 122.8, 124.4 (2C), 125.3 (2C), 127.9, 128.2, 128.9 (2C), 
129.0 (2C), 129.0 (2C), 129.9 (2C), 130.1, 130.2, 130.2, 131.3, 132.8, 135.9, 137.0, 150.5, 151.6, 
173.4; IR (ATR): ν = 521, 704, 732, 815, 1132, 1214, 1349, 1394, 1511, 1704, 1727, 2918 cm–1; 
HRMS calcd. for C30H24N4NaO3 [M + Na]+: 511.1741, found: 511.1744; [α]D25 = +54.3 (c = 0.1, 
CHCl3); HPLC (Chiralcel IB, hexane/i-propanol (85:15), flow rate = 1.0 mL min–1, λ = 210 nm, 









































Cycloaddition product 6b was prepared as described in section 
6 and isolated by FC on silica (eluting with CH2Cl2/EtOAc from 
100:1 to 40:1) in 80% yield (45.2 mg, >20:1 dr). White solid, 
melting point: 207-208 ºC. 1H NMR (400 MHz, CDCl3): δ = 2.36 
(s, 3H), 3.48 (dt, J = 2.4, 12.4 Hz, 1H), 4.14 (d, J = 12.4 Hz, 1H), 
5.17 (t, J = 7.2 Hz, 1H), 5.83 (dd, J = 2.0, 11.2 Hz, 1H), 6.04-6.09 (m, 1H), 6.40 (d, J = 9.2 Hz, 
1H), 6.64 (dd, J = 7.2, 9.2 Hz, 1H), 7.18-7.26 (m, 4H), 7.35-7.39 (m, 1H), 7.44-7.59 (m, 8H); 13C 
NMR (100 MHz, CDCl3): δ = 21.0, 50.1, 50.2, 56.3, 79.6, 122.0, 123.1, 124.5 (2C), 125.3 (2C), 
128.2, 129.0 (2C), 129.8, 130.0 (3C), 130.4, 130.6 (2C), 131.2, 132.1 (2C), 132.6, 134.8, 137.2, 
150.6, 151.6, 172.9; IR (ATR): ν = 518, 718, 759, 806, 1072, 1260, 1366, 1491, 1698, 1758, 2924 
cm–1; HRMS calcd. for C30H23BrN4NaO3 [M + Na]+: 589.0846, found: 589.0830; [α]D25 = +112.0 




Cycloaddition product 6c was prepared as described in section 6 and 
isolated by FC on silica (eluting with CH2Cl2/EtOAc from 40:1 to 10:1) 
in 70% yield (30.8 mg, >20:1 dr). White solid, melting point: 194-196 
ºC. 1H NMR (400 MHz, CDCl3): δ = 1.28 (t, J = 7.2 Hz, 3H), 2.35 (s, 
3H), 3.47 (dt, J = 2.4, 12.4 Hz, 1H), 3.65 (q, J = 7.2 Hz, 2H), 4.09 (d, J 
= 12.4 Hz, 1H), 5.03 (t, J = 7.2 Hz, 1H), 5.79 (dd, J = 2.0, 11.2 Hz, 1H), 5.92-5.97 (m, 1H), 6.34 
(d, J = 9.2 Hz, 1H), 5.57 (dd, J = 7.2, 9.2 Hz, 1H), 7.20-7.22 (m, 2H), 7.28-7.33 (m, 3H), 7.37-
7.43 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 13.4, 21.0, 34.6, 49.9, 50.8, 56.5, 79.2, 122.6, 
124.4 (2C), 127.8, 128.8 (2C), 128.9 (2C), 129.8 (3C), 130.1, 130.2, 132.8, 135.9, 136.9, 151.8, 
153.2, 173.4; IR (ATR): ν = 588, 608, 700, 727, 820, 1013, 1211, 1346, 1420, 1451, 1515, 1693, 
1718, 1758, 2924 cm–1; HRMS calcd. for C26H24N4NaO3 [M + Na]+: 463.1741, found: 463.1729; 




Cycloaddition product 6d was prepared as described in section 6 and 
isolated by FC on silica (eluting with CH2Cl2/EtOAc from 100:1 to 
40:1) in 77% yield (36.0 mg, >20:1 dr). White solid, melting point: 
192-193 ºC. 1H NMR (400 MHz, CDCl3): δ = 0.95 (t, J = 7.6 Hz, 3H), 
































12.4 Hz, 1H), 3.59 (t, J = 7.2 Hz, 2H), 4.09 (d, J = 12.4 Hz, 1H), 5.03(t, J = 7.2 Hz, 1H), 5.78 (dd, 
J = 2.0, 10.8 Hz, 1H), 5.92-5.97 (m, 1H), 6.34 (d, J = 9.2 Hz, 1H), 6.57 (dd, J = 6.8, 9.2 Hz, 1H), 
7.20-7.22 (m, 2H), 7.28-7.33 (m, 3H), 7.37-7.43 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 13.6, 
19.7, 21.0, 29.8, 39.3, 50.0, 50.8, 56.5, 79.2, 122.7, 124.5 (2C), 127.8, 128.8 (2C), 128.9 (2C), 
129.8 (3C), 130.0, 130.2, 132.8, 136.0, 136.9, 152.0, 153.4, 173.4; IR (ATR): ν = 534, 586, 694, 
727, 1016, 1219, 1366, 1418, 1446, 1516, 1688, 1711, 1754, 2957 cm–1; HRMS calcd. for 
C28H28N4NaO3 [M + Na]+: 491.2054, found: 491.2047; [α]D25 = +29.2 (c = 0.1, CHCl3).  
 
7. Hydrogenation of 4a 
 
A suspension of Pd/C (10 wt.%, 10 mg) and 4a (31.3 mg, 0.1 mmol) in ethyl acetate (3.0 
mL) was stirred at room temperature under 1 atm hydrogen atmosphere. After being 
stirred 3 hours, the mixture was filtrated through a pad of Celite and the filtration was 
concentrated in vacuo, the residue was purified by column chromatography on silica gel 
(eluting with cyclohexane/EtOAc from 20:1 to 5:1) to afford the desired the product 7 in 94% 
yield (29.8 mg, >20:1 dr). 
 
(3R,3aS)-3-Phenyl-1-(p-tolyl)-3,3a,4,5,6,7-hexahydrocyclohepta[b]pyrrol-2(1H)-one: 
Colorless oil. 1H NMR (400 MHz, CDCl3): δ = 1.19-1.30 (m, 1H), 1.39-1.45 (m, 
1H), 1.53-1.59 (m, 1H), 1.70-1.75 (m, 1H), 1.93-2.00 (m, 3H), 2.04-2.12 (m, 
1H), 2.31 (s, 3H), 2.96-3.01 (m, 1H), 3.43 (d, J = 7.2 Hz, 1H), 4.80-4.84 (m, 
1H), 7.07-7.09 (m, 2H), 7.18-7.23 (m, 5H), 7.28-7.31 (m, 2H); 13C NMR (100 
MHz, CDCl3): δ = 21.2, 26.5, 28.1, 30.8, 33.3, 47.7, 55.6, 103.3, 127.2, 127.9 
(2C), 128.2 (2C), 128.8 (2C), 130.1 (2C), 132.9, 138.0, 139.6, 147.3, 174.4; IR 
(ATR): ν = 513, 697, 728, 770, 809, 1217, 1396, 1451, 1513, 1667, 2921, 3030 cm–1; HRMS 
calcd. for C22H24NO [M + H]+: 318.1852, found: 318.1848; [α]D25 = –27.7 (c = 0.1, CHCl3); HPLC 
(Chiralcel IB, hexane/i-propanol (90:10), flow rate = 1.0 mL min–1, λ = 230 nm, 92% ee): tmajor = 
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Asymmetric Cross-Aldol Reaction of Paraldehyde Promoted by Site-




As the smallest enolizable aldehyde, acetaldehyde is the most challenging substrate in a-
functionalization reactions owing to its high reactivity and the formation of undesired by-
products due to its inherent tendency towards oligomerization and aldolization. 
Pioneering works dealing with the organocatalytic activation of acetaldehyde were 
reported by the List group[1] and the Hayashi group[2] in 2008 (Scheme 5.1). 
 
Scheme 5.1. Pioneering works of organocatalytic acetaldehyde activation 
 
Despite these excellent previous results, some problems remain unsolved.[3] For instance, 
the low boiling point of acetaldehyde seriously hampers its transportation, storage, and 
handling. The oligomerization of acetaldehyde causes quick consumption and leads to 
poor reaction yields. In order to solve these problems, we postulated the use of 
paraldehyde as a more convenient alternative to acetaldehyde, which can be 
depolymerized into three molecules of acetaldehyde under Brønsted acid catalysis.[4] 
Moreover, paraldehyde is less expensive, easier to handle and can be deoligomerized by 















up to 58% yield
         99% ee










up to 92% yield
         99% ee









Scheme 5.2. Deoligomerization of paraldehyde catalyzed by supported sulfonic acid 
 
Aminocatalysts such as proline and its derivatives have been well explored in asymmetric 
a-functionalization of acetaldehyde.[5] However, these aminocatalysts can react with 
strong acids, thus leading to the deactivation of the catalytic system. In order to avoid this, 
we proposed to exploit the dual immobilized catalytic system due to the fact that their 
inherent properties are site-isolated upon immobilization. Under this principle, two 
incompatible catalysts can work together in the same media after immobilization. 
Accordingly, we successfully applied the dual immobilized catalytic system to the 
asymmetric Michael reaction with paraldehyde as acetaldehyde  surrogate (Scheme 5.4).[6]  
 
Scheme 5.3. Deactivation mode and compatibilization by site-isolation 
 
In our previous work, polystyrene supported (PS) sulfonic acid catalyst was enclosed in 
a teabag, thus being isolated from the PS-diphenylprolinol TIPS ether catalyst to prevent 
mutual deactivation. This dual catalytic system worked compatibly in cascade Michael 
reactions with paraldehyde, providing Michael products in good yields with excellent 
enantioselectivities (Scheme 5.4).  
 











































1) dual catalytic system
       ¨Site-isolation¨
2) NaBH4, EtOH
up to 77% yield




However, this site-isolated catalytic system could not be recycled and proved sensitive to 
moisture and oxygen. For further development of this site-isolated system, we speculated 
with the application of this concept to the asymmetric cross-aldol reactions of 
acetaldehyde, as well as studies concerning the recyclability (Scheme 5.5). The results of 
asymmetric cross-aldol reactions are presented in the section 5.3 and article D.  
 
Scheme 5.5. Asymmetric aldol reaction promoted by dual site-isolated catalysts 
 
This methodology granted access to enantioenriched 1-arylpropane-1,3-diols, a 
privileged core structure occurring in a variety of drugs and natural products. However, 
the main drawback of this method was the fact that only electron-poor benzaldehydes 
could be used as effective substrates. The phenyl substituted diols cannot be obtained via 
this strategy, despite the fact that the corresponding product is a key building block in the 
synthesis of many active pharmaceutical ingredients. Thus, we assumed that the cross-
aldol reaction of benzaldehyde with paraldehyde could be facilitated by a reversible 
electronic modification. 
 
η6-Arene-Cr(CO)3 complexes are easily formed upon reaction of Cr(CO)3 with aromatic 
substrates and can be removed in quantitative yield by exposure to visible light. Owing 
to the electron-withdrawing properties of the chromium tricarbonyl group, the electron 
density of η6-arene decreases, consequently increasing its reactivity in some 
transformations. For instance, Walsh and co-workers reported a palladium catalyzed 
allylic substitution reaction of toluene derived pronucleophiles activated by the aromatic 
η6-coordination of Cr(CO)3 (Scheme 5.6).[7] A variety of cyclic and acyclic allylic 
electrophiles can be employed with benzylic nucleophiles for the synthesis of allylation 







1) dual catalytic system




















Scheme 5.6. Allylic substitution with (η6-arene-CH2Z) Cr(CO)3 
 
General methods to facilitate C−H arylation of arenes are exclusively limited to the use 
of strongly electron-withdrawing substituents or directing groups. Larrosa and co-
workers explored η6-coordination of the Cr(CO)3 unit on arene for dramatically 
promoting the reactivity of C−H bonds in arylation reaction (Scheme 5.7).[8] This strategy 
provided an efficient approach for the direct arylation of highly unreactive 
monofluorobenzenes, affording the ortho-substituted biaryls with good yields and high 
selectivity.  
 
Scheme 5.7. C−H Arylation of η6-arenes-Cr(CO)3  
 
Chiral phase-transfer catalyzed (PTC) nucleophilic aromatic substitution (SNAr) reaction 
provide an efficient approach to the enantioselective a-arylation of carbonyl compounds. 
The drawback of this method is that electrophiles are limited to electron-deficient arenes, 
such as those bearing a nitro group. To overcome this limitation, the Maruoka group 
employed chromium complexes coordinated with electron-rich fluoroarenes for 
asymmetric SNAr reactions (Scheme 5.8).[9] This strategy efficiently enhanced the 
reactivity towards SNAr reaction, giving the corresponding a,a-disubstituted a-amino 













up to 97% yieldZ = CH3, Ph, OR, NR2
Walsh et al. 2011

















Scheme 5.8. SNAr reaction of a-amino acid derivatives with η6-arenes-Cr(CO)3 
 
η6-Benzaldehyde Cr(CO)3 complex could be prepared in three steps starting from the 
benzaldehyde. The general procedure for the synthesis of this compound is shown in 
Scheme 5.9.[10]  
 


















Maruoka et al. 2014
Cr(CO)3
EDG
up to 76% yield









































To overcome the drawbacks of acetaldehyde, we postulated the use of paraldehyde as a 
more convenient alternative to acetaldehyde in asymmetric transformations. We have 
already introduced a “wolf-and-lamb” reaction system for the asymmetric Michael 
reaction of acetaldehyde (Scheme 5.4). However, the dual catalytic system required strict 
operation to avoid their mutual deactivation. 
 
In order to develop the site-isolated system and user-friendly system, we aim to identify 
a supported dual catalytic system to promote the cascade cross-aldol reactions of 
paraldehyde with various substituted benzaldehydes, as well as studies concerning the 
recyclability (Scheme5.10). 
 




Inspired by previous works on reversible electronic modification using Cr(CO)3 complex, 
we assumed that the η6-benzaldehyde Cr(CO)3 complex could be used as an activated 
benzaldehyde surrogate in the cross-aldol reaction with paraldehyde mediated by the dual 
catalytic system (Scheme 5.10). Once the cross-aldol reaction by using η6-benzaldehyde 
Cr(CO)3 had been achieved, we aimed to use the resulting phenyl substituted diols for 
further transformations. 
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1. General information 
Unless otherwise stated, all commercial reagents were used as received. Flash chromatography 
was carried out using 60 mesh silica gel and dry-packed columns. Thin layer chromatography 
was carried out using Merck TLC Silicagel 60 F254 aluminum sheets. Components were 
visualized by UV light (λ = 254 nm) and stained with p-anisaldehyde or phosphomolybdic dip. 
NMR spectra were registered in a Bruker Advance 400 Ultrashield spectrometer in CDCl3 at room 
temperature, operating at 400 or 500 MHz (1H) and 100 or 126 MHz (13C{1H}). TMS was used 
as internal standard for 1H NMR and CDCl3 for 13C NMR. Chemical shifts are reported in ppm 
referred to TMS. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Elemental 
analyses of the polystyrene supported catalysts were performed on a LECO CHNS 932 micro-
analyzer at the Universidad Complutense de Madrid, Spain. High performance liquid 
chromatography (HPLC) was performed on an Agilent Technologies chromatograph (1100 
Series), using Chiralcel columns and guard columns. The absolute configuration of the reaction 
products was confirmed by HPLC, by comparison with reported data.[1] Catalyst 2 was purchased 
from Novabiochem®. 
 
2. General procedure for cross-aldol reaction  
Catalyst 1b (20 mol%, 0.04 mmol), Catalyst 2 (10 mol%, 0.02 mmol) and the corresponding 
aldehyde (0.2 mmol) were mixed in a vial with acetonitrile (0.4 mL). Then paraldehyde (54.8 µL, 
0.4 mmol) and deionized water (1.8 µL, 0.1 mmol) were added and the vial was sealed and shaken 
at room temperature. After completion, the mixture was filtered and washed with methanol (3 × 
0.5 mL). The filtrates were combined and cooled to 0 ºC. Then NaBH4 (22.7 mg, 0.6 mmol) was 
added and the mixture was stirred for 20 minutes. The reaction was quenched with aqueous NH4Cl 
(3 mL), and extracted with ethyl acetate (3 × 5 mL). The organic phases were combined, washed 
with brine (2 mL) and dried over Na2SO4. After solvent removal, products were purified by flash 
chromatography on silica gel, with hexanes/ethyl acetate mixtures as eluent. 
 
3. Characterization data for products 4[2] 
4a. 1H NMR (400 MHz, CDCl3): δ = 2.05 - 1.95 (m, 2H), 2.42 (brs, 1H), 3.17 
(brs, 1H), 3.93 - 3.83 (m, 2H), 5.28 (t, J = 6.1 Hz, 1H), 7.06 - 6.96 (m, 1H), 
7.16 (dt, J = 7.5, 1.1 Hz, 1H), 7.30 - 7.20 (m, 1H), 7.54 (dt, J = 7.6, 1.7 Hz, 
1H); 13C{H} NMR (100 MHz, CDCl3): δ = 39.2, 61.7, 68.5, 115.4 (d, J = 21.7 Hz), 124.4, 127.3, 
129.0 (d, J = 8.2 Hz), 131.3 (d, J = 13.1 Hz), 159.6 (d, J = 245.2 Hz); HPLC (Chiralcel IC, 






4b. 1H NMR (400 MHz, CDCl3): δ = 2.06 - 1.77 (m, 2H), 2.44 (s, 1H), 3.20 (s, 
1H), 4.06 - 3.77 (m, 2H), 5.38 (d, J = 9.1 Hz, 1H), 7.38 (t, J = 7.6 Hz, 1H), 7.68 
- 7.53 (m, 2H), 7.85 (d, J = 7.8 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3): δ = 
40.8, 62.2, 70.3, 124.5 (q, J = 272.0 Hz), 125.6 (q, J = 5.8 Hz), 126.5 (q, J = 30.1 Hz), 127.6, 
127.9, 132.5, 143.6; HPLC (Chiralcel AD-H, Hexane/i-propanol (97:3), flow rate = 0.8 mL min-
1, λ = 270 nm): tmajor = 31.6 min, tminor = 29.6 min. 
 
4c. 1H NMR (400 MHz, CDCl3): δ = 1.90 - 2.03 (m, 1H), 2.04 - 2.16 (m, 1H), 
3.77 (brs, 1H), 3.88 - 4.03 (m, 2H), 5.50 (dd, J = 9.0, 2.6 Hz, 1H), 7.34 - 7.51 
(m, 1H), 7.66 (dt, J = 7.9, 1.2 Hz, 1H), 7.91 (m, 2H); 13C{H} NMR (100 MHz, 
CDCl3): δ = 39.7, 62.0, 69.9, 124.5, 128.3, 128.3, 133.8, 140.0, 147.6; HPLC (Chiralcel IC, 
Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 270 nm): tmajor = 20.4 min, tminor = 32.3 
min. 
 
4d. 1H NMR (400 MHz, CDCl3): δ = 2.05 - 1.92 (m, 2H), 2.40 (brs, 1H), 
3.67 (brs, 1H), 3.92 (t, J = 5.5 Hz, 2H), 5.10 (t, J = 6.1 Hz, 1H), 7.52 (t, J 
= 7.9 Hz, 1H), 7.72 (d, J = 7.7 Hz, 1H), 8.12 (ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 
8.25 (t, J = 1.9 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3): δ = 40.4, 61.4, 73.4, 120.8, 122.5, 
129.6, 131.9, 146.7, 148.5; HPLC (Chiralcel IC, Hexane/i-propanol (95:5), flow rate = 1.0 mL 
min-1, λ = 270 nm): tmajor = 75.2 min, tminor = 68.1 min. 
 
4e. 1H NMR (400 MHz, CDCl3): δ = 2.02 - 1.95 (m, 2H), 2.11 (t, J = 3.9 
Hz, 1H), 3.45 (d, J = 3.0 Hz, 1H), 3.93 (dt, J = 4.9, 2.3 Hz, 2H), 5.11 (dt, 
J = 6.1, 2.0 Hz, 1H), 7.56 (d, J = 8.6 Hz, 2H), 8.22 (d, J = 8.6 Hz, 2H); 
13C{H} NMR (100 MHz, CDCl3): δ = 40.4, 61.5, 73.6, 123.9 (×2), 126.6 (×2), 147.4, 151.8; 
HPLC (Chiralcel OJ, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 270 nm): tmajor = 
23.7 min, tminor = 31.5 min. 
 
4f. 1H NMR (400 MHz, CDCl3): δ = 2.06 - 1.85 (m, 2H), 2.21 (s, 1H), 2.97 
(d, J = 2.6 Hz, 1H), 3.93 - 3.80 (m, 2H), 4.96 (dt, J = 8.3, 3.0 Hz, 1H), 7.32 
(m, 4H); 13C{H} NMR (100 MHz, CDCl3): δ = 40.6, 61.6, 73.8, 127.2 (×2), 
128.8 (×2), 133.3, 143.0; HPLC (Chiralcel AS-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL 
min-1, λ = 210 nm): tmajor = 13.4 min, tminor = 12.0 min. 
 
4g. 1H NMR (400 MHz, CDCl3): δ = 1.86 - 2.04 (m, 2H), 2.31 (s, 1H), 3.08 
(s, 1H), 3.80 - 3.91 (m, 2H), 4.94 (dd, J = 8.4, 3.6 Hz, 1H), 7.21 - 7.29 (m, 














73.8, 121.4, 127.5 (×2), 131.7 (×2), 143.5; HPLC (Chiralcel IC, Hexane/i-propanol (95:5), flow 
rate = 1.0 mL min-1, λ = 270 nm): tmajor = 23.4 min, tminor = 20.4 min. 
 
4h.[3]  1H NMR (400 MHz, CDCl3): δ = 1.86 - 2.09 (m, 2H), 2.44 (s, 1H), 
3.41 (s, 1H), 3.88 (t, J = 5.5 Hz, 2H), 4.98 - 5.09 (m, 1H), 7.48 (d, J = 8.0 
Hz, 2H), 7.61 (d, J = 8.0 Hz, 2H); 13C{H} NMR (100 MHz, CDCl3): δ = 
40.5, 61.5, 73.8, 124.3 (q, J = 272.0 Hz), 125.6 (q, J = 3.8 Hz, ×2), 126.1 (×2), 129.8 (q, J = 32.4 
Hz), 148.4; HPLC (Chiralcel IC, Hexane/i-propanol (95:5), flow rate = 1.0 mL min-1, λ = 270 
nm): tmajor = 12.9 min, tminor = 11.6 min. 
 
4i. 1H NMR (400 MHz, CDCl3): δ = 1.91 - 2.00 (m, 2H), 3.46 (brs, 1H), 
3.90 (t, J = 5.3 Hz, 2H), 5.04 (t, J = 6.1 Hz, 1H), 7.50 (d, J = 8.4 Hz, 2H), 
7.64 (d, J= 8.2 Hz, 2H); 13C{H} NMR (100 MHz, CDCl3): δ = 40.4, 61.5, 
73.7, 111.3, 119.0, 126.5 (×2), 132.5 (×2), 149.9; HPLC (Chiralcel IC, Hexane/i-propanol (90:10), 
flow rate = 1.0 mL min-1, λ = 270 nm): tmajor = 24.2 min, tminor = 21.6 min. 
 
4j.[4]  1H NMR (400 MHz, CDCl3): δ = 1.80 - 1.91 (m, 1H), 1.97 - 2.07 (m, 
1H), 2.48 (brs, 1H), 3.54 (brs, 1H), 3.84 - 3.96 (m, 2H), 5.29 (dd, J = 8.8, 
2.8 Hz, 1H), 7.25 - 7.32 (m, 1H), 7.33 (d, J = 2.1 Hz, 1H), 7.57 (d, J = 8.4 
Hz, 1H); 13C{H} NMR (100 MHz, CDCl3): δ = 38.4, 61.8, 70.89, 127.6, 128.2, 129.2, 132.0, 
133.6, 140.4; HPLC (Chiralcel OD-H, Hexane/i-propanol (96:4), flow rate = 1.0 mL min-1, λ = 
270 nm): tmajor = 22.3 min, tminor = 21.2 min. 
 
4k. 1H NMR (500 MHz, CDCl3) δ = 1.86 - 1.97 (m, 1H), 1.98 - 2.11 (m, 
1H), 2.46 (brs, 1H), 3.57 (brs, 1H), 3.84 - 3.91 (m, 2H), 3.93 (s, 3H), 5.28 
(dd, J = 8.6, 3.2 Hz, 1H), 7.66 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 2.1 Hz, 1H), 
7.87 (dd, J = 8.4, 2.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ = 38.2, 56.1, 61.8, 69.3, 105.4, 
116.3, 127.0, 140.1, 148.1, 156.2; IR (ATR): ν = 521.4, 739.5, 802.8, 868.1, 1021.2, 1049.5, 
1069.3, 1247.6, 1307.9, 1344.6, 1512.5, 2929.1, 3357.1 cm-1; HPLC (Chiralcel IC, Hexane/i-
propanol (90:10), flow rate = 1.0 mL min-1, λ = 270 nm): tmajor = 27.6 min, tminor = 25.9 min; HRMS 



















4. Catalysts recycling 
4.1. NMR study on catalyst deactivation[5] 
 
To determine the oxazolidine formed from catalyst 1 and aldehyde, diarylprolinol (Ar = 3,5-
bis(trifluoromethyl)phenyl, 1.0 eq.) was mixed with 4-nitrobenzaldehyde (1.0 eq.) in D6-DMSO 
and checked by 1H NMR. The appearance of a singlet at 5.58 ppm (assigned as Hc) and a triplet 
at 4.74 ppm (assigned as Hb, J = 7.1 Hz), whose chemical shifts, peak shapes and integrations 
matched with the reported similar compounds, indicated the formation of oxazolidine as a 
parasitic species which could account for the decrease in catalytic activity observed upon 
recycling. The amount of oxazolidine was slowly increasing, 11% of oxazolidine was observed 
after 44 hours.  
 
 
4.2. Different procedures of catalysts recycling 
Catalyst 1b (20 mol%, 0.04 mmol), Catalyst 2 (10 mol%, 0.02 mmol) and 4-nitrobenzaldehyde 





































0.4 mmol) and deionized water (1.8 µL, 0.1 mmol) were added and the vial was sealed and shaken 
at room temperature.  
 
Procedure A: After 26 h, the mixture was filtered and washed with acetonitrile (3 × 0.5 mL). 
The filtrates were worked up as abovementioned (see Section 2). The mixed catalysts were 
washed with acetonitrile (3 × 3 mL) and then used in the next reaction directly. 
Procedure B: After 26 h, the mixture was filtered and washed with acetonitrile (3 × 0.5 mL). 
The filtrates were worked up as abovementioned (see Section 2). The mixed catalysts were 
washed with acetonitrile (3 × 3 mL) and dried at 40 ºC under vacuum for 3 h, and then used in 
the next reaction. 
Procedure C: After 26 h, the mixture was filtered and washed with acetonitrile (3 × 0.5 mL). 
The filtrates were worked up as abovementioned (see Section 2). The mixed catalysts were 
washed with acetic acid solution in acetonitrile (10%, 4 × 1 mL), acetonitrile (4 × 1 mL), dried at 
40 ºC under vacuum for 3 h and then used in the next reaction. 
 
Table S1 Results of recycling tests using different work up procedure.[a] 
 
 
Cycle Procedure A Procedure B Procedure C Yield (%)[b] ee (%)[c] Yield (%)[b] ee (%)[c] Yield (%)[b] ee (%)[c] 
1 80 98 80 97 81 97 
2 45 97 66 98 83 97 
3 48 98 57 97 77 97 
4 41 98 60 98 85 97 
5   54 97 84 97 
6   50 97 74 97 
7   43 96 66 97 
8   38 96 70 97 
9     67 97 
10     56 97 
 
[a] Each reaction was carried out with 4-nitrobenzaldehyde (0.2 mmol), paraldehyde (0.4 mmol), H2O (0.1 









1) Cat. 1b/2, H2O, RT, 26 h
2) NaBH4, MeOH, 0 oC, 20 min.+
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5. Synthesis and characterization of 1a, 1b, 5 and 6 
5.1 Synthesis and characterization of 1a 
 
7a and azidomethylpolystyrene resin were synthesized according to our previously reported 
procedure.[6] 
A mixture of azidomethylpolystyrene (f = 0.53 mmol g-1, 0.25 mmol, 
0.47 g), 7a (0.375 mmol, 0.12 g) and tris(triazolyl)methyl copper 
(TTM-Cu) complex (2 mol%, 0.005 mmol) in THF/DMF 1:1 (6 mL) 
were placed in a tube for microwave reactions.[7] The reaction 
mixture was heated at 80 ºC (set temperature) under microwave irradiation of 100 W without 
stirring and monitored by IR. After the cycloaddition reaction was completed (ca. 3 h), the resin 
was filtered and washed with CH2Cl2 (20 mL), MeOH (20 mL), water (20 mL), MeOH (20 mL) 
and THF (20 mL) and was dried overnight under vacuum at 40 ºC. 
IR (ATR): ν = 538.4, 696.4, 752.6, 906.8, 1028.4, 1065.4, 1181.3, 1365.3, 1450.5, 1492.2, 1600.6, 
2850.8, 2922.5, 3025.3, 3058.8 cm-1 
A 99% yield of functionalization was calculated on the basis of nitrogen elemental analysis. 







































5.2 Synthesis and characterization of 1b 
 
8 was synthesized according to our previously reported procedure.[8] 
 
8 (0.3 g, 0.44 mmol) was dissolved in 4 mL CH2Cl2 and TFA (10 eq., 4.4 
mmol) was added slowly. The mixture was stirred at room temperature 
overnight. Then, it was cooled to 0 ºC and the pH value was adjusted slowly 
to 8.0 using sat. aqueous Na2CO3 solution. The mixture was extracted with CH2Cl2 (3 × 10 mL) 
and the combined organic phase was washed with brine and dried (MgSO4). Solvent removal 
under reduced pressure afforded 0.2 g of 7b (0.34 mmol, 78% yield), which was directly used in 
the next step. 
 
A mixture of azidomethylpolystyrene (f = 0.53 mmol g-1, 0.25 mmol, 
0.47 g), 7b (0.38 mmol, 0.22 g), CuI (1.0 eq., 0.25 mmol) and DIPEA 
(10.0 eq., 2.5 mmol) in THF/DMF 1:1 (6 mL) were placed in a flask 
under orbital shaking in an oil bath at 50 ºC. The reaction was monitored by IR. After the 
cycloaddition reaction was completed (12 h), the resin was filtered and washed with 
ethylenediamine (5 × 5 mL), CH2Cl2 (20 mL), MeOH (20 mL), water (20 mL), MeOH (20 mL) 
and THF (20 mL) and was dried overnight under vacuum at 40 ºC. 
IR (ATR): ν = 539.0, 696.1, 756.0, 898.3, 1129.1, 1277.5, 1364.6, 1451.3, 1492.5, 1672.8, 2923.7, 
3025.6 cm-1 
A 95% yield of functionalization was calculated on the basis of fluorine elemental analysis. 
















































5.3 Synthesis and characterization of 5e and 6 
 
Catalyst 1b (20 mol%, 0.04 mmol), Catalyst 2 (10 mol%, 0.02 mmol) 
and 4-nitrobenzaldehyde (1.0 eq., 0.2 mmol) were mixed in a vial with 
acetonitrile (0.4 mL). Then paraldehyde (2.0 eq., 0.4 mmol) and 
deionized water (0.5 eq., 0.1 mmol) were added and the vial was sealed 
and shaken at room temperature. After 26 h, the mixture was filtered and washed with AcOH in 
THF (10%, 2 × 2 mL). The filtrates were combined. Crude product 3 was obtained after removal 
of volatile materials under reduced pressure.  
Crude 3 was dissolved in anhydrous THF (1 mL), methylamine (33 wt% in EtOH, 1.0 mmol) and 
anhydrous Na2SO4 (0.2 g) were added. The mixture was stirred for 1 hour and then NaBH(OAc)3 
(1.0 mmol) was added. After stirring overnight, the reaction was quenched with saturated aqueous 









1b (20 mol%), 2 (10 mol%)

























washed with brine (2 mL) and dried over Na2SO4. After solvent removal, products were purified 
by fast flash chromatography on silica gel, with CH2Cl2/MeOH/NH4OH mixtures as eluent. 30 
mg of 5e (0.14 mmol, 71% overall yield for two steps) were obtained with 99% ee (measured by 
chiral HPLC). 
 
1H NMR (400 MHz, CDCl3) δ = 1.66 - 1.78 (m, 1H), 1.88 - 1.93 (m, 1H), 2.47 (s, 3H), 2.89 - 
2.95 (m, 2H), 4.21 (brs, 2H), 5.05 (dd, J = 8.9, 3.0 Hz, 1H), 7.47 - 7.72 (m, 2H), 8.19 (d, J = 8.7 
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ = 36.0, 36.4, 50.5, 75.1, 123.6 (×2), 126.4 (×2), 147.0, 
152.8; HPLC (Chiralcel IC, Hexane /i-propanol (95:5, 0.05% Diethylamine used as additive), 
flow rate = 1.0 mL min-1, λ = 280 nm): tmajor = 49.7 min, tminor = 42.8 min; HRMS calcd for 
C10H15N2O3 (M + H)+: 211.1077, found: 211.1083; [α]D25 = +48.1 (c 1.0, MeOH); IR (ATR): ν = 
426.1, 547.7, 698.6, 753.4, 829.1, 852.4, 1017.4, 1099.3, 1342.8, 1524.1, 1604.5, 2793.1, 2845.4, 
2923.8, 3105.3, 3309.6 cm-1. 
 
 Catalyst 1b (20 mol%, 0.04 mmol), Catalyst 2 (10 mol%, 0.02 
mmol) and 4-nitrobenzaldehyde (1.0 eq., 0.2 mmol) were mixed in 
a vial with acetonitrile (0.4 mL). Then paraldehyde (2.0 eq., 0.4 
mmol) and deionized water (0.5 eq., 0.1 mmol) were added and the vial was sealed and shaken at 
room temperature. After 26 h, the mixture was filtered and washed with AcOH in THF (10%, 2 
× 2 mL). The filtrates were combined. Crude product 3 was obtained after removal of volatile 
materials under reduced pressure. Then it was dissolved in anhydrous THF (1 mL), and 9 (3.0 eq., 
0.6 mmol) and anhydrous Na2SO4 (0.2 g) were added. The mixture was stirred for 1 hour and then 
NaBH(OAc)3 (3.0 eq., 0.6 mmol) was added. After stirring for 5 h, the reaction was quenched 
with saturated aqueous NH4Cl (3 mL), and extracted with ethyl acetate (3 × 5 mL). The organic 
phases were combined, washed with brine (2 mL) and dried over Na2SO4. After solvent removal, 
products were purified by fast flash chromatography on silica gel, with CH2Cl2/MeOH/NH4OH 
mixtures as eluent. 56 mg of 6 (0.14 mmol, 68% overall yield for two steps) were obtained with 
98% ee (measured by chiral HPLC) as white solid. 
 
1H NMR (500 MHz, CDCl3) δ = 1.18 (t, J = 7.1 Hz, 3H), 1.75 - 1.92 (m, 2H), 1.93 - 2.42 (m, 4H), 
2.51 - 2.79 (m, 4H), 2.85 - 3.20 (m, 2H), 4.13 (q, J = 7.1 Hz, 2H), 5.03 (dd, J = 8.5, 3.0 Hz, 1H), 
7.24 - 7.29 (m, 1H), 7.31 - 7.41 (m, 4H), 7.52 - 7.57 (m, 2H), 8.20 (d, J = 8.7 Hz, 2H); 13C NMR 
(126 MHz, CDCl3) δ = 14.2, 33.6, 33.9, 34.2, 49.1, 50.9, 52.5, 57.3, 61.1, 75.1, 123.7 (×2), 125.9 
(×2), 126.4 (×2), 127.3, 128.2, 128.7 (×2), 147.1, 152.7, 174.2; HPLC (Chiralcel IA, Hexane /i-
propanol (90:10, 0.1% Diethylamine used as additive), flow rate = 1.0 mL min-1, λ = 280 nm): 
tmajor = 17.3 min, tminor = 14.2 min; HRMS calcd for C23H29N2O5 (M + H)+: 413.2071, found: 








1048.5, 1127.4, 1227.1, 1344.6, 1516.7, 1600.9, 1717.8, 2839.1, 2922.1, 2969.6 cm-1; Melting 
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A Site Isolation Enabled Organocatalytic Approach to Enantiopure g-Amino 
Alcohol Drugs 
 
Shoulei Wang, Carles Rodríguez-Escrich, Xinyuan Fan, and Miquel A. Pericàs* 
 
Abstract: Solid support-enabled site isolation has previously allowed to use paraldehyde 
as an acetaldehyde surrrogate in aldol reactions. However, only electron-poor aldehydes 
were tolerated by the system. Herein, we show that the temporary conversion of 
benzaldehyde into η6-benzaldehyde Cr(CO)3 circumvents this limitation. Asymmetric 
synthesis of (R)-Phenoperidine, as well as formal syntheses of (R)-Fluoxetine and (R)-
Atomoxetine, illustrate the benefits of this strategy. 
 
 
The direct cross-aldol reaction represents one of the most important carbon-carbon bond 
forming processes since it can provide an efficient approach to both naturally occurring 
and synthetically important building blocks.[1] During the past decade, a variety of 
enamine-mediated aminocatalytic processes have been developed and successfully 
applied in asymmetric cross-aldol reaction.[2] However, most of these examples are not 
efficient with acetaldehyde as the donor due to its high reactivity unavoidably leading to 
a variety of by-products arising from its oligomerization and self-aldolization.[3] Recently, 
the Hayashi group reported the first organocatalytic direct cross-aldol reaction of 
acetaldehyde with aromatic aldehydes using a diarylprolinol as the catalyst.[4] Later, the 
use in the same reactions of chiral primary amine catalysts under neat conditions[5] and 
of suitably modified diarylprolinol catalysts in aqueous media,[6] have also been reported. 
More recently, we have disclosed a highly enantioselective version of the reaction 
promoted by a dual catalytic system (polystyrene-bound sulfonic acid 1 and polystyrene-
supported diarylprolinol catalyst 2, Figure 1) which enabled the use of paraldehyde as a 
convenient source of acetaldehyde.[7] Compared to acetaldehyde, paraldehyde is less 
expensive, easier to handle (b.p. 123 ºC) and can be deoligomerized in situ by 
polystyrene-bound sulfonic acid 1. The site isolation scenario generated under these 
conditions[8] enabled catalyst 1 to work compatibly with 2 in one pot in a highly 






Figure 1. Cascade deoligomerization and cross-aldol reaction mediated by 1/2 operating under 
site isolation. 
 
This methodology granted access to enantioenriched 1-arylpropane-1,3-diols, a 
privileged core structure occurring in a variety of drugs and natural products.[9] However, 
the drawback of this method was the fact that only electron-poor benzaldehydes could be 
used as effective substrates (Scheme 1, top). Considering the importance of 3-phenyl-3-
hydroxypropanal as a key building block in the synthesis of many active pharmaceutical 
ingredients, we analyzed methods allowing the reversible electronic modification of 
benzaldehyde that could favor its participation in the cross-aldol reaction.  
It is known that the formation of η6-arene-Cr(CO)3  complexes importantly decreases the 
electron density of the parent arene and modifies accordingly its reactivity.[10] From a 
practical perspective, these  complexes are easily formed upon reaction of Cr(CO)6  with 
aromatic substrates, and the metal moiety can be later removed in quantitative yield by 
exposure to sunlight.[11] Thus, the complexation/decomplexation process has normally 
low impact on the efficiency of the overall process. In 2011, Walsh et al. exploited this 
approach to favor the generation of nucleophiles for allylic substitution reaction,[12] and 
the same strategy has been recently applied by Larrosa et al. for enhancing the reactivity 
of C-H bonds in arylation reactions.[13] With these precedents in mind, we assumed that 
the η6-benzaldehyde complex 3 could be used as an activated benzaldehyde surrogate in 
the cross-aldol reaction with paraldehyde mediated by the 1/2 dual catalytic system 




























Scheme 1. Deoligomerization/cross-aldol reaction of paraldehyde with complex 3 
mediated by the 1/2 dual catalytic system. 
 
Initially, we investigated the cross-aldol reaction of the tricarbonyl (η6-benzaldehyde) 
chromium (0) with paraldehyde mediated by the dual catalytic system 1/2 in DMF (Table 
1, entry 1) but the target aldol product was not formed at all in this solvent. A subsequent 
solvent screening showed that when acetonitrile was employed the product can be isolated 
in 18% yield and 93% ee (entries 3). A screening of additives including benzoic acid, p-
nitrobenzoic acid and water revealed the latter as the most convenient one (entries 4-6). 
When raising the temperature, either with conventional heating or using the microwave, 
the enantioselectivity was maintained but the yield slightly decreased (entries 7 and 8). 
In order to evaluate the effect of different reaction times on the yield and 
enantioselectivity, we carried out a series of comparative experiments (see supporting 
information) which showed that after 72 hours the reduced aldol product 4 could be 
obtained in 38% yield and 93% ee (entry 9). Subsequently, the use of different amounts 
of paraldehyde was examined (entries 10-12), but the improvement was not significant 
(entry 10). Finally, increasing the loading of polystyrene-supported catalyst 2 led to a 
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"Cr(CO)3"







Table 1. Tandem deoligomerization plus cross-aldol reaction of tricarbonyl (η6-
benzaldehyde) chromium (0) with paraldehyde catalyzed by 1/2.a 
 
 
Entry	 Time	(h)	 Solvent	 Paraldehyd
e	(equiv.)	
Yield	(%)b	 ee	(%)c	
1	 24	 DMF	 2	 0	 –	
2	 24	 CH3NO2	 2	 15	 92	
3	 24	 MeCN	 2	 18	 93	
4d	 24	 MeCN	 2	 12	 92	
5e	 24	 MeCN	 2	 17	 93	
6	 24	 MeCN/H2O	 2	 20	 93	
7f	 24	 MeCN/H2O	 2	 17	 93	
8g	 24	 MeCN/H2O	 2	 19	 93	
9	 72	 MeCN/H2O	 2		 38	 93	
10	 72	 MeCN/H2O	 5	 41	 93	
11	 72	 MeCN/H2O	 10	 33	 93	
12	 72	 MeCN/H2O	 20	 30	 92	
13	 72	 Paradehyde	 –	 20	 92	
14h	 72	 MeCN/H2O	 5	 49	 93	
15i	 72	 MeCN/H2O	 5	 61	 93	
aThe	reaction	was	carried	out	with	3	(0.1	mmol),	paraldehyde,	1	(10	mol%),	2	(20	mol%)	
and	 H2O	 (0.5	 mmol)	 in	 0.3	 mL	 solvent.	 bDetermined	 by	 1H	 NMR	 using	 mesitylene	 as	




It is to be noted that such a high catalyst loading can only be justified if the dual catalytic 
system is amenable to recycling.[14] In this regard, it is worth mentioning that the recovery 
of the two different polystyrene-supported catalysts can be achieved by simple filtration 
without separating the two resins. Gratifyingly, the mixture of the two catalysts can be 
reactivated by briefly washing with AcOH after each reaction cycle. The role of the acid 
is presumably to hydrolise the parasite oxazolidine formed by catalyst 2 and acetaldehyde, 
thus increasing the effective amount of catalytic species.[7] Using this strategy, the 1/2 
dual catalytic system could be reused for five cycles with essentially the same results. On 
the sixth cycle, the aldol product was still obtained in high enantioselectivity (90% ee), 





1) Cat. 1 (10 mol%), Solv.
    Cat. 2 (20 mol%), RT
2) NaBH4, MeOH








Table 2. Recycling in the tandem deoligomerization plus cross-aldol reaction of 










As already mentioned, enantiomerically enriched 1,3-diols and b-hydroxyaldehydes are 
versatile building blocks for the synthesis of a wide variety of natural products and 
commercially important drugs.[15] For instance, enantioenriched diol 4 is a key 
intermediate in the preparation of the selective serotonin reuptake inhibitor (R)-fluoxetine 
(Prozac®) and the norepinephrine reuptake inhibitor (R)-atomoxetine (Strattera®), which 
are important drugs for the treatment of important psychiatric disorders.[9, 16] According 
to previous literature procedures, the reduced cross-aldol product 4 can be converted into 
amino alcohol 7, a common precursor to both drugs, in four steps and 36% overall yield.[9] 
We have now found (Scheme 2) that crude aldol 6, obtained by decomplexation of 5 in 
ether solution on exposure to sunlight, can be converted into 7 (95% ee) in a single step 
by reductive amination with MeNH2 (35％ overall yield). Bearing in mind that 6 can be 
converted into 4 by simple aldehyde reduction, the improvement over previous 
approaches ultimately relying on the asymmetric Sharpless epoxidation[9] becomes 
evident. Phenoperidine 8,[17] another well-known drug can also be synthesized in a single 
step from crude 6 upon treatment with ethyl 4-phenylpiperidine-4-carboxylate and 















1) Cat. 1 (10 mol%), MeCN/H2O
    Cat. 2 (40 mol%), RT, 72 h
2) NaBH4, MeOH




Cycle Yield (%) ee (%) 
1 58 93 
2 60 93 
3 54 92 
4 53 93 
5 50 92 





Scheme 2 Synthesis of drugs and intermediates with the present methodology 
 
In conclusion, we have developed an efficient approach for enhancing the reactivity of 
benzaldehyde in the cross-aldol reaction with acetaldehyde resulting from the 
deoligomerization of paraldehyde in a tandem process mediated by the dual polymer-
supported catalytic system 1/2 operating under site isolation conditions in a recyclable 
manner. The strategy reported herein, involving η6-coordination to Cr(CO)3, has been 
applied to overcome the challenges and limitation of cross-aldol reaction of acetaldehyde 
with benzaldehyde, affording 1-phenylpropane-1,3-diol in high yield and excellent 
enantioselectivity. The crude, enantioenriched aldol 6 has been applied to the 
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1. General information 
Unless otherwise stated, all commercial reagents were used as received. Flash chromatography 
was carried out using 60 mesh silica gel and dry-packed columns. Thin layer chromatography 
was carried out using Merck TLC Silicagel 60 F254 aluminum sheets. Components were 
visualized by UV light (λ = 254 nm) and stained with p-anisaldehyde or phosphomolybdic dip. 
NMR spectra were registered in a Bruker Advance 400 Ultrashield spectrometer in CDCl3 at room 
temperature, operating at 300 or 400 MHz (1H) and 75 or 100 MHz (13C[1]). TMS was used as 
internal standard for 1H NMR and CDCl3 for 13C NMR. Chemical shifts are reported in ppm 
referred to TMS. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Elemental 
analyses of the polystyrene supported catalysts were performed on a LECO CHNS 932 micro-
analyzer at the Universidad Complutense de Madrid, Spain. High performance liquid 
chromatography (HPLC) was performed on an Agilent Technologies chromatograph (1100 
Series), using Chiralcel columns and guard columns. The absolute configuration of the reaction 
products was confirmed by HPLC, by comparison with reported data.[2] Catalyst 1 was purchased 
from Novabiochem®. Catalyst 2 was prepared according to a previously reported procedure.[1] 
 
2. General procedure for the preparation of tricarbonyl (η6-benzaldehyde) 
chromium (0) – Compound 3 
 
2-Phenyl-1,3-dioxolane: A mixture of benzaldehyde (20.0 mmol) and ethane-1,2-diol (22.0 
mmol) in toluene (20 mL), containing a catalytic quantity of p-TsOH·H2O (0.4 mmol) was 
refluxed in a Dean-Stark trap until water ceased to be removed (4 h). Evaporation of the solvent 
followed by distillation gave the product as a colorless oil (14.6 mmol, 2.19 g, 73% yield), which 
was directly used in the next step without any purification.[3] 
 
Tricarbonyl (η6-2-phenyl-1,3-dioxolane) chromium (0): A 10:1 mixture of Bu2O/THF (22 ml), 
hexcarbonylchromium (0) (10.0 mmol, 2.2 g) and 2-phenyl-1,3-dioxolane (8.3 mmol, 1.25 g) was 
heated to 135 ºC under argon atmosphere. The mixture was stirred at this temperature for 48-72 
hours until the formation of the first trace of green precipitate was observed. The cooled solution 
was filtered through celite and the solvent evaporated to give the crude complex which, after flash 
column chromatography on silica gel, gave the title compound as a yellow solid (5.9 mmol, 1.78 

















1H NMR (300 MHz, CDCl3): δ = 4.00-4.18 (m, 4H), 5.27-5.36 (m, 3H), 5.52-5.56 (m, 3H); 13C 
NMR (75 MHz, CDCl3): δ = 65.8(×2), 90.9 (×2), 91.2 (×2), 92.9, 101.4, 232.2; It is a known 
compound.[3] 
 
Tricarbonyl (η6-benzaldehyde) chromium (0): Tricarbonyl (η6-2-phenyl-1,3-dioxolane) 
chromium (0) (2.0 mmol, 0.6 g) was dissolved in THF (10 mL) and aqueous HCl (2.5 M, 5 mL) 
was added. The solution was stirred 5 hours and slowly turned to red. Then the mixture was 
extracted with ethyl acetate (3 × 5 mL) and the organic phases were combined and dried with 
anhydrous Na2SO4. After removal of the solvent, the crude products were purified by 
chromatography on silica gel to give a red solid (1.90 mmol, 488 mg,  95% yield).[3] 1H NMR 
(300 MHz, CDCl3): δ = 5.31 (t, J = 6.2 Hz, 2H), 5.71 (t, J = 6.2 Hz, 1H), 5.95 (d, J = 6.5 Hz, 2H), 
9.48 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 89.0 (×2), 94.6 (×2), 95.4, 187.6, 229.8; It is a 
known compound.[4] 
 
3. General procedure for the cross-aldol reaction[5] 
 
Catalyst 1 (10 mol%, 0.02 mmol, 6.7 mg), catalyst 2 (40 mol%, 0.08 mmol, 170.4 mg) and 
tricarbonyl (η6-benzaldehyde) chromium (0) (0.2 mmol, 51.4 mg) were mixed in a brown vial 
with acetonitrile (0.6 mL). Then paraldehyde (137 µL, 5.0 eq., 1.0 mmol) and deionized water 
(1.8 µL, 0.1 mmol) were added and the brown vial was sealed and shaken at room temperature 
for 72 hours. After that the reaction mixture was filtered and washed with methanol (3 × 0.8 mL). 
The filtrates were combined and cooled to 0 ºC, then NaBH4 (37.8 mg, 1.0 mmol) was added and 
the mixture was stirred for 20 minutes. After that, the reaction was quenched with aqueous NH4Cl 
(2 mL) and extracted with ethyl acetate (3 × 5 mL). The organic layer was then washed with 
brine (2 mL), dried with anhydrous Na2SO4 and the solvent was removed under reduced pressure. 
The residue was dissolved in Et2O (5 mL) and this solution was exposed to air and light until a 
colorless solution with a green or brown precipitate resulted. Filtration through celite, 
concentration and purification of the crude product by column chromatography on silica gel 
(hexane/ethyl acetate 1:1), provided the pure product 4[2] (0.11 mmol, 18 mg) as a colorless oil in 
















1) Cat. 1 (10 mmol%), MeCN/H2O
    Cat. 2 (40 mmol%), RT, 72 h








(R)-1-phenylpropane-1,3-diol (4). 1H NMR (300 MHz, CDCl3): δ = 1.85-
2.04 (m, 2H), 2.88 (brs, 1H), 3.34 (brs, 1H), 3.81 (t, J = 5.4 Hz, 2H), 4.92 
(dd, J = 3.9, 8.4 Hz, 1H), 7.23-7.35 (m, 5H); 13C NMR (75 MHz, CDCl3): 
δ = 40.5, 61.5, 74.4, 125.6 (×2), 127.6, 128.5 (×2), 144.3; HPLC (Chiralcel AD-H, Hexane/i-
propanol (97:3), flow rate = 1.0 mL min-1, λ = 210 nm): tmajor = 35.0 min, tminor = 37.2 min. 
 
4. Optimization of the reaction time [a] 
 
Entry Time Yield (%)[b] ee (%)[c] 
1 6 10 93 
2 12 19 93 
3 24 33 93 
4 48 48 93 
5 72 60 93 
6 96 63 93 
[a] Each reaction was carried out with tricarbonyl (η6-benzaldehyde) chromium(0) (0.2 mmol)，
paraldehyde (1.0 mmol), H2O (0.1 mmol), 1 (10 mol%) and 2 (40 mol%) in 0.6 mL MeCN at room 
temperature. [b] Yields estimated by 1H NMR. [c] Determined by HPLC. 
 
5. General procedure for catalyst recycling 
Catalyst 1 (10 mol%, 0.02 mmol, 6.7 mg), catalyst 2 (40 mol%, 0.08 mmol, 170.4 mg) and 
tricarbonyl (η6-benzaldehyde) chromium (0) (0.2 mmol, 51.4 mg) were mixed in a brown vial 
with acetonitrile (0.6 mL). Then paraldehyde (137 µL, 5.0 eq., 1.0 mmol) and deionized water 
(1.8 µL, 0.1 mmol) were added and the brown vial was sealed and shaken at room temperature. 
After 72 h, the mixture was filtered and washed with acetonitrile (3 × 1 mL), the filtrate being 
treated as described above to isolate the desired compound. As for the mixed catalysts recovered, 
they were washed with acetic acid (0.5 mL) and acetonitrile (4 × 1 mL), repeating this procedure 
several times until the solvent was colorless. After that, the mixed catalysts were dried at 40 ºC 
under vacuum for 6 h and then used in the next reaction. 






1) Cat. 1 (10 mmol%), MeCN/H2O
    Cat. 2 (40 mmol%), RT











































Catalyst 2 (40 mol%, 0.12 mmol, 255.6 mg), catalyst 1 (10 mol%, 0.03 
mmol, 10.1 mg) and the tricarbonyl (η6-benzaldehyde) chromium (0) 
(0.3 mmol, 77 mg) were mixed in a brown vial with acetonitrile (0.9 mL). 
Then, paraldehyde (5.0 eq., 206 µL, 1.5 mmol) and deionized water (2.7 
µL, 0.15 mmol) were added and the brown vial was sealed and shaken at room temperature for 
72 hours. After that, the reaction mixture was filtered and washed with acetonitrile (3 × 1.2 mL) 
and AcOH (15% in THF, 3 × 1.2 mL). The filtrates were combined and crude product 5 was 
obtained after removal of the solvent under vacuum. Then, this was dissolved in Et2O (25 mL) 
and the resulting solution was exposed to air and light until a colorless solution with a green or 
brown precipitate resulted. Filtration through celite and concentration gave the crude product 6. 
 
Crude product 6 was dissolved in anhydrous THF (3 mL) and methylamine (33 wt% in EtOH, 
1.5 mmol, 140 mg) and anhydrous Na2SO4 (2.1 mmol, 0.3 g) were added. The mixture was stirred 
for 5 hours and then NaBH(OAc)3 (2.0 eq., 0.6 mmol, 127 mg) was added in portions. After 
stirring overnight, the solution was quenched with saturated aqueous sodium bicarbonate and 
extracted with ethyl acetate (3 × 8 mL). The organic layer was washed with brine (2 mL) and 
dried with anhydrous Na2SO4. Evaporation of the solvent under reduced pressure gave the crude 
mixture, which was purified by fast column chromatography on silica gel, with 
CH2Cl2/MeOH/NH4OH mixtures as eluent. In this manner, 20 mg of 7 (0.12 mmol, 35% overall 
yield for three steps) were obtained as a colorless oil with 95% ee (determined by chiral HPLC 
analysis of their N-acyl derivative according to a reported procedure[6]).  
1H NMR (300 MHz, CDCl3) δ = 1.72-1.96 (m, 2H), 2.45 (s, 3H), 2.81-2.95 (m, 2H), 4.03 (brs, 
2H), 4.93 (dd, J = 3.1, 8.7 Hz, 1H), 7.21-7.39 (m, 5H). 13C NMR (100 MHz, CDCl3) δ = 36.0, 
36.8, 50.4, 75.5, 125.6 (×2), 126.9, 128.2 (×2), 145.1. [α]D25 = +45.8 (c = 0.1, CHCl3). It is a 
known compound.[7] 
 
The crude 6 (see above) was dissolved in anhydrous THF (3 mL) and 
ethyl 4-phenylpiperidine-4-carboxylate (2.0 eq., 0.6 mmol, 140 mg) 
and anhydrous Na2SO4 (2.1 mmol, 0.3 g) were added. The mixture was 
stirred for 5 hours and then NaBH(OAc)3 (2.0 eq., 0.6 mmol, 127 mg) 
was added in portions. After stirring overnight, the solution was quenched with saturated aqueous 
sodium bicarbonate and extracted with ethyl acetate (3 × 8 mL). The organic layer was washed 
with brine (2 mL) and dried with anhydrous Na2SO4. Evaporation of the solvent under reduced 
pressure gave a residue which was purified by fast column chromatography on silica gel, with 
CH2Cl2/MeOH/NH4OH mixtures as eluent. In this manner, 40 mg of 8 (0.11 mmol, 36% overall 











1H NMR (300 MHz, CDCl3) δ = 1.17 (t, J = 7.1 Hz, 3H), 1.47-1.53 (m, 1H), 1.67-1.73 (m, 1H), 
1.80-1.88 (m, 1H), 1.97-2.08 (m, 2H), 2.34 (t, J = 11.7 Hz, 1H), 2.55-2.67 (m, 4H), 2.87-2.88 (m, 
1H), 3.10-3.13 (m, 1H), 4.09-4.16 (q, J = 7.1 Hz, 2H), 4.97 (dd, J = 2.7, 9.9 Hz, 1H), 7.20 - 7.40 
(m, 10H). 13C NMR (75 MHz, CDCl3) δ = 14.1, 31.7, 33.5, 34.1, 46.4, 49.0, 50.5, 57.6, 61.0, 74.7, 
125.7 (×2), 127.1 (×2), 127.2 (×2), 128.3 (×2), 128.6, 128.6 (×2), 144.9, 174.1. HPLC (Chiralcel 
IA, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 215 nm): tmajor = 20.4 min, tminor = 
17.0 min. HRMS calcd for C23H29NO3 (M + H)+: 368.2220, found: 368.2213. [α]D25 = +21.5 (c = 
0.1, CHCl3). IR (ATR): ν = 539, 698, 761, 858, 1022, 1106, 1177, 1214, 1447, 1496, 1601, 1721, 
2586, 2937 cm-1. 
 
7. Preparation of the acetylated compound 9[6] 
 
To a solution of 7 (0.20 mmol, 33 mg) in CH2Cl2 (3 mL) at 0 °C was added acetic anhydride (0.20 
mmol, 20 µL). The resulting reaction mixture was stirred vigorously at this temperature for 30 
min. After removal of the solvent, the crude product was purified by column chromatography on 
silica gel (eluting with CH2Cl2/MeOH, 10:1) to afford the desired N-acyl derivative 9 as a mixture 
of rotamers. 
 
(R)-N-(3-Hydroxy-3-phenylpropyl)-N-methylacetamide (9). 1H 
NMR (400 MHz, CDCl3): δ = 1.77-1.85 (m, 1H), 1.91-1.99 (m, 1H), 
2.07 (s, 0.7H), 2.09 (s, 2.2H), 2.90 (s, 0.7H), 3.00 (s, 2.3H), 3.07-3.13 
(m, 0.8H), 3.35-3.52 (m, 0.5H), 4.05-4.15 (m, 0.8H), 4.50-4.56 (m, 1.4H), 4.68 (t, J = 6.5 Hz, 
0.2H), 7.22-7.38 (m, 5H); 13C NMR (100 MHz, CDCl3): δ = 21.2, 21.6, 33.1, 36.3, 36.7, 37.3, 
44.5, 47.4, 69.9, 71.5, 125.6, 127.1, 127.9, 128.3, 128.7, 144.0, 170.7, 172.1; HPLC (Chiralcel 
OD-H, Hexane/i-propanol (90:10), flow rate = 1.0 mL min-1, λ = 222 nm): tmajor = 22.5 min, tminor 
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The discovery and design of organocatalysts with better efficiency, able to promote new 
transformations and reaching higher turnover numbers has attracted a lot of attention in 
organocatalysis. This thesis focuses on the synthesis of organocatalysts, especially 
polymer-supported ones and their application in various asymmetric transformations. 
 
Chapter II describes the development of a H-bond-directing aminocatalyst for the 
asymmetric [4+2] cycloaddition reactions of alkylidene pyrazolones with enals. The more 
hindered 4-hydroxy dinaphthylprolinol catalyst has been prepared and displayed higher 
reactivities and enantioselectivities in the [4+2] cycloadditions, affording the 
tetrahydropyranopyrazole derivatives containing three contiguous stereocenters with 
good results (up to 89% yield, 13:1 dr, and 99% ee). 
 
Chapter III summarizes a formal [4+2] cycloadditions of unsaturated heterocycles with 
in situ activated arylacetic acids catalyzed by a robust, immobilized isothiourea. This 
annulation strategy represents an efficient approach to access a series of six-membered 
heterocycles and spiro-heterocycles in high yields and very high enantioselectivities (32 
examples, 97% mean ee). In addition, recyclability of the immobilized isothiourea 
catalyst (11 cycles, accumulated TON of 76.8) and its application in continuous flow 
process (no decrease in yield or ee after 18 h) are also demonstrated. 
 
In order to explore new transformations by utilizing this immobilized isothiourea catalyst, 
Chapter IV investigates a periselective asymmetric [8+2] annulation reaction between 
chiral ammonium enolates (generated in situ from carboxylic acids) and azaheptafulvenes. 
The [8+2] annulation reactions proceeds smoothly catalyzed by the immobilized 
isothiourea, yielding the cycloheptatriene-fused pyrrolidone derivatives in high yields 
and excellent stereoselectivities (up to 85% yield, >20:1 dr, and 98% ee). Moreover, we 
have demonstrated the derivatization of the resulting [8+2] cycloadducts to give bridged-
polycyclic products via [4+2] cycloaddition, which represents an efficient stereoselective 
synthetic approach to polycyclic compounds. 
 
 
   
 
 275 
Finally, Chapter V focuses on the cascade deoligomerization/cross-aldol reactions of 
electron-poor benzaldehydes with paraldehyde promoted by a dual catalytic system (PS-
diarylprolinol catalyst and PS-sufonic acid catalyst). The dual catalytic system can be 
recycled ten times by simple filtration of the polymer mixture and mild acidic washing to 
recover full performance. To overcome the limitation of the deoligomerization/cross-
aldol reaction with benzaldehyde, we synthesized η6-benzaldehyde Cr(CO)3 as an 
alternative and successfully applied it in this cascade process. The application of the 
resulting diol product was proven by reductive amination reaction, affording the well-
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